[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "vicuna-7b_response": "Acrokeratosis paraneoplastica is a condition characterized by the development of thick, rough, and often discolored patches of skin on the fingers, toes, and sometimes the soles of the feet. These patches are caused by the body's immune system reacting to a cancerous or precancerous growth in the body.\nOne possible name synonym for Acrokeratosis paraneoplastica is \"hand-foot syndrome.\" This name is sometimes used to describe the condition when it is limited to the hands and feet, and does not involve other parts of the body.\nAnother possible name synonym for Acrokeratosis paraneoplastica is \"pachyonychia hystrix.\" This name refers to the thick, rough texture of the skin patches that are characteristic of the condition.\nIt's important to note that while these names may be used to describe similar conditions, they may not always be used interchangeably with Acrokeratosis paraneoplastica. It's always best to consult with a medical professional for a proper diagnosis and treatment plan.",
    "vicuna-7b_fact_raw": "1. Acrokeratosis paraneoplastica is characterized by thick, rough, and discolored patches of skin.\n2. The condition often affects the fingers, toes, and sometimes the soles of the feet.\n3. Acrokeratosis paraneoplastica is caused by the body's immune system reacting to a cancerous or precancerous growth.\n4. \"Hand-foot syndrome\" is a possible name synonym for Acrokeratosis paraneoplastica when it is limited to the hands and feet.\n5. \"Pachyonychia hystrix\" is another possible name synonym for Acrokeratosis paraneoplastica, referring to the thick, rough texture of the skin patches.",
    "vicuna-7b_fact": [
      "Acrokeratosis paraneoplastica is characterized by thick, rough, and discolored patches of skin.",
      "The condition often affects the fingers, toes, and sometimes the soles of the feet.",
      "Acrokeratosis paraneoplastica is caused by the body's immune system reacting to a cancerous or precancerous growth.",
      "\"Hand-foot syndrome\" is a possible name synonym for Acrokeratosis paraneoplastica when it is limited to the hands and feet.",
      "\"Pachyonychia hystrix\" is another possible name synonym for Acrokeratosis paraneoplastica, referring to the thick, rough texture of the skin patches."
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "vicuna-7b_response": "Weaver syndrome and Sotos syndrome are two distinct genetic disorders that have some similarities but also have distinct characteristics.\nWeaver syndrome, also known as Weaver-Wintle syndrome, is a rare genetic disorder that is characterized by a combination of physical and developmental abnormalities. The main features of Weaver syndrome include:\n* Short stature\n* Broad chest and wide-set shoulders\n* Wide nasal bridge\n* Low-set and posteriorly rotated ears\n* Abnormalities of the hands and feet, such as webbing between the fingers and toes\n* Delayed bone maturation\n* Intellectual disability\n* Speech and language delays\n* Behavioral and emotional problems\nSotos syndrome, also known as 22q11.2 deletion syndrome, is a genetic disorder caused by a deletion of a small piece of chromosome 22. The main features of Sotos syndrome include:\n* Macrocephaly (abnormally large head)\n* Short stature\n* Broad chest and wide-set shoulders\n* Wide nasal bridge\n* Low-set and posteriorly rotated ears\n* Abnormalities of the hands and feet, such as webbing between the fingers and toes\n* Delayed bone maturation\n* Intellectual disability\n* Speech and language delays\n* Behavioral and emotional problems\nWhile both Weaver syndrome and Sotos syndrome have some similar physical characteristics, such as broad chest and wide-set shoulders, low-set ears, and webbed fingers, they are distinct disorders with different genetic causes and a range of other symptoms. Weaver syndrome is caused by mutations in the SHROOM3 gene, while Sotos syndrome is caused by a deletion of a small piece of chromosome 22. Additionally, Weaver syndrome is associated with intellectual disability and behavioral and emotional problems, while Sotos syndrome is not typically associated with intellectual disability.\nIn summary, while Weaver syndrome and Sotos syndrome share some similar physical characteristics, they are distinct genetic disorders with different genetic causes and a range of other symptoms.",
    "vicuna-7b_fact_raw": "1. Weaver syndrome is characterized by a combination of physical and developmental abnormalities, including short stature and delayed bone maturation.\n2. Sotos syndrome is caused by a deletion of a small piece of chromosome 22.\n3. Both Weaver syndrome and Sotos syndrome share physical characteristics such as broad chest, wide-set shoulders, and webbed fingers.\n4. Weaver syndrome is caused by mutations in the SHROOM3 gene.\n5. Sotos syndrome is also known as 22q11.2 deletion syndrome.",
    "vicuna-7b_fact": [
      "Weaver syndrome is characterized by a combination of physical and developmental abnormalities, including short stature and delayed bone maturation.",
      "Sotos syndrome is caused by a deletion of a small piece of chromosome 22.",
      "Both Weaver syndrome and Sotos syndrome share physical characteristics such as broad chest, wide-set shoulders, and webbed fingers.",
      "Weaver syndrome is caused by mutations in the SHROOM3 gene.",
      "Sotos syndrome is also known as 22q11.2 deletion syndrome."
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "vicuna-7b_response": "The JASPAR database is a repository of protein-protein interaction data that is widely used in bioinformatics research. Here is a list of the releases of the JASPAR database:\n1. JASPAR 2019: This is the latest release of the JASPAR database, which was released in 2019. It includes 83 datasets of protein-protein interactions, covering a wide range of organisms and functional categories.\n2. JASPAR 2016: This release of the JASPAR database was released in 2016 and includes 74 datasets of protein-protein interactions.\n3. JASPAR 2014: This release of the JASPAR database was released in 2014 and includes 66 datasets of protein-protein interactions.\n4. JASPAR 2012: This release of the JASPAR database was released in 2012 and includes 60 datasets of protein-protein interactions.\n5. JASPAR 2010: This release of the JASPAR database was released in 2010 and includes 53 datasets of protein-protein interactions.\nIt's worth noting that the JASPAR database is updated regularly, and new releases are made available periodically. Researchers can access the latest version of the JASPAR database through the official website of the JASPAR consortium (<https://jaspar.genereg.net/>).",
    "vicuna-7b_fact_raw": "1. The JASPAR database had a release in 2019 known as JASPAR 2019.\n2. JASPAR 2016 is a release of the JASPAR database that includes 74 datasets of protein-protein interactions.\n3. The JASPAR 2014 release includes 66 datasets of protein-protein interactions.\n4. JASPAR 2012 was released with 60 datasets of protein-protein interactions.\n5. The JASPAR 2010 release contains 53 datasets of protein-protein interactions.",
    "vicuna-7b_fact": [
      "The JASPAR database had a release in 2019 known as JASPAR 2019.",
      "JASPAR 2016 is a release of the JASPAR database that includes 74 datasets of protein-protein interactions.",
      "The JASPAR 2014 release includes 66 datasets of protein-protein interactions.",
      "JASPAR 2012 was released with 60 datasets of protein-protein interactions.",
      "The JASPAR 2010 release contains 53 datasets of protein-protein interactions."
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "vicuna-7b_response": "The viral KP4 protein is a viral protein that plays a critical role in the replication of certain viruses. The KP4 protein is found in the Kobuvirus family of viruses, which includes the Kobuvirus genus of baculoviruses.\nThe KP4 protein is a small, non-structural protein that is produced during the replication of the virus. It is thought to play a role in the regulation of viral RNA synthesis and the translation of viral RNA into proteins.\nIn addition to its role in viral replication, the KP4 protein has also been shown to play a role in the immune response to viral infection. It has been shown to inhibit the activity of the interferon signaling pathway, which is a key component of the host's antiviral response.\nOverall, the function of the KP4 protein is to help the virus replicate and evade the host's immune response.",
    "vicuna-7b_fact_raw": "1. The KP4 protein plays a critical role in the replication of certain viruses.\n2. The KP4 protein is found in the Kobuvirus family of viruses.\n3. The KP4 protein is involved in the regulation of viral RNA synthesis.\n4. The KP4 protein plays a role in the translation of viral RNA into proteins.\n5. The KP4 protein has been shown to inhibit the activity of the interferon signaling pathway.",
    "vicuna-7b_fact": [
      "The KP4 protein plays a critical role in the replication of certain viruses.",
      "The KP4 protein is found in the Kobuvirus family of viruses.",
      "The KP4 protein is involved in the regulation of viral RNA synthesis.",
      "The KP4 protein plays a role in the translation of viral RNA into proteins.",
      "The KP4 protein has been shown to inhibit the activity of the interferon signaling pathway."
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "vicuna-7b_response": "DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog that has been used in experimental and clinical studies. It is structurally similar to L-thyronine, the natural form of thyroid hormone, but with an iodine atom replaced by a hydrogen atom and a methyl group.\nDITPA has been studied for its potential to treat a variety of thyroid-related conditions, including hyperthyroidism, hypothyroidism, and thyroid cancer. It has been shown to have a similar effect to L-thyronine in terms of increasing metabolic rate and body weight, but with a longer half-life and a lower risk of side effects.\nDITPA has also been studied for its potential to improve cognitive function and memory in individuals with hypothyroidism. Some studies have found that DITPA may be effective in improving cognitive function in individuals with hypothyroidism, although more research is needed to confirm these findings.\nIt is important to note that DITPA is not currently approved for use in the treatment of any thyroid-related condition. Further research is needed to fully understand the safety and efficacy of DITPA as a treatment for thyroid-related conditions.",
    "vicuna-7b_fact_raw": "1. DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog used in experimental and clinical studies.\n2. DITPA is structurally similar to L-thyronine, the natural form of thyroid hormone.\n3. DITPA has been studied for its potential to treat conditions such as hyperthyroidism, hypothyroidism, and thyroid cancer.\n4. DITPA has a longer half-life and a lower risk of side effects compared to L-thyronine.\n5. DITPA is not currently approved for use in the treatment of any thyroid-related condition.",
    "vicuna-7b_fact": [
      "DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog used in experimental and clinical studies.",
      "DITPA is structurally similar to L-thyronine, the natural form of thyroid hormone.",
      "DITPA has been studied for its potential to treat conditions such as hyperthyroidism, hypothyroidism, and thyroid cancer.",
      "DITPA has a longer half-life and a lower risk of side effects compared to L-thyronine.",
      "DITPA is not currently approved for use in the treatment of any thyroid-related condition."
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "vicuna-7b_response": "COUGER is a tool that stands for \"COmputer-based UGer Reasoning\". It is a software application that is used to analyze and evaluate the reasoning skills of individuals. COUGER is commonly used in the field of psychology and education to assess cognitive abilities such as problem-solving, critical thinking, and decision-making.\nThe COUGER tool typically consists of a series of tasks that are designed to test specific cognitive skills. These tasks may involve solving puzzles, completing logic problems, or making decisions based on certain criteria. The results of these tasks are then analyzed to determine an individual's strengths and weaknesses in terms of cognitive abilities.\nCOUGER is often used in academic settings to assess the cognitive abilities of students, as well as in professional settings to evaluate the cognitive abilities of job candidates. It is also used in research to study cognitive development and to identify factors that may influence cognitive abilities.\nOverall, COUGER is a valuable tool for assessing cognitive abilities and can provide valuable insights into an individual's reasoning skills.",
    "vicuna-7b_fact_raw": "1. COUGER stands for \"COmputer-based UGer Reasoning\".\n2. COUGER is a software application used to analyze and evaluate reasoning skills.\n3. The tool is commonly used in the fields of psychology and education.\n4. COUGER consists of tasks designed to test cognitive skills like problem-solving and critical thinking.\n5. It is used in academic settings to assess students' cognitive abilities and in professional settings to evaluate job candidates' cognitive skills.",
    "vicuna-7b_fact": [
      "COUGER stands for \"COmputer-based UGer Reasoning\".",
      "COUGER is a software application used to analyze and evaluate reasoning skills.",
      "The tool is commonly used in the fields of psychology and education.",
      "COUGER consists of tasks designed to test cognitive skills like problem-solving and critical thinking.",
      "It is used in academic settings to assess students' cognitive abilities and in professional settings to evaluate job candidates' cognitive skills."
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "vicuna-7b_response": "Yes, there are drugs available for the treatment of Tick-borne Encephalitis (TBE). TBE is a viral infection that is spread through the bite of infected ticks. The most common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.\nThe treatment for TBE typically involves supportive care, such as rest and fluids, to help manage symptoms. Antiviral medications, such as ribavirin and oseltamivir, may also be used to help reduce the severity of the illness and shorten the duration of symptoms.\nIt is important to note that the most effective treatment for TBE is prevention. To reduce the risk of TBE, it is recommended to avoid areas where ticks are prevalent, use insect repellent, and check yourself and your children for ticks after spending time outdoors. If you do become infected with TBE, it is important to seek medical attention promptly, as early treatment can help reduce the risk of serious complications.",
    "vicuna-7b_fact_raw": "1. Tick-borne Encephalitis (TBE) is a viral infection spread through the bite of infected ticks.\n2. Common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.\n3. Supportive care such as rest and fluids is used to help manage symptoms of TBE.\n4. Antiviral medications like ribavirin and oseltamivir may be used in the treatment of TBE.\n5. Prevention strategies for TBE include avoiding areas where ticks are prevalent, using insect repellent, and checking for ticks after outdoor activities.",
    "vicuna-7b_fact": [
      "Tick-borne Encephalitis (TBE) is a viral infection spread through the bite of infected ticks.",
      "Common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.",
      "Supportive care such as rest and fluids is used to help manage symptoms of TBE.",
      "Antiviral medications like ribavirin and oseltamivir may be used in the treatment of TBE.",
      "Prevention strategies for TBE include avoiding areas where ticks are prevalent, using insect repellent, and checking for ticks after outdoor activities."
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "vicuna-7b_response": "There are several genome browser databases that allow users to annotate DNA shape information. Some of the most popular ones include:\n1. Ensembl: Ensembl is a genome browser that provides a comprehensive view of genomic data, including annotations of DNA shape. Users can view and annotate DNA shape information using Ensembl's visualization tools.\n2. UCSC Genome Browser: The UCSC Genome Browser is another popular genome browser that allows users to view and annotate DNA shape information. Users can use the browser's annotation tools to add shape information to their genome of interest.\n3. GENCODE: GENCODE is a genome annotation project that provides a comprehensive set of annotations for the human genome, including DNA shape information. Users can view and annotate DNA shape information using GENCODE's visualization tools.\n4. Flybase: Flybase is a genome annotation database for the Drosophila genome, which provides a comprehensive set of annotations, including DNA shape information. Users can view and annotate DNA shape information using Flybase's visualization tools.\n5. Wormbase: Wormbase is a genome annotation database for the Caenorhabditis elegans genome, which provides a comprehensive set of annotations, including DNA shape information. Users can view and annotate DNA shape information using Wormbase's visualization tools.\nThese are just a few examples of genome browser databases that allow users to annotate DNA shape information. There are many other genome browser databases available, each with their own unique features and capabilities.",
    "vicuna-7b_fact_raw": "1. Ensembl is a genome browser that provides annotations of DNA shape.\n2. The UCSC Genome Browser allows users to view and annotate DNA shape information.\n3. GENCODE is a genome annotation project that includes DNA shape information for the human genome.\n4. Flybase provides a comprehensive set of annotations for the Drosophila genome, including DNA shape information.\n5. Wormbase is a genome annotation database for the Caenorhabditis elegans genome that includes DNA shape information.",
    "vicuna-7b_fact": [
      "Ensembl is a genome browser that provides annotations of DNA shape.",
      "The UCSC Genome Browser allows users to view and annotate DNA shape information.",
      "GENCODE is a genome annotation project that includes DNA shape information for the human genome.",
      "Flybase provides a comprehensive set of annotations for the Drosophila genome, including DNA shape information.",
      "Wormbase is a genome annotation database for the Caenorhabditis elegans genome that includes DNA shape information."
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "vicuna-7b_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Wolf-Hirschhorn syndrome: This is a genetic disorder that is caused by a deletion on chromosome 4, which includes the EZH2 gene. It is characterized by growth retardation, intellectual disability, and distinctive facial features.\n2. Dandy-Walker syndrome: This is a congenital brain malformation that is characterized by a cyst in the cerebellum and a large ventricle in the brain. Mutations in the EZH2 gene have been found to be associated with this condition.\n3. Microcephaly: Microcephaly is a condition characterized by a small head size and intellectual disability. Mutations in the EZH2 gene have been found to be associated with this condition.\n4. Renal cell carcinoma: EZH2 has been found to be overexpressed in some cases of renal cell carcinoma, a type of kidney cancer.\n5. Prostate cancer: EZH2 has been found to be overexpressed in some cases of prostate cancer.\nIt's important to note that these are just a few examples of the syndromes associated with mutations in the EZH2 gene, and that the specific symptoms and severity of the condition can vary depending on the specific mutation and the individual affected.",
    "vicuna-7b_fact_raw": "1. Wolf-Hirschhorn syndrome is associated with a deletion on chromosome 4 that includes the EZH2 gene.\n2. Mutations in the EZH2 gene have been found to be associated with Dandy-Walker syndrome.\n3. Mutations in the EZH2 gene have been found to be associated with microcephaly.\n4. EZH2 is overexpressed in some cases of renal cell carcinoma.\n5. EZH2 is overexpressed in some cases of prostate cancer.",
    "vicuna-7b_fact": [
      "Wolf-Hirschhorn syndrome is associated with a deletion on chromosome 4 that includes the EZH2 gene.",
      "Mutations in the EZH2 gene have been found to be associated with Dandy-Walker syndrome.",
      "Mutations in the EZH2 gene have been found to be associated with microcephaly.",
      "EZH2 is overexpressed in some cases of renal cell carcinoma.",
      "EZH2 is overexpressed in some cases of prostate cancer."
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "vicuna-7b_response": "Certainly! Here is a list of human proteins that are known to undergo a dimer-to-tetramer transition:\n1. Cytochrome c\n2. Cytochrome b\n3. Cytochrome c oxidase\n4. Hemoglobin\n5. Myoglobin\n6. Thioredoxin\n7. Glutaredoxin\n8. Peroxiredoxin\n9. Thioredoxin reductase\n10. Glutathione reductase\n11. NADH dehydrogenase\n12. NADPH oxidase\n13. Pyruvate dehydrogenase\n14. Phosphoglycerate kinase\n15. Pyruvate kinase\n16. Dihydrolipoyl succinyltransferase\n17. Dihydrolipoyl dehydrogenase\n18. Aldehyde dehydrogenase\n19. Glutamate dehydrogenase\n20. Succinyl-CoA synthetase\n21. Succinyl-CoA thiokinase\n22. Malate dehydrogenase\n23. Fructose-1,6-bisphosphatase\n24. Glyceraldehyde-3-phosphate dehydrogenase\n25. Pyruvate dehydrogenase complex\n26. Pyruvate dehydrogenase kinase\n27. Pyruvate dehydrogenase phosphatase\n28. Pyruvate dehydrogenase E1 alpha\n29. Pyruvate dehydrogenase E1 beta\n30. Pyruvate dehydrogenase E2 alpha\n31. Pyruvate dehydrogenase E2 beta\n32. Pyruvate dehydrogenase iron-sulfur protein\n33. Pyruvate dehydrogenase alpha subunit\n34. Pyruvate dehydrogenase beta subunit\n35. Pyruvate dehydrogenase zinc subunit\n36. Pyruvate dehydrogenase E3 alpha\n37. Pyruv",
    "vicuna-7b_fact_raw": "1. Cytochrome c is known to undergo a dimer-to-tetramer transition.\n2. Hemoglobin is a human protein that undergoes a dimer-to-tetramer transition.\n3. Myoglobin is subject to a dimer-to-tetramer transition.\n4. Thioredoxin can undergo a dimer-to-tetramer transition.\n5. Glutathione reductase is known to undergo a dimer-to-tetramer transition.",
    "vicuna-7b_fact": [
      "Cytochrome c is known to undergo a dimer-to-tetramer transition.",
      "Hemoglobin is a human protein that undergoes a dimer-to-tetramer transition.",
      "Myoglobin is subject to a dimer-to-tetramer transition.",
      "Thioredoxin can undergo a dimer-to-tetramer transition.",
      "Glutathione reductase is known to undergo a dimer-to-tetramer transition."
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "vicuna-7b_response": "Phospholamban (PLN) is an important protein that plays a role in regulating the contraction of muscles in the heart. PLN has been found to interact with a number of other proteins, including anti-apoptotic proteins. One such protein that has been found to interact with PLN and is also an anti-apoptotic protein is Bcl-2.\nBcl-2 is a well-known anti-apoptotic protein that plays a critical role in preventing cell death. It has been shown to interact with PLN and to play a role in regulating the contraction of muscles in the heart. In fact, Bcl-2 has been shown to protect heart muscle cells from damage and to improve cardiac function in animal models of heart disease.\nIn addition to its interaction with PLN, Bcl-2 has also been shown to interact with a number of other proteins that are involved in regulating cell death and survival. These interactions allow Bcl-2 to play a critical role in maintaining the health and function of cells in a variety of tissues and organs.\nOverall, the interaction between PLN and Bcl-2 highlights the complex network of interactions that are involved in regulating cell function and survival. Further research in this area may lead to the development of new therapies for a variety of diseases and conditions.",
    "vicuna-7b_fact_raw": "1. Phospholamban (PLN) plays a role in regulating the contraction of muscles in the heart.\n2. Bcl-2 is an anti-apoptotic protein that interacts with PLN.\n3. Bcl-2 plays a critical role in preventing cell death.\n4. Bcl-2 has been shown to protect heart muscle cells from damage and improve cardiac function in animal models of heart disease.\n5. Bcl-2 interacts with other proteins involved in regulating cell death and survival.",
    "vicuna-7b_fact": [
      "Phospholamban (PLN) plays a role in regulating the contraction of muscles in the heart.",
      "Bcl-2 is an anti-apoptotic protein that interacts with PLN.",
      "Bcl-2 plays a critical role in preventing cell death.",
      "Bcl-2 has been shown to protect heart muscle cells from damage and improve cardiac function in animal models of heart disease.",
      "Bcl-2 interacts with other proteins involved in regulating cell death and survival."
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "vicuna-7b_response": "Yes, there is evidence to suggest that vitamin D supplementation may help to reduce the incidence of falls in older people. Several clinical trials have investigated the effects of vitamin D supplementation on falls in older adults, with some studies finding that vitamin D supplementation may reduce the risk of falls.\nFor example, a meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a significant reduction in the risk of falls in older adults. The study, published in the Journal of Clinical Endocrinology and Metabolism, found that vitamin D supplementation was associated with a 19% reduction in the risk of falls.\nAnother study, published in the Journal of Bone and Mineral Research, found that vitamin D supplementation may also improve balance and reduce the risk of falls in older adults. The study found that vitamin D supplementation improved balance and reduced the risk of falls in older adults with vitamin D deficiency.\nIt is important to note that while vitamin D supplementation may have some benefits in reducing the risk of falls in older people, it is not a guarantee of preventing falls. Other factors, such as age, gender, and underlying health conditions, can also play a role in falls. It is always best to consult with a healthcare professional before starting any new supplement regimen.",
    "vicuna-7b_fact_raw": "1. Vitamin D supplementation may help to reduce the incidence of falls in older people according to several clinical trials.\n2. A meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a 19% reduction in the risk of falls in older adults.\n3. The meta-analysis mentioned was published in the Journal of Clinical Endocrinology and Metabolism.\n4. Another study published in the Journal of Bone and Mineral Research found that vitamin D supplementation improved balance in older adults with vitamin D deficiency.\n5. The same study indicated that vitamin D supplementation reduced the risk of falls in older adults with vitamin D deficiency.",
    "vicuna-7b_fact": [
      "Vitamin D supplementation may help to reduce the incidence of falls in older people according to several clinical trials.",
      "A meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a 19% reduction in the risk of falls in older adults.",
      "The meta-analysis mentioned was published in the Journal of Clinical Endocrinology and Metabolism.",
      "Another study published in the Journal of Bone and Mineral Research found that vitamin D supplementation improved balance in older adults with vitamin D deficiency.",
      "The same study indicated that vitamin D supplementation reduced the risk of falls in older adults with vitamin D deficiency."
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "vicuna-7b_response": "Yes, there is an association between JARID2 and miR-155 in Th17 cells.\nJARID2, which stands for JmjC domain-containing protein that regulates inflammatory disease, has been shown to play a role in the regulation of Th17 cells. JARID2 has been shown to negatively regulate the transcription of the miR-155 gene, which is a microRNA that has been shown to be involved in the regulation of Th17 cell differentiation and function.\nIn addition, miR-155 has been shown to negatively regulate the expression of JARID2 in Th17 cells. This suggests that the JARID2-miR-155 axis may play a role in the regulation of Th17 cell differentiation and function.\nOverall, the association between JARID2 and miR-155 in Th17 cells suggests that these two molecules may play a role in the regulation of Th17 cell differentiation and function. Further research is needed to fully understand the role of JARID2 and miR-155 in Th17 cells and their potential as therapeutic targets for inflammatory diseases.",
    "vicuna-7b_fact_raw": "1. JARID2 negatively regulates the transcription of the miR-155 gene.\n2. miR-155 is involved in the regulation of Th17 cell differentiation and function.\n3. miR-155 negatively regulates the expression of JARID2 in Th17 cells.\n4. The JARID2-miR-155 axis may play a role in the regulation of Th17 cell differentiation and function.\n5. JARID2 stands for JmjC domain-containing protein that regulates inflammatory disease.",
    "vicuna-7b_fact": [
      "JARID2 negatively regulates the transcription of the miR-155 gene.",
      "miR-155 is involved in the regulation of Th17 cell differentiation and function.",
      "miR-155 negatively regulates the expression of JARID2 in Th17 cells.",
      "The JARID2-miR-155 axis may play a role in the regulation of Th17 cell differentiation and function.",
      "JARID2 stands for JmjC domain-containing protein that regulates inflammatory disease."
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "vicuna-7b_response": "The human HOXD cluster contains 13 genes.",
    "vicuna-7b_fact_raw": "1. The human HOXD cluster contains 13 genes.",
    "vicuna-7b_fact": [
      "The human HOXD cluster contains 13 genes."
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "vicuna-7b_response": "Casein Kinase 1 (CK1) is a serine/threonine protein kinase that plays a role in various cellular processes, including cell division, mitosis, and the regulation of gene expression. Phosphorylation of specific residues on substrate proteins by CK1 is an important mechanism for its regulation and function. Here are some of the phosphorylation consensus motifs for CK1:\n1. S/T-X-X-X-R: This motif is found in many substrates of CK1 and is recognized by the CK1 catalytic subunit. The X's represent any amino acid, and R represents the phosphorylated serine or threonine residue.\n2. S/T-X-X-X-X-R: This motif is similar to the first one, but includes an additional phosphate group.\n3. S/T-X-X-X-X-X-R: This motif is also found in many substrates of CK1 and is recognized by the CK1 regulatory subunit. The X's represent any amino acid, and R represents the phosphorylated serine or threonine residue.\n4. S/T-X-X-X-X-X-X-R: This motif is similar to the third one, but includes an additional phosphate group.\nIt's important to note that these are not the only consensus motifs recognized by CK1, and different substrates may have different motifs recognized by the kinase. Additionally, the specific residues that are phosphorylated by CK1 can vary depending on the substrate and the cellular context in which CK1 is acting.",
    "vicuna-7b_fact_raw": "1. Casein Kinase 1 (CK1) is a serine/threonine protein kinase.\n2. CK1 plays a role in cell division, mitosis, and the regulation of gene expression.\n3. The phosphorylation consensus motif S/T-X-X-X-R is recognized by the CK1 catalytic subunit.\n4. The phosphorylation consensus motif S/T-X-X-X-X-X-R is recognized by the CK1 regulatory subunit.\n5. The specific residues phosphorylated by CK1 can vary depending on the substrate and the cellular context.",
    "vicuna-7b_fact": [
      "Casein Kinase 1 (CK1) is a serine/threonine protein kinase.",
      "CK1 plays a role in cell division, mitosis, and the regulation of gene expression.",
      "The phosphorylation consensus motif S/T-X-X-X-R is recognized by the CK1 catalytic subunit.",
      "The phosphorylation consensus motif S/T-X-X-X-X-X-R is recognized by the CK1 regulatory subunit.",
      "The specific residues phosphorylated by CK1 can vary depending on the substrate and the cellular context."
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "vicuna-7b_response": "The ASPH gene, also known as the GATase gene, encodes for the aspartate beta-hydroxylase enzyme. This enzyme is involved in the metabolism of l-aspartate, a non-essential amino acid, and is responsible for the first step in the metabolism of aspartate in the urea cycle.\nThere are two main isoforms of the ASPH enzyme, which are produced by alternative splicing of the ASPH gene:\n1. Aspartate beta-hydroxylase (E1) isoform: This isoform is responsible for the first step in the metabolism of aspartate, which is the conversion of l-aspartate to aspartate.\n2. Aspartate beta-hydroxylase (E2) isoform: This isoform is responsible for the conversion of aspartate to N-acetylaspartate.\nBoth of these isoforms are expressed in the liver, kidney, and brain, and are involved in the metabolism of l-aspartate. The E1 isoform is responsible for the majority of the aspartate metabolism in the body, while the E2 isoform is responsible for the conversion of aspartate to N-acetylaspartate, which is then further metabolized in the urea cycle.\nIt is important to note that there are other genes that are involved in the metabolism of aspartate, such as the GAD genes (glutamate decarboxylase) and the GLA genes (glutamate-oxaloacetate transaminase), which are also involved in the urea cycle.",
    "vicuna-7b_fact_raw": "1. The ASPH gene encodes for the aspartate beta-hydroxylase enzyme.\n2. The aspartate beta-hydroxylase enzyme is involved in the metabolism of l-aspartate.\n3. There are two main isoforms of the ASPH enzyme: Aspartate beta-hydroxylase (E1) isoform and Aspartate beta-hydroxylase (E2) isoform.\n4. The E1 isoform of the ASPH enzyme is responsible for the conversion of l-aspartate to aspartate.\n5. The E2 isoform of the ASPH enzyme is responsible for the conversion of aspartate to N-acetylaspartate.",
    "vicuna-7b_fact": [
      "The ASPH gene encodes for the aspartate beta-hydroxylase enzyme.",
      "The aspartate beta-hydroxylase enzyme is involved in the metabolism of l-aspartate.",
      "There are two main isoforms of the ASPH enzyme: Aspartate beta-hydroxylase (E1) isoform and Aspartate beta-hydroxylase (E2) isoform.",
      "The E1 isoform of the ASPH enzyme is responsible for the conversion of l-aspartate to aspartate.",
      "The E2 isoform of the ASPH enzyme is responsible for the conversion of aspartate to N-acetylaspartate."
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "vicuna-7b_response": "Empagliflozin was approved by the US Food and Drug Administration (FDA) in 2014 for the treatment of type 2 diabetes. It is marketed under the brand name Jardiance and is a medication that is used to lower blood sugar levels in people with the condition. Empagliflozin works by helping the body to release more insulin and by reducing the amount of glucose that is absorbed by the body from food. It is typically taken once daily and is often used in combination with other diabetes medications.",
    "vicuna-7b_fact_raw": "1. Empagliflozin was approved by the US Food and Drug Administration (FDA) in 2014.\n2. It is approved for the treatment of type 2 diabetes.\n3. Empagliflozin is marketed under the brand name Jardiance.\n4. The medication works by helping the body to release more insulin.\n5. It also reduces the amount of glucose absorbed by the body from food.",
    "vicuna-7b_fact": [
      "Empagliflozin was approved by the US Food and Drug Administration (FDA) in 2014.",
      "It is approved for the treatment of type 2 diabetes.",
      "Empagliflozin is marketed under the brand name Jardiance.",
      "The medication works by helping the body to release more insulin.",
      "It also reduces the amount of glucose absorbed by the body from food."
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "vicuna-7b_response": "Loss of the protein Lon1 in the plant Arabidopsis can result in various negative effects on plant growth and development. Lon1 is a member of the Lon family of proteases, which are enzymes that break down other proteins. In Arabidopsis, Lon1 has been shown to play a role in the degradation of certain proteins involved in stress responses, such as those involved in the heat shock response.\nWhen Lon1 is lost in Arabidopsis, the degradation of these proteins is impaired, leading to an accumulation of these proteins in the cell. This can result in the inhibition of stress responses, leading to increased sensitivity to environmental stressors such as heat, drought, and salt. Additionally, the accumulation of these proteins can also lead to the inhibition of other cellular processes, such as protein synthesis and metabolism, which can further impair plant growth and development.\nOverall, the loss of Lon1 in Arabidopsis can have a significant impact on plant growth and development, making it more susceptible to environmental stressors and impairing its overall health.",
    "vicuna-7b_fact_raw": "1. Lon1 is a member of the Lon family of proteases in the plant Arabidopsis.\n2. Lon1 is involved in the degradation of proteins related to stress responses in Arabidopsis.\n3. Loss of Lon1 in Arabidopsis leads to the accumulation of proteins involved in stress responses.\n4. The accumulation of these proteins due to the loss of Lon1 can inhibit stress responses in Arabidopsis.\n5. The loss of Lon1 in Arabidopsis can increase the plant's sensitivity to environmental stressors such as heat, drought, and salt.",
    "vicuna-7b_fact": [
      "Lon1 is a member of the Lon family of proteases in the plant Arabidopsis.",
      "Lon1 is involved in the degradation of proteins related to stress responses in Arabidopsis.",
      "Loss of Lon1 in Arabidopsis leads to the accumulation of proteins involved in stress responses.",
      "The accumulation of these proteins due to the loss of Lon1 can inhibit stress responses in Arabidopsis.",
      "The loss of Lon1 in Arabidopsis can increase the plant's sensitivity to environmental stressors such as heat, drought, and salt."
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "vicuna-7b_response": "Yes, a linker histone does exist in the yeast genome.\nLinker histones are a type of histone that plays a crucial role in the regulation of chromatin structure and gene expression. In the yeast genome, there are several types of linker histones, including H1, H5, and H7.\nH1 is the most abundant linker histone in eukaryotic cells, including yeast. It is responsible for maintaining the structure of chromatin and facilitating the interaction between DNA and other proteins. In yeast, H1 is encoded by the HOP1 gene and is essential for cell viability.\nH5 and H7 are less abundant linker histones in yeast, but they also play important roles in chromatin structure and gene expression. H5 is involved in the regulation of transcription and is required for proper development in yeast. H7 is involved in the regulation of DNA replication and is required for the proper segregation of chromosomes during cell division.\nOverall, linker histones are important components of the chromatin structure in yeast and play a crucial role in regulating gene expression.",
    "vicuna-7b_fact_raw": "1. Linker histones exist in the yeast genome.\n2. H1 is the most abundant linker histone in eukaryotic cells, including yeast.\n3. In yeast, the H1 linker histone is encoded by the HOP1 gene.\n4. H5 is a linker histone involved in the regulation of transcription in yeast.\n5. H7 is a linker histone involved in the regulation of DNA replication in yeast and is required for proper chromosome segregation during cell division.",
    "vicuna-7b_fact": [
      "Linker histones exist in the yeast genome.",
      "H1 is the most abundant linker histone in eukaryotic cells, including yeast.",
      "In yeast, the H1 linker histone is encoded by the HOP1 gene.",
      "H5 is a linker histone involved in the regulation of transcription in yeast.",
      "H7 is a linker histone involved in the regulation of DNA replication in yeast and is required for proper chromosome segregation during cell division."
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "vicuna-7b_response": "Yes, there is evidence that tomato juice may help lower cholesterol levels.\nResearch has shown that consuming tomato juice or tomato products, such as tomato sauce or ketchup, may help lower cholesterol levels due to the high levels of lycopene in them. Lycopene is an antioxidant that has been shown to help reduce inflammation in the body, which can contribute to lower cholesterol levels.\nAdditionally, tomato juice contains other nutrients that may also help lower cholesterol levels, such as potassium, vitamin C, and vitamin K. These nutrients work together to help keep the body's cholesterol levels in check.\nIt's important to note that while tomato juice may be beneficial in helping to lower cholesterol levels, it is not a substitute for medical treatment. If you have high cholesterol, it's important to work with your healthcare provider to develop a treatment plan that includes a healthy diet, regular exercise, and potentially medication.",
    "vicuna-7b_fact_raw": "1. Consuming tomato juice or tomato products may help lower cholesterol levels.\n2. Lycopene, found in high levels in tomatoes, is an antioxidant that can help reduce inflammation in the body.\n3. Lycopene has been shown to contribute to lower cholesterol levels.\n4. Tomato juice contains nutrients such as potassium, vitamin C, and vitamin K that may help lower cholesterol levels.\n5. Tomato juice is not a substitute for medical treatment for high cholesterol.",
    "vicuna-7b_fact": [
      "Consuming tomato juice or tomato products may help lower cholesterol levels.",
      "Lycopene, found in high levels in tomatoes, is an antioxidant that can help reduce inflammation in the body.",
      "Lycopene has been shown to contribute to lower cholesterol levels.",
      "Tomato juice contains nutrients such as potassium, vitamin C, and vitamin K that may help lower cholesterol levels.",
      "Tomato juice is not a substitute for medical treatment for high cholesterol."
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "vicuna-7b_response": "Hsp70 and Hsp110 are two types of heat shock proteins (HSPs) that play important roles in regulating mRNA stability.\nHsp70 is a highly conserved protein that functions as a chaperone, helping to fold and stabilize proteins. It also plays a role in regulating the stability of mRNAs by binding to unstable RNA molecules and preventing their degradation by RNA-degrading enzymes. In addition, Hsp70 can also help to stabilize mRNAs by promoting the formation of RNA-protein complexes.\nHsp110 is another type of HSP that is involved in the regulation of mRNA stability. It has been shown to bind to unstable RNA molecules and promote their degradation by RNA-degrading enzymes. Hsp110 can also interact with other proteins, such as RNA-binding proteins, to regulate the stability of mRNAs.\nOverall, Hsp70 and Hsp110 play important roles in regulating the stability of mRNAs by binding to unstable RNA molecules and promoting their degradation or stabilization, respectively. These proteins are important for maintaining the proper balance of gene expression and ensuring that mRNAs are degraded when they are no longer needed.",
    "vicuna-7b_fact_raw": "1. Hsp70 functions as a chaperone that helps fold and stabilize proteins.\n2. Hsp70 regulates mRNA stability by binding to unstable RNA molecules and preventing their degradation.\n3. Hsp70 can promote the formation of RNA-protein complexes to stabilize mRNAs.\n4. Hsp110 binds to unstable RNA molecules and promotes their degradation by RNA-degrading enzymes.\n5. Hsp110 can interact with RNA-binding proteins to regulate mRNA stability.",
    "vicuna-7b_fact": [
      "Hsp70 functions as a chaperone that helps fold and stabilize proteins.",
      "Hsp70 regulates mRNA stability by binding to unstable RNA molecules and preventing their degradation.",
      "Hsp70 can promote the formation of RNA-protein complexes to stabilize mRNAs.",
      "Hsp110 binds to unstable RNA molecules and promotes their degradation by RNA-degrading enzymes.",
      "Hsp110 can interact with RNA-binding proteins to regulate mRNA stability."
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "vicuna-7b_response": "Skeletal muscle contains several types of deiodinases, which are enzymes that convert inactive thyroid hormones into their active forms. The main types of deiodinases present in skeletal muscle are:\n1. Type 1 deiodinase (D1): This enzyme converts the inactive thyroid hormone, T4, into the active form, T3. D1 is primarily found in skeletal muscle, as well as in other tissues such as the liver and kidneys.\n2. Type 2 deiodinase (D2): This enzyme converts the inactive hormone, T4, into the active form, T3, but also has the ability to convert T3 into the inactive form, rT3. D2 is also found in skeletal muscle, as well as in other tissues such as the brain and heart.\n3. Type 3 deiodinase (D3): This enzyme converts T4 into the active form, T3, but also has the ability to convert T3 into the inactive form, rT3. D3 is primarily found in the brain and pituitary gland, but has also been found in skeletal muscle.\nIn summary, skeletal muscle contains Type 1, Type 2, and Type 3 deiodinases, which are responsible for converting inactive thyroid hormones into their active forms, allowing for proper regulation of metabolism and other physiological processes.",
    "vicuna-7b_fact_raw": "1. Type 1 deiodinase (D1) is present in skeletal muscle and converts the inactive thyroid hormone T4 into the active form T3.\n2. Type 1 deiodinase (D1) is also found in the liver and kidneys.\n3. Type 2 deiodinase (D2) is present in skeletal muscle and can convert T4 into T3 as well as T3 into the inactive form rT3.\n4. Type 2 deiodinase (D2) is also found in the brain and heart.\n5. Type 3 deiodinase (D3) is found in skeletal muscle and has the ability to convert T4 into T3 and T3 into rT3.",
    "vicuna-7b_fact": [
      "Type 1 deiodinase (D1) is present in skeletal muscle and converts the inactive thyroid hormone T4 into the active form T3.",
      "Type 1 deiodinase (D1) is also found in the liver and kidneys.",
      "Type 2 deiodinase (D2) is present in skeletal muscle and can convert T4 into T3 as well as T3 into the inactive form rT3.",
      "Type 2 deiodinase (D2) is also found in the brain and heart.",
      "Type 3 deiodinase (D3) is found in skeletal muscle and has the ability to convert T4 into T3 and T3 into rT3."
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "vicuna-7b_response": "Caspases are a family of enzymes that play a crucial role in the process of programmed cell death, also known as apoptosis. There are several inflammatory caspases that have been identified, including:\n1. Caspase-1: also known as interleukin-1β-converting enzyme (ICE), is activated in response to bacterial infections and plays a role in the inflammatory response.\n2. Caspase-4: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n3. Caspase-5: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n4. Caspase-6: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n5. Caspase-7: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n6. Caspase-8: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n7. Caspase-9: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n8. Caspase-11: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\nIt's important to note that this list is not exhaustive and there are other caspases that have been identified as inflammatory caspases. Additionally, the role of caspases in inflammation is complex and not fully understood, and further research is needed to fully understand the function of these proteins in the immune response.",
    "vicuna-7b_fact_raw": "1. Caspase-1 is also known as interleukin-1β-converting enzyme (ICE).\n2. Caspase-1 is activated in response to bacterial infections and plays a role in the inflammatory response.\n3. Caspase-4, Caspase-5, Caspase-6, Caspase-7, Caspase-8, Caspase-9, and Caspase-11 are activated in response to viral infections.\n4. Caspases play a crucial role in the process of programmed cell death, known as apoptosis.\n5. The role of caspases in inflammation is complex and not fully understood, indicating that further research is needed.",
    "vicuna-7b_fact": [
      "Caspase-1 is also known as interleukin-1β-converting enzyme (ICE).",
      "Caspase-1 is activated in response to bacterial infections and plays a role in the inflammatory response.",
      "Caspase-4, Caspase-5, Caspase-6, Caspase-7, Caspase-8, Caspase-9, and Caspase-11 are activated in response to viral infections.",
      "Caspases play a crucial role in the process of programmed cell death, known as apoptosis.",
      "The role of caspases in inflammation is complex and not fully understood, indicating that further research is needed."
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "vicuna-7b_response": "Yes, there is a link between the aurora B kinase and the polycomb protein ring1B.\nThe aurora B kinase is a serine/threonine kinase that plays a crucial role in the regulation of the mitotic process, including the formation of spindle poles, chromosome alignment, and the separation of sister chromatids. It is also involved in the regulation of cell division and the maintenance of genomic stability.\nThe polycomb protein ring1B is a member of the polycomb group (PcG) of proteins, which are involved in the regulation of gene expression through the repression of genes involved in cell growth and differentiation. Ring1B is a histone methyltransferase that adds methyl groups to histone H3 at lysine 27 (H3K27me1), which is a mark that is associated with the repression of gene expression.\nRecent studies have shown that the aurora B kinase and ring1B are interacting partners and that the activity of aurora B kinase is required for the proper localization and function of ring1B. Specifically, it has been shown that the interaction between aurora B kinase and ring1B is important for the maintenance of genomic stability and the regulation of cell division.\nIn summary, the aurora B kinase and the polycomb protein ring1B are interacting partners and their activities are interconnected. The regulation of the mitotic process by aurora B kinase is important for the proper localization and function of ring1B, which is involved in the regulation of gene expression through the repression of genes involved in cell growth and differentiation.",
    "vicuna-7b_fact_raw": "1. Aurora B kinase is a serine/threonine kinase that is involved in the regulation of the mitotic process.\n2. Aurora B kinase plays a role in the formation of spindle poles, chromosome alignment, and the separation of sister chromatids.\n3. The polycomb protein ring1B is a histone methyltransferase that adds methyl groups to histone H3 at lysine 27 (H3K27me1).\n4. Recent studies have indicated that aurora B kinase and ring1B are interacting partners.\n5. The interaction between aurora B kinase and ring1B is important for the maintenance of genomic stability and the regulation of cell division.",
    "vicuna-7b_fact": [
      "Aurora B kinase is a serine/threonine kinase that is involved in the regulation of the mitotic process.",
      "Aurora B kinase plays a role in the formation of spindle poles, chromosome alignment, and the separation of sister chromatids.",
      "The polycomb protein ring1B is a histone methyltransferase that adds methyl groups to histone H3 at lysine 27 (H3K27me1).",
      "Recent studies have indicated that aurora B kinase and ring1B are interacting partners.",
      "The interaction between aurora B kinase and ring1B is important for the maintenance of genomic stability and the regulation of cell division."
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "vicuna-7b_response": "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are the \"splice consensus sequences\" which are composed of specific nucleotides that are recognized by the spliceosome, the complex of proteins that catalyzes the splicing of RNA.\nThe splice consensus sequences at the donor site are:\n* 5'GT-AG-3' (guanine and thymine followed by adenine and guanine)\n* 5'AGT-3' (adenine, guanine, and thymine followed by adenine and guanine)\n* 5'GGT-3' (guanine, thymine, and cytosine followed by adenine and guanine)\n* 5'GGT-AG-3' (guanine, thymine, and cytosine followed by adenine and guanine)\nThe splice consensus sequences at the acceptor site are:\n* 3'CTG-5' (cytosine, thymine, and guanine followed by adenine and cytosine)\n* 3'CGG-5' (cytosine, guanine, and thymine followed by adenine and cytosine)\n* 3'CGG-CTG-5' (cytosine, guanine, and thymine followed by adenine and cytosine, followed by guanine and thymine)\n* 3'CGG-CGG-5' (cytosine, guanine, and thymine followed by adenine and cytosine, followed by guanine and thymine)\nIt's important to note that these are the most frequent motifs, but not all of them are present in all species and some can be modified by the presence of other nucleotides.\nIt's also important to note that the splice consensus sequences are not absolute and can be modified by the presence of other nucleotides, and that the specific sequence motifs recognized by the spliceosome can vary between different species.",
    "vicuna-7b_fact_raw": "1. The most frequent non-canonical sequence motifs at the donor splice site in vertebrates include 5'GT-AG-3', 5'AGT-3', 5'GGT-3', and 5'GGT-AG-3'.\n2. The most frequent non-canonical sequence motifs at the acceptor splice site in vertebrates include 3'CTG-5', 3'CGG-5', 3'CGG-CTG-5', and 3'CGG-CGG-5'.\n3. The splice consensus sequences are recognized by the spliceosome, which catalyzes the splicing of RNA.\n4. The specific sequence motifs recognized by the spliceosome can vary between different species.\n5. The splice consensus sequences are not absolute and can be modified by the presence of other nucleotides.",
    "vicuna-7b_fact": [
      "The most frequent non-canonical sequence motifs at the donor splice site in vertebrates include 5'GT-AG-3', 5'AGT-3', 5'GGT-3', and 5'GGT-AG-3'.",
      "The most frequent non-canonical sequence motifs at the acceptor splice site in vertebrates include 3'CTG-5', 3'CGG-5', 3'CGG-CTG-5', and 3'CGG-CGG-5'.",
      "The splice consensus sequences are recognized by the spliceosome, which catalyzes the splicing of RNA.",
      "The specific sequence motifs recognized by the spliceosome can vary between different species.",
      "The splice consensus sequences are not absolute and can be modified by the presence of other nucleotides."
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "vicuna-7b_response": "The event that results in the acetylation of S6K1 is the interaction between S6K1 and p300/CBP coactivators.\nS6K1 is a serine/threonine kinase that plays a crucial role in regulating cell growth and metabolism. It is activated by the phosphorylation of its T-loop by AKT, which is activated by PI3K signaling. However, S6K1 activity can also be regulated by post-translational modifications, such as acetylation.\nThe interaction between S6K1 and p300/CBP coactivators is a key event in the regulation of S6K1 activity. p300/CBP are transcriptional coactivators that play a role in the regulation of gene expression. They interact with S6K1 and acetylate its lysine residues, leading to the inhibition of its kinase activity and the repression of its target genes.\nIn summary, the acetylation of S6K1 is regulated by the interaction between S6K1 and p300/CBP coactivators, which leads to the inhibition of its kinase activity and the repression of its target genes.",
    "vicuna-7b_fact_raw": "1. The acetylation of S6K1 is a result of its interaction with p300/CBP coactivators.\n2. S6K1 is a serine/threonine kinase involved in regulating cell growth and metabolism.\n3. S6K1 is activated by the phosphorylation of its T-loop by AKT.\n4. AKT activation is a consequence of PI3K signaling.\n5. p300/CBP are transcriptional coactivators that acetylate lysine residues of S6K1, leading to inhibition of its kinase activity.",
    "vicuna-7b_fact": [
      "The acetylation of S6K1 is a result of its interaction with p300/CBP coactivators.",
      "S6K1 is a serine/threonine kinase involved in regulating cell growth and metabolism.",
      "S6K1 is activated by the phosphorylation of its T-loop by AKT.",
      "AKT activation is a consequence of PI3K signaling.",
      "p300/CBP are transcriptional coactivators that acetylate lysine residues of S6K1, leading to inhibition of its kinase activity."
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "vicuna-7b_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder that is caused by a mutation in the CACNA1A gene. This gene provides instructions for making a protein called the alpha-1A subunit of the voltage-gated calcium channel, which is responsible for regulating the flow of calcium ions into cells.\nThe mutation in the CACNA1A gene that causes EA6 results in a loss of function of the alpha-1A subunit, which leads to an imbalance of calcium ions in the cells of the nervous system. This imbalance can cause a variety of symptoms, including episodic ataxia, which is characterized by sudden, recurrent episodes of poor coordination and balance.\nOther symptoms of EA6 can include vertigo, dizziness, nausea, and difficulty speaking. The severity of the symptoms can vary widely among individuals, and some people with EA6 may experience only a few episodes of ataxia throughout their lives, while others may have frequent and severe episodes.\nEpisodic ataxia type 6 is inherited in an autosomal dominant pattern, which means that a person only needs one copy of the mutated gene to develop the disorder. However, it is estimated that only about 50% of individuals with a mutation in the CACNA1A gene will develop symptoms of EA6.\nThere is currently no cure for EA6, but treatment options may include medications to help manage symptoms and prevent episodes, as well as lifestyle modifications such as avoiding triggers that can bring on episodes.",
    "vicuna-7b_fact_raw": "1. Episodic ataxia type 6 (EA6) is caused by a mutation in the CACNA1A gene.\n2. The CACNA1A gene is responsible for making the alpha-1A subunit of the voltage-gated calcium channel.\n3. A mutation in the CACNA1A gene leads to a loss of function of the alpha-1A subunit.\n4. The loss of function of the alpha-1A subunit causes an imbalance of calcium ions in the cells of the nervous system.\n5. Episodic ataxia type 6 is inherited in an autosomal dominant pattern.",
    "vicuna-7b_fact": [
      "Episodic ataxia type 6 (EA6) is caused by a mutation in the CACNA1A gene.",
      "The CACNA1A gene is responsible for making the alpha-1A subunit of the voltage-gated calcium channel.",
      "A mutation in the CACNA1A gene leads to a loss of function of the alpha-1A subunit.",
      "The loss of function of the alpha-1A subunit causes an imbalance of calcium ions in the cells of the nervous system.",
      "Episodic ataxia type 6 is inherited in an autosomal dominant pattern."
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "vicuna-7b_response": "Chromomethylases are enzymes that add a methyl group to a DNA base, resulting in the formation of a methylated base. These enzymes are commonly found in bacteria and plants, but they are not present in animal genomes.\nIn animals, the methylation of DNA bases is primarily carried out by DNA methyltransferases (DNMTs). DNMTs add a methyl group to cytosine residues in the DNA, resulting in the formation of 5-methylcytosine. This process is important for regulating gene expression and maintaining the stability of the genome.\nWhile chromomethylases are not present in animal genomes, they have been found in some viruses, such as bacteriophages and retroviruses. These viruses use chromomethylases to add methyl groups to the DNA of their host cells, allowing them to establish long-term infections and evade the host's immune system.\nIn summary, chromomethylases are not present in animal genomes, but they have been found in some viruses. In animals, the methylation of DNA bases is primarily carried out by DNA methyltransferases (DNMTs).",
    "vicuna-7b_fact_raw": "1. Chromomethylases are enzymes that add a methyl group to a DNA base.\n2. Chromomethylases are commonly found in bacteria and plants.\n3. Chromomethylases are not present in animal genomes.\n4. DNA methyltransferases (DNMTs) are responsible for the methylation of DNA bases in animals.\n5. Some viruses, including bacteriophages and retroviruses, have been found to contain chromomethylases.",
    "vicuna-7b_fact": [
      "Chromomethylases are enzymes that add a methyl group to a DNA base.",
      "Chromomethylases are commonly found in bacteria and plants.",
      "Chromomethylases are not present in animal genomes.",
      "DNA methyltransferases (DNMTs) are responsible for the methylation of DNA bases in animals.",
      "Some viruses, including bacteriophages and retroviruses, have been found to contain chromomethylases."
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "vicuna-7b_response": "There are several packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis. Here are some of the most popular ones:\n1. ChIPS: This package provides tools for ChIP-seq data analysis, including the identification of TFBSs.\n2. DRIMMER: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n3. MEME: This package is used for the discovery of motifs in DNA sequences, including TFBSs.\n4. PITA: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n5. TESS: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n6. TRANSFAC: This package provides a database of TFBSs and can be used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n7. MotifSampler: This package is used for the discovery of motifs in DNA sequences, including TFBSs.\nThese are just a few examples of the many packages available for TFBS analysis in R/Bioconductor. The choice of package will depend on the specific needs of the analysis and the type of data available.",
    "vicuna-7b_fact_raw": "1. ChIPS is a package in R/Bioconductor for ChIP-seq data analysis and identification of transcription factor binding sites.\n2. DRIMMER is a package in R/Bioconductor used for identifying transcription factor binding sites from ChIP-seq or ChIP-chip data.\n3. MEME is a package in R/Bioconductor used for discovering motifs in DNA sequences, including transcription factor binding sites.\n4. TRANSFAC is a package in R/Bioconductor that provides a database of transcription factor binding sites.\n5. MotifSampler is a package in R/Bioconductor used for the discovery of motifs in DNA sequences, including transcription factor binding sites.",
    "vicuna-7b_fact": [
      "ChIPS is a package in R/Bioconductor for ChIP-seq data analysis and identification of transcription factor binding sites.",
      "DRIMMER is a package in R/Bioconductor used for identifying transcription factor binding sites from ChIP-seq or ChIP-chip data.",
      "MEME is a package in R/Bioconductor used for discovering motifs in DNA sequences, including transcription factor binding sites.",
      "TRANSFAC is a package in R/Bioconductor that provides a database of transcription factor binding sites.",
      "MotifSampler is a package in R/Bioconductor used for the discovery of motifs in DNA sequences, including transcription factor binding sites."
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "vicuna-7b_response": "Certainly! Here is a list of clinical trials for the prevention of sarcopenia:\n1. Sarcopenia Prevention with Resistance Training (SPRT) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.\n2. Sarcopenia Prevention with Resistance Exercise (SPRE) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of resistance exercise in preventing sarcopenia in older adults.\n3. Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance exercise in preventing sarcopenia in older adults.\n4. Sarcopenia Prevention with Progressive Resistance Training (SPRT) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance training in preventing sarcopenia in older adults.\n5. Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance exercise and nutrition intervention in preventing sarcopenia in older adults.\n6. Sarcopenia Prevention with Progressive Resistance Training and Nutrition Intervention (SPRTNI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance training and nutrition intervention in preventing sarcopenia in older adults.\n7. Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance exercise and nutrition intervention in preventing sarcopenia in older adults.\n8. Sarcopenia Prevention with Progressive Resistance Training and Nutrition Intervention (SPRTNI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of",
    "vicuna-7b_fact_raw": "1. The Sarcopenia Prevention with Resistance Training (SPRT) Trial is a randomized controlled trial.\n2. The SPRT Trial aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.\n3. The Sarcopenia Prevention with Resistance Exercise (SPRE) Trial is a randomized controlled trial.\n4. The Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial is a randomized controlled trial.\n5. The Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial is a randomized controlled trial.",
    "vicuna-7b_fact": [
      "The Sarcopenia Prevention with Resistance Training (SPRT) Trial is a randomized controlled trial.",
      "The SPRT Trial aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.",
      "The Sarcopenia Prevention with Resistance Exercise (SPRE) Trial is a randomized controlled trial.",
      "The Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial is a randomized controlled trial.",
      "The Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial is a randomized controlled trial."
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "vicuna-7b_response": "There are several databases that focus on molecular recognition features in membrane proteins. Here are a few examples:\n1. The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins. It includes information on molecular recognition features such as ligand binding sites, ion channels, and transporters.\n2. The Membrane Protein Structure Prediction (MPSP) database is a database that contains information on the structure prediction of membrane proteins. It includes information on the methods used to predict the structure of membrane proteins, as well as information on the molecular recognition features that were predicted.\n3. The Membrane Protein Classification (MPC) database is a database that contains information on the classification of membrane proteins. It includes information on the molecular recognition features of membrane proteins, such as their function and the types of molecules they interact with.\n4. The Membrane Protein Structure Annotation (MPSA) database is a database that contains information on the annotation of membrane protein structures. It includes information on the molecular recognition features of membrane proteins, such as their function and the types of molecules they interact with.\nThese are just a few examples of databases that focus on molecular recognition features in membrane proteins. There are many other databases that may also be relevant, depending on the specific research question or interest.",
    "vicuna-7b_fact_raw": "1. The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins.\n2. The MPDB includes information on molecular recognition features such as ligand binding sites, ion channels, and transporters.\n3. The Membrane Protein Structure Prediction (MPSP) database contains information on the structure prediction of membrane proteins.\n4. The Membrane Protein Classification (MPC) database contains information on the classification of membrane proteins.\n5. The Membrane Protein Structure Annotation (MPSA) database contains information on the annotation of membrane protein structures.",
    "vicuna-7b_fact": [
      "The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins.",
      "The MPDB includes information on molecular recognition features such as ligand binding sites, ion channels, and transporters.",
      "The Membrane Protein Structure Prediction (MPSP) database contains information on the structure prediction of membrane proteins.",
      "The Membrane Protein Classification (MPC) database contains information on the classification of membrane proteins.",
      "The Membrane Protein Structure Annotation (MPSA) database contains information on the annotation of membrane protein structures."
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "vicuna-7b_response": "Yes, rivaroxaban is metabolized in the kidneys. It is a medication that is primarily metabolized by the liver, but a small portion of the drug is also metabolized by the kidneys. The kidneys play an important role in the elimination of rivaroxaban from the body.\nRivaroxaban is a direct factor Xa inhibitor that is used to prevent blood clots from forming in the body. It is commonly used to prevent blood clots from forming in people who have atrial fibrillation, a type of irregular heartbeat that increases the risk of blood clots.\nThe medication is taken orally and is typically taken once daily. It is important to note that the kidneys play a role in the elimination of rivaroxaban from the body, so kidney function should be considered when prescribing the medication.\nIn summary, rivaroxaban is metabolized in the kidneys, and the kidneys play an important role in the elimination of the drug from the body.",
    "vicuna-7b_fact_raw": "1. Rivaroxaban is metabolized by the kidneys.\n2. The liver is the primary organ responsible for the metabolism of rivaroxaban.\n3. Rivaroxaban is a direct factor Xa inhibitor.\n4. Rivaroxaban is used to prevent blood clots in people with atrial fibrillation.\n5. Rivaroxaban is taken orally, typically once daily.",
    "vicuna-7b_fact": [
      "Rivaroxaban is metabolized by the kidneys.",
      "The liver is the primary organ responsible for the metabolism of rivaroxaban.",
      "Rivaroxaban is a direct factor Xa inhibitor.",
      "Rivaroxaban is used to prevent blood clots in people with atrial fibrillation.",
      "Rivaroxaban is taken orally, typically once daily."
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "vicuna-7b_response": "TRalpha2 is a transcription factor that plays a crucial role in the regulation of gene expression in various tissues, including the heart. TRalpha2 is a member of the thyroid hormone receptor (TR) family, which is a group of nuclear receptors that regulate the expression of genes involved in metabolism, development, and other processes.\nIn the heart, TRalpha2 has been shown to play a role in the regulation of gene expression related to cardiac function and development. Studies have shown that TRalpha2 is expressed in the heart and regulates the expression of genes involved in cardiac growth and development, as well as the regulation of contractility and electrical activity of the heart.\nSome of the genes that have been shown to be regulated by TRalpha2 in the heart include:\n* Myh7: Myosin heavy chain 7 (Myh7) is a gene that encodes for a protein that is involved in the development and function of skeletal muscle, including the heart. TRalpha2 has been shown to regulate the expression of Myh7 in the heart.\n* Nkx2.5: Nkx2.5 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Nkx2.5 in the heart.\n* Tbx20: Tbx20 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Tbx20 in the heart.\n* Gata4: Gata4 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Gata4 in the heart.\n* Mef2c: Mef2c is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Mef2c in the heart.\nThese are just a few examples of the genes that have been shown to be regulated by TRalpha2 in the heart. TRalpha2 plays a crucial role",
    "vicuna-7b_fact_raw": "1. TRalpha2 is a transcription factor that regulates gene expression in various tissues, including the heart.\n2. TRalpha2 is a member of the thyroid hormone receptor (TR) family.\n3. TRalpha2 regulates the expression of the Myh7 gene in the heart.\n4. TRalpha2 regulates the expression of the Nkx2.5 gene in the heart.\n5. TRalpha2 regulates the expression of the Tbx20 gene in the heart.",
    "vicuna-7b_fact": [
      "TRalpha2 is a transcription factor that regulates gene expression in various tissues, including the heart.",
      "TRalpha2 is a member of the thyroid hormone receptor (TR) family.",
      "TRalpha2 regulates the expression of the Myh7 gene in the heart.",
      "TRalpha2 regulates the expression of the Nkx2.5 gene in the heart.",
      "TRalpha2 regulates the expression of the Tbx20 gene in the heart."
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "vicuna-7b_response": "There are several biomedical question answering systems available, including:\n1. BioASQ: A system developed by the European Bioinformatics Institute (EMBL-EBI) that uses machine learning algorithms to answer biomedical questions.\n2. CRAFT: A system developed by the National Center for Biomedical Ontology (NCBO) that uses natural language processing techniques to extract information from unstructured text.\n3. Biocreative: A system developed by the National Institutes of Health (NIH) that uses machine learning algorithms to generate hypotheses for biomedical questions.\n4. Biomedical Text Mining (BioTM): A system developed by the University of Manchester that uses natural language processing techniques to extract information from unstructured text.\n5. MIMIC-III: A system developed by the Broad Institute of MIT and Harvard that uses machine learning algorithms to extract information from electronic health records (EHRs).\nThese are just a few examples of the many biomedical question answering systems available.",
    "vicuna-7b_fact_raw": "1. BioASQ is a biomedical question answering system developed by the European Bioinformatics Institute (EMBL-EBI).\n2. CRAFT is a biomedical question answering system developed by the National Center for Biomedical Ontology (NCBO).\n3. Biocreative is a biomedical question answering system developed by the National Institutes of Health (NIH).\n4. Biomedical Text Mining (BioTM) is a system developed by the University of Manchester.\n5. MIMIC-III is a biomedical question answering system developed by the Broad Institute of MIT and Harvard.",
    "vicuna-7b_fact": [
      "BioASQ is a biomedical question answering system developed by the European Bioinformatics Institute (EMBL-EBI).",
      "CRAFT is a biomedical question answering system developed by the National Center for Biomedical Ontology (NCBO).",
      "Biocreative is a biomedical question answering system developed by the National Institutes of Health (NIH).",
      "Biomedical Text Mining (BioTM) is a system developed by the University of Manchester.",
      "MIMIC-III is a biomedical question answering system developed by the Broad Institute of MIT and Harvard."
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "vicuna-7b_response": "The transcription factor that activates the betalain pathway is known as the Beta-carotene-15,15'-oxygenase (BCO) transcription factor. BCO is a transcription factor that is responsible for activating the genes involved in the betalain pathway, which is responsible for the synthesis of betalains in plants.\nThe betalain pathway is a complex pathway that involves several enzymes and genes. The BCO transcription factor is responsible for activating the genes involved in the pathway, which are located on the long arm of chromosome 4 in the genome of Solanum tuberosum, the species that is commonly used as a source of potatoes.\nThe BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family, which is a family of transcription factors that play important roles in the regulation of gene expression in plants. The BCO transcription factor is a key regulator of the betalain pathway, and its activity is required for the synthesis of betalains in plants.\nIn summary, the BCO transcription factor is the transcription factor that activates the betalain pathway in plants. The BCO transcription factor is a key regulator of the betalain pathway, and its activity is required for the synthesis of betalains in plants.",
    "vicuna-7b_fact_raw": "1. The Beta-carotene-15,15'-oxygenase (BCO) transcription factor activates the betalain pathway.\n2. The BCO transcription factor is responsible for activating genes involved in the synthesis of betalains in plants.\n3. Genes involved in the betalain pathway are located on the long arm of chromosome 4 in the genome of Solanum tuberosum.\n4. The BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family.\n5. The activity of the BCO transcription factor is required for the synthesis of betalains in plants.",
    "vicuna-7b_fact": [
      "The Beta-carotene-15,15'-oxygenase (BCO) transcription factor activates the betalain pathway.",
      "The BCO transcription factor is responsible for activating genes involved in the synthesis of betalains in plants.",
      "Genes involved in the betalain pathway are located on the long arm of chromosome 4 in the genome of Solanum tuberosum.",
      "The BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family.",
      "The activity of the BCO transcription factor is required for the synthesis of betalains in plants."
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "vicuna-7b_response": "There are several technologies that are commonly used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses. Some of the preferred technologies include:\n1. Ion exchange chromatography (IEX): IEX is a common technique used for the enrichment of phosphorylated peptides. It works by using an ion exchange resin to bind to phosphorylated peptides, while other peptides and proteins pass through the column.\n2. TiO2 beads: TiO2 beads are another commonly used technique for the enrichment of phosphorylated peptides. They work by using a combination of size exclusion and ion exchange chromatography to separate phosphorylated peptides from other peptides and proteins.\n3. Phosphopeptide enrichment columns: These columns are specifically designed to enrich for phosphorylated peptides. They work by using a combination of chemical and physical methods to bind to phosphorylated peptides, while other peptides and proteins pass through the column.\n4. Phospho-specific antibodies: Phospho-specific antibodies can also be used for the enrichment of phosphorylated peptides. These antibodies bind specifically to phosphorylated peptides, allowing for their enrichment from other peptides and proteins.\nOverall, the choice of technology for the enrichment of phosphorylated peptides will depend on the specific requirements of the experiment, such as the sensitivity and specificity of the enrichment, as well as the cost and time requirements.",
    "vicuna-7b_fact_raw": "1. Ion exchange chromatography is used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses.\n2. TiO2 beads are used for the enrichment of phosphorylated peptides and involve a combination of size exclusion and ion exchange chromatography.\n3. Phosphopeptide enrichment columns are designed specifically to enrich for phosphorylated peptides using chemical and physical methods.\n4. Phospho-specific antibodies are used to specifically bind and enrich phosphorylated peptides from other peptides and proteins.",
    "vicuna-7b_fact": [
      "Ion exchange chromatography is used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses.",
      "TiO2 beads are used for the enrichment of phosphorylated peptides and involve a combination of size exclusion and ion exchange chromatography.",
      "Phosphopeptide enrichment columns are designed specifically to enrich for phosphorylated peptides using chemical and physical methods.",
      "Phospho-specific antibodies are used to specifically bind and enrich phosphorylated peptides from other peptides and proteins."
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "vicuna-7b_response": "The Palmini classification is a system used to rate the severity of various medical conditions. It is not a specific disorder, but rather a way of categorizing and comparing the severity of different conditions. The Palmini classification is typically used in the field of neurology to assess the severity of conditions such as stroke, traumatic brain injury, and other neurological disorders.\nThe Palmini classification is based on the degree of motor and sensory impairment, as well as the presence of other symptoms such as language and cognitive impairment. The classification is divided into five levels, ranging from level 1 (mild impairment) to level 5 (severe impairment).\nIt is important to note that the Palmini classification is not a diagnostic tool and should not be used to diagnose a specific condition. If you have concerns about a medical condition, it is important to speak with a qualified healthcare professional.",
    "vicuna-7b_fact_raw": "1. The Palmini classification is used to rate the severity of various medical conditions.\n2. It is commonly used in the field of neurology.\n3. The Palmini classification assesses conditions such as stroke and traumatic brain injury.\n4. This classification system is based on the degree of motor and sensory impairment, as well as language and cognitive impairment.\n5. The Palmini classification is divided into five levels, with level 1 indicating mild impairment and level 5 indicating severe impairment.",
    "vicuna-7b_fact": [
      "The Palmini classification is used to rate the severity of various medical conditions.",
      "It is commonly used in the field of neurology.",
      "The Palmini classification assesses conditions such as stroke and traumatic brain injury.",
      "This classification system is based on the degree of motor and sensory impairment, as well as language and cognitive impairment.",
      "The Palmini classification is divided into five levels, with level 1 indicating mild impairment and level 5 indicating severe impairment."
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "vicuna-7b_response": "Subacute thyroiditis is an inflammatory condition of the thyroid gland that can be caused by a variety of factors, including viruses.\nViruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis. These viruses can cause direct damage to the thyroid gland or trigger an immune response that leads to inflammation.\nThe symptoms of subacute thyroiditis can be similar to those of other thyroid disorders, such as hyperthyroidism (too much thyroid hormone) and hypothyroidism (too little thyroid hormone). Therefore, it can be difficult to definitively diagnose subacute thyroiditis without further testing.\nTreatment for subacute thyroiditis typically involves medications to reduce inflammation and symptoms, as well as hormone replacement therapy if the thyroid gland is damaged. In some cases, surgery may be necessary to remove part or all of the thyroid gland.\nIt is important to note that while viruses can play a role in the development of subacute thyroiditis, other factors such as autoimmune disorders, infections, and medications can also cause this condition. Therefore, a thorough evaluation by a healthcare professional is necessary to determine the underlying cause of subacute thyroiditis and develop an appropriate treatment plan.",
    "vicuna-7b_fact_raw": "1. Subacute thyroiditis is an inflammatory condition of the thyroid gland that can be caused by viruses.\n2. Viruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis.\n3. Symptoms of subacute thyroiditis can be similar to those of hyperthyroidism and hypothyroidism.\n4. Treatment for subacute thyroiditis typically involves medications to reduce inflammation and symptoms, and may include hormone replacement therapy.\n5. Surgery may be necessary in some cases of subacute thyroiditis to remove part or all of the thyroid gland.",
    "vicuna-7b_fact": [
      "Subacute thyroiditis is an inflammatory condition of the thyroid gland that can be caused by viruses.",
      "Viruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis.",
      "Symptoms of subacute thyroiditis can be similar to those of hyperthyroidism and hypothyroidism.",
      "Treatment for subacute thyroiditis typically involves medications to reduce inflammation and symptoms, and may include hormone replacement therapy.",
      "Surgery may be necessary in some cases of subacute thyroiditis to remove part or all of the thyroid gland."
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "vicuna-7b_response": "STAT3 (signal transducer and activator of transcription 3) is a transcription factor that plays a role in various cellular processes, including cell growth, differentiation, and survival. It has been shown to be involved in the regulation of autophagy, a process of cellular self-digestion that is important for maintaining cellular homeostasis.\nEIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2) is a kinase that plays a role in the regulation of cellular metabolism and autophagy. It has been shown to be involved in the suppression of autophagy in response to various stimuli, such as nutrient availability and stress.\nThere is evidence to suggest that STAT3 may be involved in the EIF2AK2-dependent suppression of autophagy. For example, studies have shown that STAT3 can bind to the promoter region of the EIF2AK2 gene and regulate its expression. Additionally, STAT3 has been shown to interact with and phosphorylate EIF2AK2, which may play a role in the suppression of autophagy.\nHowever, the exact mechanism by which STAT3 is involved in the EIF2AK2-dependent suppression of autophagy is not fully understood, and further research is needed to fully elucidate this relationship.",
    "vicuna-7b_fact_raw": "1. STAT3 is a transcription factor involved in cell growth, differentiation, and survival.\n2. STAT3 plays a role in the regulation of autophagy.\n3. EIF2AK2 is a kinase that regulates cellular metabolism and autophagy.\n4. EIF2AK2 has been shown to be involved in the suppression of autophagy in response to various stimuli.\n5. There is evidence suggesting that STAT3 can regulate the expression of the EIF2AK2 gene and may interact with and phosphorylate EIF2AK2.",
    "vicuna-7b_fact": [
      "STAT3 is a transcription factor involved in cell growth, differentiation, and survival.",
      "STAT3 plays a role in the regulation of autophagy.",
      "EIF2AK2 is a kinase that regulates cellular metabolism and autophagy.",
      "EIF2AK2 has been shown to be involved in the suppression of autophagy in response to various stimuli.",
      "There is evidence suggesting that STAT3 can regulate the expression of the EIF2AK2 gene and may interact with and phosphorylate EIF2AK2."
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "vicuna-7b_response": "Theatre is a software tool for genomic analysis that provides a comprehensive solution for analyzing and interpreting genomic data. It is designed to help researchers and clinicians to identify genetic variants that are associated with disease, and to understand the functional impact of these variants on gene expression and protein function.\nTheatre provides a user-friendly interface that allows users to easily navigate and analyze large-scale genomic data sets. It includes a range of tools for data visualization, variant annotation, and functional analysis, which can be used to identify and prioritize genetic variants for further study.\nOne of the key features of Theatre is its ability to integrate data from a variety of sources, including whole-genome sequencing, exome sequencing, and RNA sequencing data. This allows users to analyze data from multiple angles and to gain a more comprehensive understanding of the genetic basis of disease.\nIn addition, Theatre includes a range of tools for functional analysis, which can be used to predict the impact of genetic variants on gene expression and protein function. This information can be used to identify potential therapeutic targets and to develop personalized treatment strategies for patients.\nOverall, Theatre is a powerful tool for genomic analysis that provides a comprehensive solution for analyzing and interpreting large-scale genomic data sets. It is widely used by researchers and clinicians in the fields of genomics, genetics, and personalized medicine.",
    "vicuna-7b_fact_raw": "1. Theatre is a software tool used for analyzing and interpreting genomic data.\n2. The software is designed to help identify genetic variants associated with disease.\n3. Theatre offers a user-friendly interface for navigating and analyzing large-scale genomic data sets.\n4. It integrates data from various sources, including whole-genome sequencing, exome sequencing, and RNA sequencing.\n5. Theatre includes tools for functional analysis to predict the impact of genetic variants on gene expression and protein function.",
    "vicuna-7b_fact": [
      "Theatre is a software tool used for analyzing and interpreting genomic data.",
      "The software is designed to help identify genetic variants associated with disease.",
      "Theatre offers a user-friendly interface for navigating and analyzing large-scale genomic data sets.",
      "It integrates data from various sources, including whole-genome sequencing, exome sequencing, and RNA sequencing.",
      "Theatre includes tools for functional analysis to predict the impact of genetic variants on gene expression and protein function."
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "vicuna-7b_response": "The Smith-Waterman algorithm is a widely used algorithm for the alignment of two sequences. The execution time (complexity) of the Smith-Waterman algorithm depends on several factors, including the length of the sequences being aligned, the gap penalty and extension penalty used, and the algorithm's parameters.\nIn general, the execution time of the Smith-Waterman algorithm is O(n^2), where n is the length of the sequences being aligned. This is because the algorithm performs a sliding window search, where it compares each position in one sequence with every position in the other sequence.\nHowever, the actual execution time of the algorithm can be affected by several factors, including the gap penalty and extension penalty used. The gap penalty is a cost associated with the presence of gaps in the sequences being aligned, while the extension penalty is a cost associated with the extension of a base in one sequence by a base in the other sequence. The choice of gap and extension penalties can significantly affect the alignment of the sequences and the execution time of the algorithm.\nIn addition to the gap and extension penalties, the algorithm's parameters, such as the window size and the maximum allowed distance between two matches, can also affect the execution time of the algorithm.\nIn summary, the execution time of the Smith-Waterman algorithm for the alignment of two sequences is O(n^2), but it can be affected by several factors, including the gap and extension penalties, the algorithm's parameters, and the length of the sequences being aligned.",
    "vicuna-7b_fact_raw": "1. The Smith-Waterman algorithm is used for the alignment of two sequences.\n2. The general execution time (complexity) of the Smith-Waterman algorithm is O(n^2).\n3. The length of the sequences being aligned is a factor that affects the execution time of the Smith-Waterman algorithm.\n4. The gap penalty and extension penalty used in the Smith-Waterman algorithm can affect its execution time.\n5. The algorithm's parameters, such as the window size and the maximum allowed distance between two matches, can influence the execution time of the Smith-Waterman algorithm.",
    "vicuna-7b_fact": [
      "The Smith-Waterman algorithm is used for the alignment of two sequences.",
      "The general execution time (complexity) of the Smith-Waterman algorithm is O(n^2).",
      "The length of the sequences being aligned is a factor that affects the execution time of the Smith-Waterman algorithm.",
      "The gap penalty and extension penalty used in the Smith-Waterman algorithm can affect its execution time.",
      "The algorithm's parameters, such as the window size and the maximum allowed distance between two matches, can influence the execution time of the Smith-Waterman algorithm."
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "vicuna-7b_response": "FLVCR1 is a member of the SLC22A1 family.",
    "vicuna-7b_fact_raw": "NO FACTS",
    "vicuna-7b_fact": []
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "vicuna-7b_response": "GATA-1 is a transcription factor that plays a crucial role in the regulation of gene expression in various cell types. It has been shown to interact with a wide range of proteins, including other transcription factors, chromatin-modifying enzymes, and signaling molecules.\nOne approach to identifying GATA-1 interacting partners is through the use of biotinylation tagging. This method involves introducing a biotinylated version of GATA-1 into cells, which allows for the capture of proteins that interact with GATA-1.\nSeveral studies have used biotinylation tagging to identify GATA-1 interacting partners. Here are some examples:\n1. A study published in the journal Molecular Cell in 2011 used biotinylation tagging to identify GATA-1 interacting partners in hematopoietic cells. The study found that GATA-1 interacted with a number of proteins involved in the regulation of gene expression, including other transcription factors, chromatin-modifying enzymes, and signaling molecules.\n2. Another study published in the journal Molecular Cell in 2014 used biotinylation tagging to identify GATA-1 interacting partners in embryonic stem cells. The study found that GATA-1 interacted with a number of proteins involved in the regulation of gene expression, including other transcription factors, chromatin-modifying enzymes, and signaling molecules.\n3. A study published in the journal Cell in 2016 used biotinylation tagging to identify GATA-1 interacting partners in cardiac cells. The study found that GATA-1 interacted with a number of proteins involved in the regulation of cardiac function, including other transcription factors, chromatin-modifying enzymes, and signaling molecules.\nOverall, these studies have identified a wide range of proteins that interact with GATA-1 through the use of biotinylation tagging. These interactions are likely to play important roles in the regulation of gene expression and the development and function of various cell types.",
    "vicuna-7b_fact_raw": "1. A study published in Molecular Cell in 2011 identified GATA-1 interacting partners in hematopoietic cells using biotinylation tagging.\n2. The 2011 study found that GATA-1 interacted with proteins involved in the regulation of gene expression, including transcription factors and chromatin-modifying enzymes.\n3. A study published in Molecular Cell in 2014 used biotinylation tagging to identify GATA-1 interacting partners in embryonic stem cells.\n4. The 2014 study reported that GATA-1 interacted with proteins involved in gene expression regulation, such as transcription factors and chromatin-modifying enzymes.\n5. A study published in Cell in 2016 identified GATA-1 interacting partners in cardiac cells through biotinylation tagging, finding interactions with proteins involved in the regulation of cardiac function.",
    "vicuna-7b_fact": [
      "A study published in Molecular Cell in 2011 identified GATA-1 interacting partners in hematopoietic cells using biotinylation tagging.",
      "The 2011 study found that GATA-1 interacted with proteins involved in the regulation of gene expression, including transcription factors and chromatin-modifying enzymes.",
      "A study published in Molecular Cell in 2014 used biotinylation tagging to identify GATA-1 interacting partners in embryonic stem cells.",
      "The 2014 study reported that GATA-1 interacted with proteins involved in gene expression regulation, such as transcription factors and chromatin-modifying enzymes.",
      "A study published in Cell in 2016 identified GATA-1 interacting partners in cardiac cells through biotinylation tagging, finding interactions with proteins involved in the regulation of cardiac function."
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "vicuna-7b_response": "TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1. The interaction between TAF10 and GATA1 can affect gene expression and play a role in the regulation of cellular processes.\nThe specific outcome of TAF10 interacting with GATA1 depends on the context in which they interact. In some cases, the interaction may enhance the transcriptional activity of GATA1, leading to increased expression of target genes. In other cases, the interaction may inhibit the transcriptional activity of GATA1, leading to decreased expression of target genes.\nThe exact outcome of TAF10 and GATA1 interaction will depend on the specific genes they are regulating, the cellular context, and other factors. However, it is clear that the interaction between TAF10 and GATA1 can have a significant impact on gene expression and cellular processes.",
    "vicuna-7b_fact_raw": "1. TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1.\n2. The interaction between TAF10 and GATA1 can affect gene expression.\n3. The interaction between TAF10 and GATA1 can play a role in the regulation of cellular processes.\n4. The interaction may enhance the transcriptional activity of GATA1, leading to increased expression of target genes.\n5. The interaction may also inhibit the transcriptional activity of GATA1, leading to decreased expression of target genes.",
    "vicuna-7b_fact": [
      "TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1.",
      "The interaction between TAF10 and GATA1 can affect gene expression.",
      "The interaction between TAF10 and GATA1 can play a role in the regulation of cellular processes.",
      "The interaction may enhance the transcriptional activity of GATA1, leading to increased expression of target genes.",
      "The interaction may also inhibit the transcriptional activity of GATA1, leading to decreased expression of target genes."
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "vicuna-7b_response": "Yes, there are several decision support systems for chronic pain management. These systems are designed to help healthcare providers make informed decisions about the treatment of chronic pain.\nOne example of a decision support system for chronic pain management is the Clinical Decision Support (CDS) system. CDS systems are computerized tools that provide healthcare providers with patient-specific information and recommendations to support clinical decision-making. CDS systems for chronic pain management can provide recommendations on medication dosages, treatment options, and follow-up care.\nAnother example is the Pain Management Decision Support System (PMDSS). PMDSS is a web-based tool that provides healthcare providers with patient-specific information and recommendations for the management of chronic pain. The system uses a patient-specific algorithm to generate recommendations based on the patient's medical history, medications, and other relevant factors.\nIn addition, some electronic health record (EHR) systems have built-in decision support systems for chronic pain management. These systems can provide healthcare providers with patient information and recommendations based on the patient's medical history and other relevant factors.\nOverall, decision support systems for chronic pain management can help healthcare providers make informed decisions about the treatment of chronic pain, and can improve patient outcomes.",
    "vicuna-7b_fact_raw": "1. Decision support systems for chronic pain management are designed to assist healthcare providers in making informed treatment decisions.\n2. The Clinical Decision Support (CDS) system is a computerized tool that provides patient-specific information and recommendations to support clinical decision-making for chronic pain management.\n3. The Pain Management Decision Support System (PMDSS) is a web-based tool that offers patient-specific recommendations for managing chronic pain.\n4. PMDSS uses a patient-specific algorithm to generate recommendations based on medical history, medications, and other relevant factors.\n5. Some electronic health record (EHR) systems include built-in decision support systems for chronic pain management.",
    "vicuna-7b_fact": [
      "Decision support systems for chronic pain management are designed to assist healthcare providers in making informed treatment decisions.",
      "The Clinical Decision Support (CDS) system is a computerized tool that provides patient-specific information and recommendations to support clinical decision-making for chronic pain management.",
      "The Pain Management Decision Support System (PMDSS) is a web-based tool that offers patient-specific recommendations for managing chronic pain.",
      "PMDSS uses a patient-specific algorithm to generate recommendations based on medical history, medications, and other relevant factors.",
      "Some electronic health record (EHR) systems include built-in decision support systems for chronic pain management."
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "vicuna-7b_response": "Angiogenin is a protein that is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus. It is also found in the nucleus of certain cells, such as those in the liver and kidney. Angiogenin is a glycoprotein that is involved in the regulation of cell growth and differentiation, and it has been implicated in the development of cancer. It is also a potent inducer of angiogenesis, the process by which new blood vessels are formed. Angiogenin is a secreted protein and it can also be found in the extracellular space.",
    "vicuna-7b_fact_raw": "1. Angiogenin is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus.\n2. Angiogenin is found in the nucleus of certain cells, including those in the liver and kidney.\n3. Angiogenin is involved in the regulation of cell growth and differentiation.\n4. Angiogenin has been implicated in the development of cancer.\n5. Angiogenin is a potent inducer of angiogenesis, the process by which new blood vessels are formed.",
    "vicuna-7b_fact": [
      "Angiogenin is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus.",
      "Angiogenin is found in the nucleus of certain cells, including those in the liver and kidney.",
      "Angiogenin is involved in the regulation of cell growth and differentiation.",
      "Angiogenin has been implicated in the development of cancer.",
      "Angiogenin is a potent inducer of angiogenesis, the process by which new blood vessels are formed."
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "vicuna-7b_response": "Ranolazine is a medication that is used to treat angina, a condition characterized by chest pain due to reduced blood flow to the heart muscle. It works by blocking the late sodium current in heart cells, which helps to reduce the amount of energy required by the heart to contract and pump blood.\nOne of the ways in which ranolazine affects kinase signaling activation in the heart is by blocking the activity of the voltage-gated sodium channel. This channel is responsible for allowing sodium ions to flow into heart cells, which can lead to the activation of several signaling pathways, including the protein kinase C (PKC) pathway. By blocking the activity of this channel, ranolazine can prevent the activation of PKC and other downstream signaling pathways, which can help to reduce the energy requirements of the heart and improve blood flow.\nAnother way in which ranolazine affects kinase signaling activation in the heart is by blocking the activity of the late sodium current. This current is activated in response to increased intracellular calcium levels, and it can lead to the activation of several signaling pathways, including the protein kinase C (PKC) pathway. By blocking the activity of this current, ranolazine can prevent the activation of PKC and other downstream signaling pathways, which can help to reduce the energy requirements of the heart and improve blood flow.\nOverall, ranolazine can have a beneficial effect on kinase signaling activation in the heart by blocking the activity of the voltage-gated sodium channel and the late sodium current, which can help to reduce the energy requirements of the heart and improve blood flow.",
    "vicuna-7b_fact_raw": "1. Ranolazine is used to treat angina, which is characterized by chest pain due to reduced blood flow to the heart muscle.\n2. Ranolazine works by blocking the late sodium current in heart cells.\n3. Blocking the late sodium current helps to reduce the energy required by the heart to contract and pump blood.\n4. Ranolazine affects kinase signaling activation in the heart by blocking the activity of the voltage-gated sodium channel.\n5. Blocking the voltage-gated sodium channel and the late sodium current can prevent the activation of protein kinase C (PKC) and other downstream signaling pathways.",
    "vicuna-7b_fact": [
      "Ranolazine is used to treat angina, which is characterized by chest pain due to reduced blood flow to the heart muscle.",
      "Ranolazine works by blocking the late sodium current in heart cells.",
      "Blocking the late sodium current helps to reduce the energy required by the heart to contract and pump blood.",
      "Ranolazine affects kinase signaling activation in the heart by blocking the activity of the voltage-gated sodium channel.",
      "Blocking the voltage-gated sodium channel and the late sodium current can prevent the activation of protein kinase C (PKC) and other downstream signaling pathways."
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "vicuna-7b_response": "VSR endonuclease is a type of restriction endonuclease that is involved in the regulation of genetic recombination in bacteria. The regulation of VSR endonuclease is not independent of the growth phase of bacteria.\nIn general, the expression of restriction endonucleases, including VSR endonuclease, is regulated by the growth phase of bacteria. The expression of these enzymes is typically higher during the exponential phase of growth and lower during the stationary phase.\nThe regulation of VSR endonuclease expression is complex and involves a variety of factors, including the availability of certain nutrients, the presence of certain signaling molecules, and the activity of other genes involved in the regulation of gene expression.\nIn summary, the regulation of VSR endonuclease expression is not independent of the growth phase of bacteria, but rather is influenced by a variety of factors that are involved in the regulation of bacterial growth and gene expression.",
    "vicuna-7b_fact_raw": "1. VSR endonuclease is involved in the regulation of genetic recombination in bacteria.\n2. The regulation of VSR endonuclease is not independent of the growth phase of bacteria.\n3. The expression of restriction endonucleases, including VSR endonuclease, is typically higher during the exponential phase of bacterial growth.\n4. The expression of these enzymes is lower during the stationary phase of bacterial growth.\n5. The regulation of VSR endonuclease expression involves the availability of certain nutrients, the presence of signaling molecules, and the activity of other genes.",
    "vicuna-7b_fact": [
      "VSR endonuclease is involved in the regulation of genetic recombination in bacteria.",
      "The regulation of VSR endonuclease is not independent of the growth phase of bacteria.",
      "The expression of restriction endonucleases, including VSR endonuclease, is typically higher during the exponential phase of bacterial growth.",
      "The expression of these enzymes is lower during the stationary phase of bacterial growth.",
      "The regulation of VSR endonuclease expression involves the availability of certain nutrients, the presence of signaling molecules, and the activity of other genes."
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "vicuna-7b_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Here are some of the most commonly used methods:\n1. TMHMM: TMHMM is a widely used software tool for the prediction of transmembrane helices in proteins. It uses a hidden Markov model to identify beta-barrel structures in proteins. TMHMM can also predict the length and orientation of transmembrane helices.\n2. beta-barrel: beta-barrel is a web-based server that uses a combination of sequence and structural information to predict beta-barrel transmembrane proteins. It can also predict the length and orientation of transmembrane helices.\n3. PONDR-VLXT: PONDR-VLXT is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins. It can also predict the length and orientation of transmembrane helices.\n4. SOPMA: SOPMA is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins. It can also predict the length and orientation of transmembrane helices.\n5. BetaBars: BetaBars is a web-based server that uses a combination of sequence and structural information to predict beta-barrel transmembrane proteins. It can also predict the length and orientation of transmembrane helices.\nThese computational tools can be useful for identifying beta-barrel transmembrane proteins, but it is important to note that they are not always accurate and may produce false positives or false negatives. Therefore, it is always a good idea to validate the predictions using experimental data.",
    "vicuna-7b_fact_raw": "1. TMHMM is a software tool used for predicting transmembrane helices in proteins.\n2. TMHMM utilizes a hidden Markov model to identify beta-barrel structures in proteins.\n3. beta-barrel is a web-based server that predicts beta-barrel transmembrane proteins using sequence and structural information.\n4. PONDR-VLXT is a software tool that predicts transmembrane helices in proteins based on sequence and structural information.\n5. BetaBars is a web-based server designed to predict beta-barrel transmembrane proteins using a combination of sequence and structural information.",
    "vicuna-7b_fact": [
      "TMHMM is a software tool used for predicting transmembrane helices in proteins.",
      "TMHMM utilizes a hidden Markov model to identify beta-barrel structures in proteins.",
      "beta-barrel is a web-based server that predicts beta-barrel transmembrane proteins using sequence and structural information.",
      "PONDR-VLXT is a software tool that predicts transmembrane helices in proteins based on sequence and structural information.",
      "BetaBars is a web-based server designed to predict beta-barrel transmembrane proteins using a combination of sequence and structural information."
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "vicuna-7b_response": "Galassi classification is used for the classification of skeletal disorders. It is a system of classification that was developed by the Italian radiologist, Galassi, in the 1970s. The Galassi classification system is based on the location and the type of bone lesion. It is widely used in radiology to describe and classify bone tumors and other bone disorders. The Galassi classification system is divided into three main categories: benign, malignant, and uncertain. Benign tumors are non-cancerous and do not spread to other parts of the body. Malignant tumors are cancerous and can spread to other parts of the body. Uncertain tumors are not clearly benign or malignant and require further evaluation.",
    "vicuna-7b_fact_raw": "1. The Galassi classification is used for the classification of skeletal disorders.\n2. It was developed by an Italian radiologist named Galassi in the 1970s.\n3. The Galassi classification system is based on the location and type of bone lesion.\n4. The system is used to describe and classify bone tumors and other bone disorders.\n5. The Galassi classification system divides bone tumors into three main categories: benign, malignant, and uncertain.",
    "vicuna-7b_fact": [
      "The Galassi classification is used for the classification of skeletal disorders.",
      "It was developed by an Italian radiologist named Galassi in the 1970s.",
      "The Galassi classification system is based on the location and type of bone lesion.",
      "The system is used to describe and classify bone tumors and other bone disorders.",
      "The Galassi classification system divides bone tumors into three main categories: benign, malignant, and uncertain."
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "vicuna-7b_response": "Shapiro syndrome is a rare genetic disorder characterized by a variety of symptoms, including:\n1. Elevated levels of uric acid in the blood (hyperuricemia)\n2. Gout: recurrent attacks of joint pain, swelling, and redness (inflammation) caused by the buildup of uric acid crystals in the joints.\n3. High blood pressure (hypertension)\n4. Kidney stones: small, hard deposits that form in the kidneys and can cause pain and other complications.\n5. Low blood counts: a decrease in the number of red blood cells, white blood cells, and platelets.\n6. Eye problems: such as cataracts, glaucoma, and other vision problems.\n7. Skin problems: such as psoriasis, eczema, and other skin rashes.\n8. Heart problems: such as high blood pressure, abnormal heart rhythms, and heart failure.\n9. Kidney problems: such as kidney stones, chronic kidney disease, and kidney failure.\n10. Joint pain and stiffness.\nIt's important to note that not all individuals with Shapiro syndrome will experience all of these symptoms, and the severity of symptoms can vary from person to person. Additionally, there are different types of Shapiro syndrome, and the symptoms can vary depending on the type.\nIt's important to consult a doctor for proper diagnosis and treatment.",
    "vicuna-7b_fact_raw": "1. Shapiro syndrome is characterized by elevated levels of uric acid in the blood (hyperuricemia).\n2. Individuals with Shapiro syndrome may experience gout, which includes recurrent attacks of joint pain, swelling, and redness due to uric acid crystals in the joints.\n3. High blood pressure (hypertension) is a symptom associated with Shapiro syndrome.\n4. People with Shapiro syndrome can develop kidney stones.\n5. Shapiro syndrome can lead to low blood counts, affecting red blood cells, white blood cells, and platelets.",
    "vicuna-7b_fact": [
      "Shapiro syndrome is characterized by elevated levels of uric acid in the blood (hyperuricemia).",
      "Individuals with Shapiro syndrome may experience gout, which includes recurrent attacks of joint pain, swelling, and redness due to uric acid crystals in the joints.",
      "High blood pressure (hypertension) is a symptom associated with Shapiro syndrome.",
      "People with Shapiro syndrome can develop kidney stones.",
      "Shapiro syndrome can lead to low blood counts, affecting red blood cells, white blood cells, and platelets."
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "vicuna-7b_response": "BRAG1 is a protein that is involved in the regulation of cell division. Mutations in the BRAG1 gene have been linked to the development of a rare genetic disorder called Bragg syndrome. Bragg syndrome is characterized by the development of multiple tumors, particularly in the brain, spinal cord, and other parts of the nervous system. These tumors are called brainstem gliomas and are typically aggressive and difficult to treat.\nThe BRAG1 gene provides instructions for making a protein that plays a role in the regulation of cell division. Mutations in the BRAG1 gene can disrupt this process and lead to the development of brainstem gliomas. These mutations can be inherited in an autosomal dominant pattern, meaning that a person only needs one copy of the mutated gene to be affected.\nIt's important to note that Bragg syndrome is a very rare disorder and it's not common for people to have this condition. However, it's important to be aware of the signs and symptoms of brainstem gliomas and to seek medical attention if you or a loved one experiences any of these symptoms.",
    "vicuna-7b_fact_raw": "1. Mutations in the BRAG1 gene have been linked to the development of Bragg syndrome.\n2. Bragg syndrome is characterized by the development of multiple tumors, particularly in the brain, spinal cord, and other parts of the nervous system.\n3. Tumors associated with Bragg syndrome are called brainstem gliomas.\n4. Brainstem gliomas are typically aggressive and difficult to treat.\n5. Mutations in the BRAG1 gene can be inherited in an autosomal dominant pattern.",
    "vicuna-7b_fact": [
      "Mutations in the BRAG1 gene have been linked to the development of Bragg syndrome.",
      "Bragg syndrome is characterized by the development of multiple tumors, particularly in the brain, spinal cord, and other parts of the nervous system.",
      "Tumors associated with Bragg syndrome are called brainstem gliomas.",
      "Brainstem gliomas are typically aggressive and difficult to treat.",
      "Mutations in the BRAG1 gene can be inherited in an autosomal dominant pattern."
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "vicuna-7b_response": "Protein phosphatase 1 (PP1) is a serine/threonine protein phosphatase that plays a critical role in regulating various cellular processes, including cell growth, division, and apoptosis. PP1 is inhibited by a number of proteins, including the regulatory subunit B' (PP1β) and the inhibitor B (PPIB).\nPP1β is the main regulatory subunit of PP1 and is responsible for its catalytic activity. PP1β binds to the catalytic subunit of PP1, PP1γ, and forms a complex that is responsible for dephosphorylating a variety of target proteins. PP1β is also responsible for the specificity of PP1 for certain substrates.\nPPIB is a protein that binds to PP1 and inhibits its activity. PPIB is a potent inhibitor of PP1 and is responsible for the long-term regulation of PP1 activity. PPIB binds to PP1 and prevents it from dephosphorylating its substrates, thereby maintaining the activity of PP1 in the cell.\nIn summary, PP1β is the main inhibitor of PP1, while PPIB is a potent inhibitor of PP1 that is responsible for the long-term regulation of PP1 activity.",
    "vicuna-7b_fact_raw": "1. Protein phosphatase 1 (PP1) is a serine/threonine protein phosphatase.\n2. PP1 is inhibited by the regulatory subunit B' (PP1β) and the inhibitor B (PPIB).\n3. PP1β is the main regulatory subunit of PP1 and is responsible for its catalytic activity.\n4. PP1β binds to the catalytic subunit of PP1, PP1γ, to form a complex.\n5. PPIB is a potent inhibitor of PP1 and is responsible for the long-term regulation of PP1 activity.",
    "vicuna-7b_fact": [
      "Protein phosphatase 1 (PP1) is a serine/threonine protein phosphatase.",
      "PP1 is inhibited by the regulatory subunit B' (PP1β) and the inhibitor B (PPIB).",
      "PP1β is the main regulatory subunit of PP1 and is responsible for its catalytic activity.",
      "PP1β binds to the catalytic subunit of PP1, PP1γ, to form a complex.",
      "PPIB is a potent inhibitor of PP1 and is responsible for the long-term regulation of PP1 activity."
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "vicuna-7b_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a process by which bacteria, such as Bacillus subtilis, undergo mutations in response to environmental stress. This process is a form of genetic adaptation that allows bacteria to survive in harsh conditions.\nThere are several mechanisms that underlie adaptive mutagenesis in Bacillus subtilis:\n1. Mutation accumulation: As bacteria undergo stress, such as starvation or exposure to antibiotics, they experience DNA damage. This damage can lead to mutations in the bacterial genome. Over time, the accumulation of mutations can lead to the evolution of new traits that allow the bacteria to survive in their environment.\n2. DNA repair mechanisms: Bacteria have several mechanisms to repair DNA damage, such as base excision repair, mismatch repair, and nucleotide excision repair. However, these mechanisms are not perfect, and some DNA damage can go unrepaired, leading to mutations.\n3. Transposable elements: Transposable elements are DNA sequences that can move around the genome, sometimes disrupting the normal functioning of genes. In Bacillus subtilis, transposable elements have been shown to play a role in adaptive mutagenesis. They can cause mutations by inserting themselves into the genome or by disrupting the normal functioning of genes.\n4. CRISPR-Cas system: The CRISPR-Cas system is a defense mechanism that allows bacteria to protect themselves against viruses and other foreign DNA. However, it can also be used as a mechanism for adaptive mutagenesis. The Cas proteins can cut DNA, leading to mutations.\n5. Environmental stress: Environmental stress, such as starvation or exposure to antibiotics, can cause DNA damage and lead to mutations. Bacteria may undergo adaptive mutagenesis in response to these stresses in order to survive and reproduce.\nOverall, adaptive mutagenesis is a complex process that involves multiple mechanisms, including mutation accumulation, DNA repair mechanisms, transposable elements, the CRISPR-Cas system, and environmental stress.",
    "vicuna-7b_fact_raw": "1. Bacillus subtilis undergoes mutations in response to environmental stress through a process known as adaptive mutagenesis or stationary-phase mutagenesis.\n2. DNA damage in Bacillus subtilis can lead to mutations due to environmental stressors such as starvation or exposure to antibiotics.\n3. Bacillus subtilis has DNA repair mechanisms like base excision repair, mismatch repair, and nucleotide excision repair, which can sometimes result in mutations if the damage is not perfectly repaired.\n4. Transposable elements in Bacillus subtilis can move around the genome and contribute to adaptive mutagenesis by causing mutations.\n5. The CRISPR-Cas system in Bacillus subtilis can cut DNA, which can lead to mutations as part of adaptive mutagenesis.",
    "vicuna-7b_fact": [
      "Bacillus subtilis undergoes mutations in response to environmental stress through a process known as adaptive mutagenesis or stationary-phase mutagenesis.",
      "DNA damage in Bacillus subtilis can lead to mutations due to environmental stressors such as starvation or exposure to antibiotics.",
      "Bacillus subtilis has DNA repair mechanisms like base excision repair, mismatch repair, and nucleotide excision repair, which can sometimes result in mutations if the damage is not perfectly repaired.",
      "Transposable elements in Bacillus subtilis can move around the genome and contribute to adaptive mutagenesis by causing mutations.",
      "The CRISPR-Cas system in Bacillus subtilis can cut DNA, which can lead to mutations as part of adaptive mutagenesis."
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "vicuna-7b_response": "Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that causes red, itchy, and scaly patches on the skin. The exact cause of eczema is not fully understood, but it is thought to be caused by a combination of genetic and environmental factors.\nOne of the main triggers of eczema is exposure to certain allergens and irritants, such as dust mites, pollen, and harsh soaps and detergents. Additionally, eczema can be triggered by environmental factors, such as changes in temperature and humidity, and stress.\nAnother possible cause of eczema is a malfunction of the skin barrier. The skin barrier is a protective layer that keeps moisture in and irritants out. In people with eczema, the skin barrier may not function properly, leading to dry, itchy, and inflamed skin.\nIt is important to note that eczema can be managed with proper skin care and avoidance of triggers. If you have eczema, it is important to work with your healthcare provider to develop a treatment plan that is right for you.",
    "vicuna-7b_fact_raw": "1. Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition.\n2. The exact cause of eczema is thought to be a combination of genetic and environmental factors.\n3. Exposure to allergens and irritants like dust mites, pollen, and harsh soaps and detergents can trigger eczema.\n4. Environmental factors such as changes in temperature and humidity, as well as stress, can trigger eczema.\n5. A malfunction of the skin barrier, which is supposed to keep moisture in and irritants out, may be a cause of eczema.",
    "vicuna-7b_fact": [
      "Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition.",
      "The exact cause of eczema is thought to be a combination of genetic and environmental factors.",
      "Exposure to allergens and irritants like dust mites, pollen, and harsh soaps and detergents can trigger eczema.",
      "Environmental factors such as changes in temperature and humidity, as well as stress, can trigger eczema.",
      "A malfunction of the skin barrier, which is supposed to keep moisture in and irritants out, may be a cause of eczema."
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "vicuna-7b_response": "Hydrochlorothiazide is a diuretic medication that is used to reduce the amount of water and salt in the body. It is primarily used to treat high blood pressure, but it can also be used to treat other conditions such as heart failure, kidney disease, and certain types of edema (swelling).\nHydrochlorothiazide works by increasing the amount of urine that the body produces, which helps to reduce the amount of fluid and salt in the body. This can help to lower blood pressure and reduce the risk of complications associated with high blood pressure, such as heart attack and stroke.\nIt is important to note that hydrochlorothiazide is not suitable for everyone, and it may not be appropriate for use in certain individuals. It is important to consult with a healthcare professional before starting treatment with hydrochlorothiazide to determine if it is the right treatment for you.\nIn addition to its use in treating high blood pressure, hydrochlorothiazide may also be used to treat other conditions such as diabetes insipidus, a condition in which the body is unable to regulate the amount of urine that it produces. It may also be used to treat certain types of kidney disease, such as nephrotic syndrome, and to prevent kidney damage in individuals who are at risk of developing kidney disease.\nIt is important to follow the dosage instructions provided by your healthcare professional when taking hydrochlorothiazide. It is also important to inform your healthcare professional of any other medications that you are taking, as hydrochlorothiazide can interact with certain medications and may not be suitable for everyone.",
    "vicuna-7b_fact_raw": "1. Hydrochlorothiazide is used to treat high blood pressure.\n2. Hydrochlorothiazide can be used to treat heart failure.\n3. Hydrochlorothiazide is used to treat certain types of edema.\n4. Hydrochlorothiazide works by increasing the amount of urine produced by the body.\n5. Hydrochlorothiazide may be used to treat diabetes insipidus and certain types of kidney disease, such as nephrotic syndrome.",
    "vicuna-7b_fact": [
      "Hydrochlorothiazide is used to treat high blood pressure.",
      "Hydrochlorothiazide can be used to treat heart failure.",
      "Hydrochlorothiazide is used to treat certain types of edema.",
      "Hydrochlorothiazide works by increasing the amount of urine produced by the body.",
      "Hydrochlorothiazide may be used to treat diabetes insipidus and certain types of kidney disease, such as nephrotic syndrome."
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "vicuna-7b_response": "Yes, silicon has been used in the treatment of incontinence. Silicon is a synthetic material that is commonly used in the medical field for various purposes, including the treatment of incontinence.\nThere are several types of incontinence, including stress incontinence, urge incontinence, and overflow incontinence. Stress incontinence is caused by a weakening of the muscles and tissues that support the bladder, and it is most commonly treated with pelvic floor exercises, bladder training, and in some cases, with devices such as pessaries or vaginal slings.\nUrge incontinence, also known as overactive bladder, is caused by involuntary contractions of the bladder muscles, and it is treated with medications, bladder training, and in some cases, with devices such as pelvic muscle exercisers or electrical stimulation.\nOverflow incontinence is caused by an overproduction of urine, and it is treated with medications, bladder training, and in some cases, with devices such as urinary catheters or intermittent self-catheterization.\nSilicon is used in the treatment of incontinence in several ways, including the use of silicone-based pelvic floor exercisers, silicone-based pessaries, and silicone-based urinary catheters. These devices are designed to provide support to the pelvic floor muscles, bladder neck, and urethra, which can help to reduce the symptoms of incontinence.\nIt is important to note that silicone is a biocompatible material, which means that it is not toxic to the body and is not likely to cause any adverse reactions. However, it is important to consult with a healthcare professional before using any device to treat incontinence, as the best treatment plan will depend on the specific type and severity of the incontinence.",
    "vicuna-7b_fact_raw": "1. Silicon has been used in the treatment of incontinence.\n2. Stress incontinence is commonly treated with pelvic floor exercises, bladder training, and devices such as pessaries or vaginal slings.\n3. Urge incontinence is treated with medications, bladder training, and devices such as pelvic muscle exercisers or electrical stimulation.\n4. Overflow incontinence is treated with medications, bladder training, and devices such as urinary catheters or intermittent self-catheterization.\n5. Silicone is a biocompatible material that is not toxic to the body.",
    "vicuna-7b_fact": [
      "Silicon has been used in the treatment of incontinence.",
      "Stress incontinence is commonly treated with pelvic floor exercises, bladder training, and devices such as pessaries or vaginal slings.",
      "Urge incontinence is treated with medications, bladder training, and devices such as pelvic muscle exercisers or electrical stimulation.",
      "Overflow incontinence is treated with medications, bladder training, and devices such as urinary catheters or intermittent self-catheterization.",
      "Silicone is a biocompatible material that is not toxic to the body."
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "vicuna-7b_response": "The association between the moon cycle and rupture risk of intracranial aneurysms is a topic of ongoing research and debate. Some studies have suggested that the moon's gravitational pull may affect the pressure inside an intracranial aneurysm, leading to an increased risk of rupture during certain phases of the lunar cycle. However, other studies have found no significant association between the moon and the rupture risk of aneurysms.\nIntracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain. They can be caused by a variety of factors, including genetics, high blood pressure, and smoking. When an aneurysm ruptures, it can cause severe brain damage or even death.\nThe theory that the moon's gravitational pull affects the pressure inside an aneurysm is based on the idea that the tides on Earth are caused by the moon's gravitational pull. Some researchers have suggested that this gravitational pull may also affect the pressure inside an aneurysm, leading to an increased risk of rupture during certain phases of the lunar cycle.\nHowever, other researchers have found no significant association between the moon and the rupture risk of aneurysms. They argue that the moon's gravitational pull is too weak to have a significant effect on the pressure inside an aneurysm.\nOverall, the association between the moon cycle and rupture risk of intracranial aneurysms is still not well understood. Further research is needed to determine whether there is any link between the two.",
    "vicuna-7b_fact_raw": "1. Some studies have suggested that the moon's gravitational pull may affect the pressure inside an intracranial aneurysm.\n2. Other studies have found no significant association between the moon's gravitational pull and the rupture risk of intracranial aneurysms.\n3. Intracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain.\n4. Factors that can cause intracranial aneurysms include genetics, high blood pressure, and smoking.\n5. A ruptured aneurysm can cause severe brain damage or death.",
    "vicuna-7b_fact": [
      "Some studies have suggested that the moon's gravitational pull may affect the pressure inside an intracranial aneurysm.",
      "Other studies have found no significant association between the moon's gravitational pull and the rupture risk of intracranial aneurysms.",
      "Intracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain.",
      "Factors that can cause intracranial aneurysms include genetics, high blood pressure, and smoking.",
      "A ruptured aneurysm can cause severe brain damage or death."
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "vicuna-7b_response": "Yes, the HU Antisense RNA (HuR) protein has been shown to regulate the splicing process. HuR is a nuclear protein that binds to messenger RNA (mRNA) and regulates the stability and translation of mRNAs, including those involved in splicing.\nHuR has been shown to interact with a variety of splicing factors, including the splicing factor SF2/ASF, which is involved in the recognition of exons and the recruitment of splicing complexes to the splice site. By binding to SF2/ASF, HuR may help to stabilize the splicing complex and promote the efficient recognition and splicing of exons.\nIn addition, HuR has been shown to interact with the splicing factor SC35, which is involved in the formation of the spliceosome, the complex that catalyzes the splicing reaction. By binding to SC35, HuR may help to recruit the spliceosome to the splice site and promote the efficient recognition and splicing of exons.\nOverall, the interaction of HuR with splicing factors suggests that HuR plays a critical role in the regulation of the splicing process.",
    "vicuna-7b_fact_raw": "1. The HU Antisense RNA (HuR) protein regulates the splicing process.\n2. HuR is a nuclear protein that binds to messenger RNA (mRNA).\n3. HuR regulates the stability and translation of mRNAs involved in splicing.\n4. HuR interacts with the splicing factor SF2/ASF, which is involved in exon recognition and recruitment of splicing complexes.\n5. HuR also interacts with the splicing factor SC35, which is involved in the formation of the spliceosome.",
    "vicuna-7b_fact": [
      "The HU Antisense RNA (HuR) protein regulates the splicing process.",
      "HuR is a nuclear protein that binds to messenger RNA (mRNA).",
      "HuR regulates the stability and translation of mRNAs involved in splicing.",
      "HuR interacts with the splicing factor SF2/ASF, which is involved in exon recognition and recruitment of splicing complexes.",
      "HuR also interacts with the splicing factor SC35, which is involved in the formation of the spliceosome."
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "vicuna-7b_response": "Prothymosin alpha (PTMA) is a protein that plays a crucial role in the development and function of the thymus gland. The c-terminal peptide of PTMA, which is the part of the protein that is located at the end of the protein chain, has several known functions.\nOne of the known functions of the c-terminal peptide of PTMA is its ability to bind to and regulate the activity of other proteins. This binding can affect the activity of proteins involved in the development and maturation of T cells, which are a type of immune cell that is produced in the thymus gland.\nAnother known function of the c-terminal peptide of PTMA is its ability to regulate the expression of certain genes. This regulation can affect the production of proteins involved in the development and maturation of T cells, as well as the production of other types of cells.\nIn addition to its role in the development and maturation of T cells, the c-terminal peptide of PTMA has also been shown to play a role in the regulation of cell growth and survival. This regulation can affect the growth and survival of T cells and other types of cells, and may be important for the proper functioning of the immune system.\nOverall, the c-terminal peptide of PTMA is a complex and multifunctional protein that plays a critical role in the development and function of the immune system. Further research is needed to fully understand the functions of this protein and its role in the regulation of cell growth and survival.",
    "vicuna-7b_fact_raw": "1. The c-terminal peptide of prothymosin alpha (PTMA) can bind to and regulate the activity of other proteins.\n2. This binding by the c-terminal peptide of PTMA can affect the activity of proteins involved in the development and maturation of T cells.\n3. The c-terminal peptide of PTMA can regulate the expression of certain genes.\n4. The regulation of gene expression by the c-terminal peptide of PTMA can affect the production of proteins involved in the development and maturation of T cells.\n5. The c-terminal peptide of PTMA plays a role in the regulation of cell growth and survival.",
    "vicuna-7b_fact": [
      "The c-terminal peptide of prothymosin alpha (PTMA) can bind to and regulate the activity of other proteins.",
      "This binding by the c-terminal peptide of PTMA can affect the activity of proteins involved in the development and maturation of T cells.",
      "The c-terminal peptide of PTMA can regulate the expression of certain genes.",
      "The regulation of gene expression by the c-terminal peptide of PTMA can affect the production of proteins involved in the development and maturation of T cells.",
      "The c-terminal peptide of PTMA plays a role in the regulation of cell growth and survival."
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "vicuna-7b_response": "Cystatin C is a cysteine protease inhibitor that is found in various tissues and fluids in the human body. It is a small protein that is composed of 126 amino acids and is involved in regulating the activity of proteases, which are enzymes that break down other proteins.\nThere are several peptides that have been identified as playing a role in the fibrillization of cystatin C. One of these is the C-terminal peptide, which is located at the end of the protein and is composed of 12 amino acids. This peptide has been shown to be important for the formation of fibrils, which are the aggregates of cystatin C that are responsible for its fibrillization.\nOther peptides that have been implicated in cystatin C fibrillization include the N-terminal peptide, which is located at the beginning of the protein, and the middle peptide, which is located in the middle of the protein. These peptides may also play a role in the formation of fibrils, although their exact functions are not yet fully understood.\nOverall, the C-terminal peptide is one of the peptides that plays a pivotal role in human cystatin C fibrillization.",
    "vicuna-7b_fact_raw": "1. Cystatin C is a cysteine protease inhibitor found in various tissues and fluids in the human body.\n2. Cystatin C is composed of 126 amino acids.\n3. The C-terminal peptide of cystatin C is composed of 12 amino acids.\n4. The C-terminal peptide is important for the formation of fibrils in cystatin C fibrillization.\n5. The N-terminal peptide and the middle peptide of cystatin C may also play a role in the formation of fibrils.",
    "vicuna-7b_fact": [
      "Cystatin C is a cysteine protease inhibitor found in various tissues and fluids in the human body.",
      "Cystatin C is composed of 126 amino acids.",
      "The C-terminal peptide of cystatin C is composed of 12 amino acids.",
      "The C-terminal peptide is important for the formation of fibrils in cystatin C fibrillization.",
      "The N-terminal peptide and the middle peptide of cystatin C may also play a role in the formation of fibrils."
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "vicuna-7b_response": "The concentration of protein HIF-1α (hypoxia-inducible factor 1 alpha) can increase after the administration of the cytoprotective prodrug amifostine (ethyol) in certain circumstances.\nAmifostine is a cytoprotective agent that is commonly used in cancer therapy to protect healthy cells from the toxic effects of radiation and chemotherapy. It works by binding to and inactivating endogenous and exogenous toxic compounds, including free radicals and other reactive oxygen species (ROS), before they can cause damage to cells.\nOne of the mechanisms by which amifostine exerts its cytoprotective effects is by increasing the expression and activity of the transcription factor HIF-1α. HIF-1α is a key regulator of the cellular response to hypoxia (low oxygen levels), and its activation leads to the expression of genes involved in the synthesis of erythropoietin, angiogenesis, and other processes that help the body adapt to low oxygen conditions.\nIn some studies, amifostine has been shown to increase the expression and activity of HIF-1α in cancer cells, leading to the upregulation of genes involved in angiogenesis and the synthesis of erythropoietin. This can help to improve the delivery of oxygen to the tumor and promote the growth of new blood vessels, which can enhance the efficacy of cancer therapy.\nHowever, it is important to note that the effects of amifostine on HIF-1α concentration can vary depending on the specific context and the type of cancer being treated. In some cases, amifostine may not increase the concentration of HIF-1α, and its cytoprotective effects may be mediated through other mechanisms.\nOverall, the effect of amifostine on the concentration of HIF-1α depends on various factors, including the dose and duration of treatment, the type of cancer being treated, and the presence of other cytoprotective agents. Further research is needed to fully understand the mechanisms underlying the effects of amifostine on HIF-1α and its potential therapeutic applications.",
    "vicuna-7b_fact_raw": "1. Amifostine is a cytoprotective agent used in cancer therapy to protect healthy cells from the toxic effects of radiation and chemotherapy.\n2. Amifostine works by binding to and inactivating toxic compounds, including free radicals and reactive oxygen species (ROS).\n3. One mechanism of amifostine's cytoprotective effects is by increasing the expression and activity of the transcription factor HIF-1α.\n4. HIF-1α is a key regulator of the cellular response to hypoxia and its activation leads to the expression of genes involved in erythropoietin synthesis and angiogenesis.\n5. In some studies, amifostine has been shown to increase the expression and activity of HIF-1α in cancer cells.",
    "vicuna-7b_fact": [
      "Amifostine is a cytoprotective agent used in cancer therapy to protect healthy cells from the toxic effects of radiation and chemotherapy.",
      "Amifostine works by binding to and inactivating toxic compounds, including free radicals and reactive oxygen species (ROS).",
      "One mechanism of amifostine's cytoprotective effects is by increasing the expression and activity of the transcription factor HIF-1α.",
      "HIF-1α is a key regulator of the cellular response to hypoxia and its activation leads to the expression of genes involved in erythropoietin synthesis and angiogenesis.",
      "In some studies, amifostine has been shown to increase the expression and activity of HIF-1α in cancer cells."
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "vicuna-7b_response": "Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1). This modification is typically associated with transcriptional repression and is often found in developmental genes and in the heterochromatin of eukaryotic cells. Set7 is also known to deposit other histone marks, including H3K9me2 and H3K27me3, but these modifications are less common than H3K56me1.\nH3K9me2 is a mono-methylation of histone H3 on lysine 9 (H3K9me2), which is typically associated with transcriptional repression. Set7 has been shown to deposit H3K9me2 at the boundary between active and inactive chromatin, where it acts as a repressor of transcription.\nH3K27me3 is a trimethylation of histone H3 on lysine 27 (H3K27me3), which is also associated with transcriptional repression. Set7 has been shown to deposit H3K27me3 at the boundary between active and inactive chromatin, where it acts as a repressor of transcription.\nIt's important to note that while Set7 is known to deposit these other histone marks, H3K56me1 is the most common and well-studied modification associated with Set7.",
    "vicuna-7b_fact_raw": "1. Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1).\n2. The H3K56me1 modification is typically associated with transcriptional repression.\n3. Set7 is known to deposit the histone mark H3K9me2, which is a mono-methylation of histone H3 on lysine 9.\n4. Set7 is also known to deposit the histone mark H3K27me3, which is a trimethylation of histone H3 on lysine 27.\n5. H3K56me1 is the most common and well-studied modification associated with Set7.",
    "vicuna-7b_fact": [
      "Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1).",
      "The H3K56me1 modification is typically associated with transcriptional repression.",
      "Set7 is known to deposit the histone mark H3K9me2, which is a mono-methylation of histone H3 on lysine 9.",
      "Set7 is also known to deposit the histone mark H3K27me3, which is a trimethylation of histone H3 on lysine 27.",
      "H3K56me1 is the most common and well-studied modification associated with Set7."
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "vicuna-7b_response": "Hepcidin is a protein that plays a crucial role in the regulation of iron metabolism in the body. The exact number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.\nIn humans, hepcidin is composed of 296 amino acids and contains 10 disulfide bridges. These disulfide bridges are important for the stability and function of the protein. The presence of these disulfide bridges helps to maintain the tertiary structure of the protein and prevents it from becoming denatured.\nIt is worth noting that the number of disulfide bridges in a protein can vary significantly depending on the protein's structure and function. Some proteins may contain only a few disulfide bridges, while others may contain many more. The number of disulfide bridges in a protein can also be influenced by factors such as the species in which the protein is found and the environmental conditions in which the protein is expressed.",
    "vicuna-7b_fact_raw": "1. Hepcidin is a protein involved in the regulation of iron metabolism in the body.\n2. The number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.\n3. In humans, hepcidin is composed of 296 amino acids.\n4. Human hepcidin contains 10 disulfide bridges.\n5. Disulfide bridges contribute to the stability and function of hepcidin by maintaining its tertiary structure.",
    "vicuna-7b_fact": [
      "Hepcidin is a protein involved in the regulation of iron metabolism in the body.",
      "The number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.",
      "In humans, hepcidin is composed of 296 amino acids.",
      "Human hepcidin contains 10 disulfide bridges.",
      "Disulfide bridges contribute to the stability and function of hepcidin by maintaining its tertiary structure."
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "vicuna-7b_response": "DNAJC11 is a protein encoded by a gene that is localized in various tissues and organisms.\nIn humans, DNAJC11 is expressed in many tissues, including the brain, heart, liver, kidney, and pancreas. It is also expressed in fetal tissues, such as the lung and intestine. DNAJC11 has been localized to the endoplasmic reticulum (ER) and the mitochondria.\nIn mice, DNAJC11 is expressed in many tissues, including the brain, heart, liver, kidney, and pancreas. It is also expressed in fetal tissues, such as the lung and intestine. DNAJC11 has been localized to the ER and the mitochondria.\nIn other organisms, such as zebrafish and fruit flies, DNAJC11 has been localized to the ER and the mitochondria.\nOverall, DNAJC11 is a protein that is localized in various tissues and organisms, including the ER and the mitochondria.",
    "vicuna-7b_fact_raw": "1. DNAJC11 is a protein encoded by a gene that is expressed in human tissues including the brain, heart, liver, kidney, and pancreas.\n2. In humans, DNAJC11 is also expressed in fetal tissues such as the lung and intestine.\n3. DNAJC11 has been localized to the endoplasmic reticulum (ER) and the mitochondria in humans.\n4. In mice, DNAJC11 expression is found in tissues including the brain, heart, liver, kidney, and pancreas, as well as in fetal tissues like the lung and intestine.\n5. DNAJC11 has been localized to the ER and the mitochondria in other organisms, such as zebrafish and fruit flies.",
    "vicuna-7b_fact": [
      "DNAJC11 is a protein encoded by a gene that is expressed in human tissues including the brain, heart, liver, kidney, and pancreas.",
      "In humans, DNAJC11 is also expressed in fetal tissues such as the lung and intestine.",
      "DNAJC11 has been localized to the endoplasmic reticulum (ER) and the mitochondria in humans.",
      "In mice, DNAJC11 expression is found in tissues including the brain, heart, liver, kidney, and pancreas, as well as in fetal tissues like the lung and intestine.",
      "DNAJC11 has been localized to the ER and the mitochondria in other organisms, such as zebrafish and fruit flies."
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "vicuna-7b_response": "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species, meaning that they are found in similar forms in different organisms. UCEs are typically found in the 3' region of genes and are thought to be important for gene regulation.\nCopy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome. CNVs can be either gain, which means that a region of DNA is present in more copies than expected, or loss, which means that a region of DNA is present in fewer copies than expected.\nIt is possible that UCEs could be depleted among CNVs, meaning that CNVs are more likely to occur in regions of the genome that do not contain UCEs. However, the relationship between UCEs and CNVs is complex and not well understood. Some studies have suggested that UCEs may be more likely to be present in regions of the genome that are not affected by CNVs, while other studies have found that UCEs are more likely to be present in regions of the genome that are affected by CNVs.\nOverall, it is difficult to make generalizations about the relationship between UCEs and CNVs, as the relationship may vary depending on the specific context and the type of CNV that is being considered.",
    "vicuna-7b_fact_raw": "1. Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species.\n2. UCEs are typically found in the 3' region of genes.\n3. UCEs are thought to be important for gene regulation.\n4. Copy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome.\n5. CNVs can be categorized as either gain (more copies than expected) or loss (fewer copies than expected).",
    "vicuna-7b_fact": [
      "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species.",
      "UCEs are typically found in the 3' region of genes.",
      "UCEs are thought to be important for gene regulation.",
      "Copy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome.",
      "CNVs can be categorized as either gain (more copies than expected) or loss (fewer copies than expected)."
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "vicuna-7b_response": "The Haspin kinase is a mitotic kinase that is active during the G2 phase of the cell cycle. It is a serine/threonine kinase that is involved in regulating the progression of the cell cycle by phosphorylating and inactivating several proteins, including the anaphase-promoting complex/cyclosome (APC/C) and the mitotic kinesin-like protein 2 (MKLP2).\nDuring mitosis, the Haspin kinase is primarily localized to the centromeres, where it plays a role in regulating the separation of sister chromatids during anaphase. It is thought that the substrate of the Haspin kinase during mitosis is the proteins that it phosphorylates and inactivates, such as APC/C and MKLP2.\nIn summary, the substrate of the Haspin kinase during mitosis is the proteins that it phosphorylates and inactivates, such as APC/C and MKLP2.",
    "vicuna-7b_fact_raw": "1. The Haspin kinase is active during the G2 phase of the cell cycle.\n2. Haspin kinase is a serine/threonine kinase.\n3. Haspin kinase phosphorylates and inactivates several proteins, including the anaphase-promoting complex/cyclosome (APC/C) and the mitotic kinesin-like protein 2 (MKLP2).\n4. During mitosis, Haspin kinase is primarily localized to the centromeres.\n5. The substrate of the Haspin kinase during mitosis includes proteins such as APC/C and MKLP2.",
    "vicuna-7b_fact": [
      "The Haspin kinase is active during the G2 phase of the cell cycle.",
      "Haspin kinase is a serine/threonine kinase.",
      "Haspin kinase phosphorylates and inactivates several proteins, including the anaphase-promoting complex/cyclosome (APC/C) and the mitotic kinesin-like protein 2 (MKLP2).",
      "During mitosis, Haspin kinase is primarily localized to the centromeres.",
      "The substrate of the Haspin kinase during mitosis includes proteins such as APC/C and MKLP2."
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "vicuna-7b_response": "Viroids are small infectious RNA molecules that replicate in the cytoplasm of host cells. They are not considered to be true viruses, but rather a unique class of infectious agents that are capable of replicating themselves using a single-stranded RNA as a template.\nThe mechanism of viroid replication involves the following steps:\n1. Entry: Viroids enter host cells through receptor-mediated endocytosis or by binding to specific cellular receptors.\n2. Uncoating: The viroid-containing vesicle fuses with the endosome and the viroid is released into the cytoplasm.\n3. RNA replication: The viroid RNA is replicated by the host cell's RNA replicase enzyme. The replication process is initiated at the 5' end of the RNA and proceeds in the 5' to 3' direction.\n4. Transcription: The replicated RNA is transcribed into complementary DNA (cDNA) by the host cell's RNA-dependent RNA polymerase enzyme.\n5. Replication: The cDNA is used as a template to synthesize new viroid RNA. This process is repeated until a large quantity of viroid RNA is produced.\n6. Maturation: The newly synthesized viroid RNA is assembled into a capsid, which is then released from the host cell.\nOverall, the mechanism of viroid replication is a simple and efficient process that allows these RNA viruses to replicate rapidly within host cells.",
    "vicuna-7b_fact_raw": "1. Viroids replicate in the cytoplasm of host cells.\n2. Viroids use a single-stranded RNA as a template for replication.\n3. Viroid RNA is replicated by the host cell's RNA replicase enzyme.\n4. The replication of viroid RNA is initiated at the 5' end and proceeds in the 5' to 3' direction.\n5. The replicated viroid RNA is transcribed into complementary DNA (cDNA) by the host cell's RNA-dependent RNA polymerase enzyme.",
    "vicuna-7b_fact": [
      "Viroids replicate in the cytoplasm of host cells.",
      "Viroids use a single-stranded RNA as a template for replication.",
      "Viroid RNA is replicated by the host cell's RNA replicase enzyme.",
      "The replication of viroid RNA is initiated at the 5' end and proceeds in the 5' to 3' direction.",
      "The replicated viroid RNA is transcribed into complementary DNA (cDNA) by the host cell's RNA-dependent RNA polymerase enzyme."
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "vicuna-7b_response": "Fibronectin is a protein that is found in the extracellular matrix and plays a role in cell adhesion and migration. It is not typically considered a serum biomarker for Duchenne muscular dystrophy (DMD).\nDMD is a genetic disorder that affects muscle strength and function. It is caused by a mutation in the dystrophin gene, which results in a lack of dystrophin protein in muscle cells. The hallmark of DMD is progressive muscle weakness and wasting, particularly in the legs.\nThere are several serum biomarkers that have been studied in DMD, including creatine kinase (CK), muscle enzymes such as aldolase and aspartate aminotransferase (AST/ALT), and muscle-specific proteins such as myoglobin and troponin. These biomarkers can be used to diagnose DMD and monitor disease progression.\nHowever, it is important to note that fibronectin is not a specific biomarker for DMD, and its levels in the serum are not typically used to diagnose or monitor the disease. Further research is needed to determine the potential role of fibronectin in DMD.",
    "vicuna-7b_fact_raw": "1. Fibronectin is a protein found in the extracellular matrix involved in cell adhesion and migration.\n2. Duchenne muscular dystrophy (DMD) is caused by a mutation in the dystrophin gene.\n3. The lack of dystrophin protein in muscle cells is a characteristic of DMD.\n4. Creatine kinase (CK), aldolase, aspartate aminotransferase (AST/ALT), myoglobin, and troponin are serum biomarkers studied in DMD.\n5. Fibronectin is not typically considered a serum biomarker for Duchenne muscular dystrophy.",
    "vicuna-7b_fact": [
      "Fibronectin is a protein found in the extracellular matrix involved in cell adhesion and migration.",
      "Duchenne muscular dystrophy (DMD) is caused by a mutation in the dystrophin gene.",
      "The lack of dystrophin protein in muscle cells is a characteristic of DMD.",
      "Creatine kinase (CK), aldolase, aspartate aminotransferase (AST/ALT), myoglobin, and troponin are serum biomarkers studied in DMD.",
      "Fibronectin is not typically considered a serum biomarker for Duchenne muscular dystrophy."
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "vicuna-7b_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n1. ENCODE (Encyclopedia Of DNA Elements) Project: The ENCODE project is a large-scale effort to identify all of the functional elements in the human genome. The project has generated a vast amount of data on DNA methylation, histone modifications, and other epigenetic marks, which are available on the DeepBlue epigenomic data server.\n2. Roadmap Epigenomics Project: The Roadmap Epigenomics Project is a large-scale effort to map the epigenomes of several human cell types. The project has generated data on DNA methylation, histone modifications, and other epigenetic marks, which are available on the DeepBlue epigenomic data server.\n3. Epigenomics Project: The Epigenomics Project is a large-scale effort to map the epigenomes of several human cell types. The project has generated data on DNA methylation, histone modifications, and other epigenetic marks, which are available on the DeepBlue epigenomic data server.\n4. 1000 Genomes Project: The 1000 Genomes Project is a large-scale effort to sequence the genomes of several thousand individuals from diverse populations. The project has generated data on DNA methylation, histone modifications, and other epigenetic marks, which are available on the DeepBlue epigenomic data server.\n5. ENCODE Drug Targets Project: The ENCODE Drug Targets Project is a large-scale effort to identify potential drug targets based on the functional elements identified in the ENCODE project. The project has generated data on DNA methylation, histone modifications, and other epigenetic marks, which are available on the DeepBlue epigenomic data server.\nThese are some of the major epigenome projects that are contained in the DeepBlue epigenomic data server. The data available on the server is constantly growing and evolving, so it is always a good idea to check the website for the latest updates and new data releases.",
    "vicuna-7b_fact_raw": "1. The DeepBlue epigenomic data server contains data from the ENCODE (Encyclopedia Of DNA Elements) Project.\n2. The Roadmap Epigenomics Project data is available on the DeepBlue epigenomic data server.\n3. Data from the Epigenomics Project can be found on the DeepBlue epigenomic data server.\n4. The 1000 Genomes Project data on DNA methylation, histone modifications, and other epigenetic marks are included in the DeepBlue epigenomic data server.\n5. The ENCODE Drug Targets Project data is part of the DeepBlue epigenomic data server's collection.",
    "vicuna-7b_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE (Encyclopedia Of DNA Elements) Project.",
      "The Roadmap Epigenomics Project data is available on the DeepBlue epigenomic data server.",
      "Data from the Epigenomics Project can be found on the DeepBlue epigenomic data server.",
      "The 1000 Genomes Project data on DNA methylation, histone modifications, and other epigenetic marks are included in the DeepBlue epigenomic data server.",
      "The ENCODE Drug Targets Project data is part of the DeepBlue epigenomic data server's collection."
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "vicuna-7b_response": "One tool that employs self-organizing maps (SOMs) for analyzing synonymous codon usage is the program CodonRun.\nCodonRun is a bioinformatics tool that uses SOMs to analyze synonymous codon usage in DNA sequences. It can identify codons that are used more frequently than others and can also predict the effect of mutations on codon usage. CodonRun can be used to analyze both prokaryotic and eukaryotic DNA sequences.\nThe tool can be useful for understanding the impact of mutations on gene expression and protein synthesis. It can also be used to identify potential optimization strategies for gene expression and protein production.\nCodonRun is available as a web-based tool and can be accessed through the website <https://www.codonrun.org/>. It is open source and can be downloaded and used locally.\nIn summary, CodonRun is a useful tool for analyzing synonymous codon usage and can be used to identify potential optimization strategies for gene expression and protein production.",
    "vicuna-7b_fact_raw": "1. The program CodonRun employs self-organizing maps (SOMs) for analyzing synonymous codon usage.\n2. CodonRun can analyze synonymous codon usage in both prokaryotic and eukaryotic DNA sequences.\n3. CodonRun is capable of identifying codons that are used more frequently than others.\n4. CodonRun can predict the effect of mutations on codon usage.\n5. CodonRun is available as a web-based tool and can be accessed at <https://www.codonrun.org/>.",
    "vicuna-7b_fact": [
      "The program CodonRun employs self-organizing maps (SOMs) for analyzing synonymous codon usage.",
      "CodonRun can analyze synonymous codon usage in both prokaryotic and eukaryotic DNA sequences.",
      "CodonRun is capable of identifying codons that are used more frequently than others.",
      "CodonRun can predict the effect of mutations on codon usage.",
      "CodonRun is available as a web-based tool and can be accessed at <https://www.codonrun.org/>."
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "vicuna-7b_response": "MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory (RAIL) at the University of California, Berkeley. It stands for Modular Interactive Robot with Intuitive Control. MINDY-1 is a research platform designed to study the principles of human-robot interaction and the development of advanced robotics technologies.\nThe robot is designed to be highly interactive and adaptable, with a modular structure that allows researchers to easily modify and upgrade its capabilities. It has a humanoid form with a body made of lightweight materials, seven degrees of freedom, and a head with a camera and microphone. MINDY-1 is equipped with sensors that allow it to perceive its environment and respond to stimuli, such as touch and sound.\nThe robot is controlled through a graphical user interface that allows users to program its movements and behaviors. MINDY-1 is also capable of learning from its interactions with humans, allowing it to adapt its behavior over time.\nOverall, MINDY-1 is a powerful research platform that is helping to advance the field of robotics and pave the way for more advanced and intuitive human-robot interactions in the future.",
    "vicuna-7b_fact_raw": "1. MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory at the University of California, Berkeley.\n2. MINDY-1 stands for Modular Interactive Robot with Intuitive Control.\n3. The robot is designed with a modular structure to allow for easy modifications and upgrades.\n4. MINDY-1 has seven degrees of freedom and is equipped with a camera and microphone in its head.\n5. The robot can perceive its environment and respond to stimuli using its sensors.",
    "vicuna-7b_fact": [
      "MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory at the University of California, Berkeley.",
      "MINDY-1 stands for Modular Interactive Robot with Intuitive Control.",
      "The robot is designed with a modular structure to allow for easy modifications and upgrades.",
      "MINDY-1 has seven degrees of freedom and is equipped with a camera and microphone in its head.",
      "The robot can perceive its environment and respond to stimuli using its sensors."
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "vicuna-7b_response": "There are several software packages available for the analysis of conserved genomic loci. Some of the most popular ones include:\n1. MEME: MEME (Multiple Experiment Markup Language) is a software tool that can be used to identify motifs in DNA or protein sequences. It can be used to identify conserved regions in genomic sequences, and can output the results in various formats.\n2. ConservED: ConservED is a software tool that can be used to identify conserved regions in multiple species. It can output the results in various formats, including a graphical representation of the conserved regions.\n3. RepeatMasker: RepeatMasker is a software tool that can be used to identify repetitive elements in genomic sequences. It can also be used to identify conserved regions, and can output the results in various formats.\n4. MACS: MACS (Model-based Analysis of ChIP-seq) is a software tool that can be used to identify enriched regions in genomic sequences. It can be used to identify conserved regions, and can output the results in various formats.\n5. GENE-EST: GENE-EST is a software tool that can be used to identify conserved regions in multiple species. It can output the results in various formats, including a graphical representation of the conserved regions.\nThese are just a few examples of the software packages available for the analysis of conserved genomic loci. The choice of software package will depend on the specific requirements of the user and the type of data that is available.",
    "vicuna-7b_fact_raw": "1. MEME (Multiple Experiment Markup Language) is a software tool designed to identify motifs in DNA or protein sequences.\n2. ConservED is a software tool used for identifying conserved regions across multiple species.\n3. RepeatMasker is a software tool that identifies repetitive elements and conserved regions in genomic sequences.\n4. MACS (Model-based Analysis of ChIP-seq) is a software tool used for identifying enriched regions in genomic sequences.\n5. GENE-EST is a software tool that identifies conserved regions in multiple species.",
    "vicuna-7b_fact": [
      "MEME (Multiple Experiment Markup Language) is a software tool designed to identify motifs in DNA or protein sequences.",
      "ConservED is a software tool used for identifying conserved regions across multiple species.",
      "RepeatMasker is a software tool that identifies repetitive elements and conserved regions in genomic sequences.",
      "MACS (Model-based Analysis of ChIP-seq) is a software tool used for identifying enriched regions in genomic sequences.",
      "GENE-EST is a software tool that identifies conserved regions in multiple species."
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "vicuna-7b_response": "The PIEZO2 gene is a gene that encodes for a protein called Piezo2, which is a member of the Piezo family of ion channels. Piezo2 is expressed in various tissues, including the inner ear, heart, and blood vessels, and plays a role in sensing mechanical stimuli such as pressure and touch.\nThere are several diseases that have been associated with mutations or dysfunction of the PIEZO2 gene. Here are three examples:\n1. Autosomal recessive non-syndromic hearing loss: Mutations in the PIEZO2 gene have been identified as a cause of non-syndromic hearing loss, which is a common type of hearing impairment that is not associated with any other medical symptoms.\n2. Hypertension: Dysfunction of the Piezo2 channel has been implicated in the development of hypertension, or high blood pressure. This is because Piezo2 plays a role in regulating blood pressure by sensing changes in blood volume and blood pressure.\n3. Congenital malformations, including cleft lip and palate: Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate. This is because Piezo2 is expressed in the developing embryo, and its dysfunction can disrupt normal development and cause malformations.",
    "vicuna-7b_fact_raw": "1. Mutations in the PIEZO2 gene have been identified as a cause of autosomal recessive non-syndromic hearing loss.\n2. Dysfunction of the Piezo2 channel has been implicated in the development of hypertension.\n3. Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate.",
    "vicuna-7b_fact": [
      "Mutations in the PIEZO2 gene have been identified as a cause of autosomal recessive non-syndromic hearing loss.",
      "Dysfunction of the Piezo2 channel has been implicated in the development of hypertension.",
      "Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate."
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "vicuna-7b_response": "ERAP1 and ERAP2 are two proteins that are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway, which is responsible for removing misfolded proteins from the endoplasmic reticulum (ER) in the cell.\nERAP1 and ERAP2 are the key components of the ERAD pathway, and they work together to promote the degradation of misfolded proteins. When a misfolded protein is detected in the ER, it is recognized by the ERAD-C complex, which is composed of ERAD-component 1 (ERAD-C1), ERAD-component 2 (ERAD-C2), and the trans-membrane protein RMS-1. The ERAD-C complex then targets the misfolded protein for degradation by the proteasome, a protein-degradation machine located in the cytoplasm.\nERAP1 and ERAP2 are responsible for recruiting the ERAD-C complex to the site of the misfolded protein. When ERAP1 and ERAP2 dimerize, they form a complex that is able to bind to the misfolded protein and recruit the ERAD-C complex to the site of the protein. This allows the ERAD-C complex to recognize the misfolded protein and target it for degradation by the proteasome.\nIn summary, ERAP1 and ERAP2 dimerization promotes the degradation of misfolded proteins by recruiting the ERAD-C complex to the site of the protein and allowing the ERAD-C complex to recognize and target the misfolded protein for degradation by the proteasome.",
    "vicuna-7b_fact_raw": "1. ERAP1 and ERAP2 are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway.\n2. The ERAD pathway is responsible for removing misfolded proteins from the endoplasmic reticulum (ER).\n3. ERAP1 and ERAP2 work together to promote the degradation of misfolded proteins.\n4. The ERAD-C complex, composed of ERAD-component 1 (ERAD-C1), ERAD-component 2 (ERAD-C2), and the trans-membrane protein RMS-1, targets misfolded proteins for degradation.\n5. Dimerization of ERAP1 and ERAP2 forms a complex that can bind to misfolded proteins and recruit the ERAD-C complex for degradation by the proteasome.",
    "vicuna-7b_fact": [
      "ERAP1 and ERAP2 are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway.",
      "The ERAD pathway is responsible for removing misfolded proteins from the endoplasmic reticulum (ER).",
      "ERAP1 and ERAP2 work together to promote the degradation of misfolded proteins.",
      "The ERAD-C complex, composed of ERAD-component 1 (ERAD-C1), ERAD-component 2 (ERAD-C2), and the trans-membrane protein RMS-1, targets misfolded proteins for degradation.",
      "Dimerization of ERAP1 and ERAP2 forms a complex that can bind to misfolded proteins and recruit the ERAD-C complex for degradation by the proteasome."
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "vicuna-7b_response": "R-spondin 1 and noggin are both proteins that play important roles in the development and maintenance of the gallbladder.\nR-spondin 1 is a protein that is expressed in the developing gallbladder and is involved in the formation of the gallbladder's epithelial lining. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells, which are the cells that make up the lining of the gallbladder. R-spondin 1 also promotes the formation of tight junctions between epithelial cells, which are important for maintaining the integrity of the epithelial lining.\nNoggin is a protein that is expressed in the developing embryo and is involved in the regulation of bone morphogenetic protein (BMP) signaling. BMP signaling is important for the development of many tissues, including the gallbladder. Noggin inhibits BMP signaling, which is important for the development of the gallbladder. Noggin also promotes the differentiation of epithelial cells into cuboidal cells, which are the cells that make up the lining of the gallbladder.\nIn non-damaged gallbladders, R-spondin 1 and noggin work together to promote the development and maintenance of the gallbladder's epithelial lining. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells and the formation of tight junctions between epithelial cells, while noggin inhibits BMP signaling and promotes the differentiation of epithelial cells into cuboidal cells.\nIn summary, R-spondin 1 and noggin play important roles in the development and maintenance of the gallbladder. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells and the formation of tight junctions between epithelial cells, while noggin inhibits BMP signaling and promotes the differentiation of epithelial cells into cuboidal cells.",
    "vicuna-7b_fact_raw": "1. R-spondin 1 is expressed in the developing gallbladder and is involved in the formation of the gallbladder's epithelial lining.\n2. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells in the gallbladder.\n3. R-spondin 1 also promotes the formation of tight junctions between epithelial cells in the gallbladder.\n4. Noggin is involved in the regulation of bone morphogenetic protein (BMP) signaling, which is important for the development of the gallbladder.\n5. Noggin inhibits BMP signaling and promotes the differentiation of epithelial cells into cuboidal cells in the gallbladder.",
    "vicuna-7b_fact": [
      "R-spondin 1 is expressed in the developing gallbladder and is involved in the formation of the gallbladder's epithelial lining.",
      "R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells in the gallbladder.",
      "R-spondin 1 also promotes the formation of tight junctions between epithelial cells in the gallbladder.",
      "Noggin is involved in the regulation of bone morphogenetic protein (BMP) signaling, which is important for the development of the gallbladder.",
      "Noggin inhibits BMP signaling and promotes the differentiation of epithelial cells into cuboidal cells in the gallbladder."
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "vicuna-7b_response": "Yes, NADPH oxidase 5 (Nox5) requires multiple subunits for its function. Nox5 is a subunit of the NADPH oxidase complex, which is responsible for generating reactive oxygen species (ROS) in cells. The NADPH oxidase complex is composed of several subunits, including p22phox, p47phox, p67phox, and Nox5.\nThe p22phox, p47phox, and p67phox subunits are required for the assembly and activation of the NADPH oxidase complex. These subunits interact with Nox5 to form the functional NADPH oxidase complex, which is localized in the plasma membrane of cells.\nIn the absence of these subunits, the NADPH oxidase complex is not assembled or activated, and ROS generation is impaired. This can lead to a variety of cellular dysfunctions, including inflammation, oxidative stress, and cell death.\nTherefore, Nox5 requires the p22phox, p47phox, and p67phox subunits for its function as a subunit of the NADPH oxidase complex.",
    "vicuna-7b_fact_raw": "1. NADPH oxidase 5 (Nox5) is a subunit of the NADPH oxidase complex.\n2. The NADPH oxidase complex is responsible for generating reactive oxygen species (ROS) in cells.\n3. The NADPH oxidase complex includes subunits such as p22phox, p47phox, p67phox, and Nox5.\n4. The p22phox, p47phox, and p67phox subunits are necessary for the assembly and activation of the NADPH oxidase complex.\n5. Without these subunits, the NADPH oxidase complex cannot assemble or activate, leading to impaired ROS generation.",
    "vicuna-7b_fact": [
      "NADPH oxidase 5 (Nox5) is a subunit of the NADPH oxidase complex.",
      "The NADPH oxidase complex is responsible for generating reactive oxygen species (ROS) in cells.",
      "The NADPH oxidase complex includes subunits such as p22phox, p47phox, p67phox, and Nox5.",
      "The p22phox, p47phox, and p67phox subunits are necessary for the assembly and activation of the NADPH oxidase complex.",
      "Without these subunits, the NADPH oxidase complex cannot assemble or activate, leading to impaired ROS generation."
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "vicuna-7b_response": "Furin and hepcidin are two different proteins that have a connection in the regulation of iron metabolism.\nHepcidin is a hormone produced by cells in the liver that plays a key role in regulating the amount of iron available in the body. It does this by binding to iron transporters in the duodenum, preventing iron from being absorbed from the diet. Hepcidin production is regulated by the body's need for iron, with higher levels of hepcidin being produced when iron stores are low and vice versa.\nFurin is an enzyme that plays a role in the processing of proteins. It is involved in the cleavage of certain proteins, including hepcidin, to release the active form of the protein. This is important because the inactive form of hepcidin is not as effective at regulating iron metabolism.\nIn summary, furin and hepcidin are connected in the regulation of iron metabolism because furin is involved in the processing of hepcidin, allowing it to function properly and regulate the amount of iron available in the body.",
    "vicuna-7b_fact_raw": "1. Hepcidin is a hormone produced by cells in the liver.\n2. Hepcidin regulates the amount of iron available in the body by binding to iron transporters in the duodenum.\n3. The production of hepcidin is regulated by the body's need for iron.\n4. Furin is an enzyme that plays a role in the processing of proteins, including hepcidin.\n5. Furin is involved in the cleavage of certain proteins to release their active forms.",
    "vicuna-7b_fact": [
      "Hepcidin is a hormone produced by cells in the liver.",
      "Hepcidin regulates the amount of iron available in the body by binding to iron transporters in the duodenum.",
      "The production of hepcidin is regulated by the body's need for iron.",
      "Furin is an enzyme that plays a role in the processing of proteins, including hepcidin.",
      "Furin is involved in the cleavage of certain proteins to release their active forms."
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "vicuna-7b_response": "The largest metabolic gene cluster in yeast is the PHO5 cluster, which is located on chromosome V. The PHO5 cluster encodes for the transcription factors that regulate the expression of genes involved in the synthesis of the amino acids tryptophan and tyrosine. These amino acids are essential for the growth of yeast and are therefore highly regulated. The PHO5 cluster is composed of 11 genes, including PHO5, PHO8, PHO10, PHO11, PHO12, PHO13, PHO14, PHO15, PHO16, PHO17, and PHO18. The PHO5 cluster is the largest metabolic gene cluster in yeast because it is responsible for regulating the synthesis of several essential amino acids, which are required for the growth and survival of yeast.",
    "vicuna-7b_fact_raw": "1. The largest metabolic gene cluster in yeast is the PHO5 cluster.\n2. The PHO5 cluster is located on chromosome V of yeast.\n3. The PHO5 cluster is responsible for encoding transcription factors that regulate genes involved in the synthesis of tryptophan and tyrosine.\n4. Tryptophan and tyrosine are essential amino acids for the growth of yeast.\n5. The PHO5 cluster is composed of 11 genes, including PHO5, PHO8, PHO10, PHO11, PHO12, PHO13, PHO14, PHO15, PHO16, PHO17, and PHO18.",
    "vicuna-7b_fact": [
      "The largest metabolic gene cluster in yeast is the PHO5 cluster.",
      "The PHO5 cluster is located on chromosome V of yeast.",
      "The PHO5 cluster is responsible for encoding transcription factors that regulate genes involved in the synthesis of tryptophan and tyrosine.",
      "Tryptophan and tyrosine are essential amino acids for the growth of yeast.",
      "The PHO5 cluster is composed of 11 genes, including PHO5, PHO8, PHO10, PHO11, PHO12, PHO13, PHO14, PHO15, PHO16, PHO17, and PHO18."
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "vicuna-7b_response": "LIMT (Long intergenic non-coding RNA METastasis) is a lncRNA (long non-coding RNA) that has been shown to play a role in the regulation of metastasis, which is the spread of cancer cells from one organ or tissue to another.\nResearch has shown that LIMT is upregulated in a variety of cancer types, including breast, lung, and colon cancer, and that it promotes the migration and invasion of cancer cells. Additionally, studies have shown that LIMT can interact with and regulate the expression of various genes involved in the metastatic process, including genes involved in cell adhesion, migration, and invasion.\nOverall, the role of LIMT in the regulation of metastasis is an area of active research, and further studies are needed to fully understand the mechanisms by which LIMT promotes the spread of cancer cells and to develop targeted therapies that can inhibit its function.",
    "vicuna-7b_fact_raw": "1. LIMT stands for Long intergenic non-coding RNA METastasis.\n2. LIMT is a long non-coding RNA (lncRNA).\n3. LIMT has been shown to play a role in the regulation of metastasis in cancer.\n4. LIMT is upregulated in various cancer types, including breast, lung, and colon cancer.\n5. LIMT promotes the migration and invasion of cancer cells.",
    "vicuna-7b_fact": [
      "LIMT stands for Long intergenic non-coding RNA METastasis.",
      "LIMT is a long non-coding RNA (lncRNA).",
      "LIMT has been shown to play a role in the regulation of metastasis in cancer.",
      "LIMT is upregulated in various cancer types, including breast, lung, and colon cancer.",
      "LIMT promotes the migration and invasion of cancer cells."
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "vicuna-7b_response": "The R/Bioconductor package used for performing SNP enrichment analysis is called \"SNPEff\".",
    "vicuna-7b_fact_raw": "NO FACTS",
    "vicuna-7b_fact": []
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "vicuna-7b_response": "Radial glial cells are a type of glial cell that play a crucial role in the development of the central nervous system, including the formation of the ependymal cells that line the ventricular system of the brain. The key players in radial glial specification to ependymal cells are transcription factors.\nOne of the most important transcription factors in the specification of radial glial cells to ependymal cells is the transcription factor Sox2. Sox2 is expressed in radial glial cells during embryonic development and is necessary for the differentiation of these cells into ependymal cells.\nAnother important transcription factor in the specification of radial glial cells to ependymal cells is the transcription factor Nkx2.1. Nkx2.1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nAdditionally, the transcription factor Ascl1 is also important in the specification of radial glial cells to ependymal cells. Ascl1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nFinally, the transcription factor Foxj1 is also important in the specification of radial glial cells to ependymal cells. Foxj1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nIn summary, the key players in radial glial specification to ependymal cells are transcription factors such as Sox2, Nkx2.1, Ascl1 and Foxj1. These transcription factors are necessary for the differentiation of radial glial cells into ependymal cells, and play a crucial role in the development of the central nervous system.",
    "vicuna-7b_fact_raw": "1. Radial glial cells are involved in the development of the central nervous system and the formation of ependymal cells.\n2. The transcription factor Sox2 is necessary for the differentiation of radial glial cells into ependymal cells.\n3. The transcription factor Nkx2.1 is necessary for the differentiation of radial glial cells into ependymal cells.\n4. The transcription factor Ascl1 is necessary for the differentiation of radial glial cells into ependymal cells.\n5. The transcription factor Foxj1 is necessary for the differentiation of radial glial cells into ependymal cells.",
    "vicuna-7b_fact": [
      "Radial glial cells are involved in the development of the central nervous system and the formation of ependymal cells.",
      "The transcription factor Sox2 is necessary for the differentiation of radial glial cells into ependymal cells.",
      "The transcription factor Nkx2.1 is necessary for the differentiation of radial glial cells into ependymal cells.",
      "The transcription factor Ascl1 is necessary for the differentiation of radial glial cells into ependymal cells.",
      "The transcription factor Foxj1 is necessary for the differentiation of radial glial cells into ependymal cells."
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "vicuna-7b_response": "Triple negative gliomas (TNGs) are a type of brain tumor that do not express the proteins normally found on the surface of most brain tumors, such as glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE). Instead, TNGs express other proteins, such as epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).\nTNGs are also characterized by the absence of positive staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). This is why they are called \"triple negative\" - they do not express any of the three main proteins that are typically found on the surface of brain tumors.\nIn addition to these characteristic markers, TNGs are also characterized by their aggressive behavior and poor prognosis. They tend to grow quickly and invade surrounding tissue, and they are often resistant to radiation and chemotherapy.\nOverall, the diagnosis of TNGs is based on a combination of histological and immunohistochemical features, as well as the absence of expression of the typical markers of other types of brain tumors.",
    "vicuna-7b_fact_raw": "1. Triple negative gliomas do not express glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE).\n2. Triple negative gliomas express epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).\n3. Triple negative gliomas do not express estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu).\n4. Triple negative gliomas are characterized by aggressive behavior and poor prognosis.\n5. The diagnosis of triple negative gliomas is based on histological and immunohistochemical features, and the absence of typical brain tumor markers.",
    "vicuna-7b_fact": [
      "Triple negative gliomas do not express glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE).",
      "Triple negative gliomas express epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).",
      "Triple negative gliomas do not express estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu).",
      "Triple negative gliomas are characterized by aggressive behavior and poor prognosis.",
      "The diagnosis of triple negative gliomas is based on histological and immunohistochemical features, and the absence of typical brain tumor markers."
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "vicuna-7b_response": "TOPAZ1 is a cryptocurrency that was created in 2017. It is a privacy-focused cryptocurrency that uses a technology called \"Zero Knowledge Proofs\" to provide users with enhanced privacy and security. TOPAZ1 is based on the Zerocoin protocol, which was developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.\nTOPAZ1 aims to provide users with the ability to conduct private transactions without the need for a trusted third party, such as a bank or government. This is achieved by using a technique called \"Zero Knowledge Proofs\" to verify transactions without revealing the underlying details of the transaction.\nTOPAZ1 also uses a decentralized governance model, where the network is governed by a group of elected community members known as \"stewards\". The stewards are responsible for making decisions about the future development of the TOPAZ1 network, such as implementing new features or upgrading the network's security.\nIn summary, TOPAZ1 is a privacy-focused cryptocurrency that uses Zero Knowledge Proofs to provide users with enhanced privacy and security. It is based on the Zerocoin protocol and uses a decentralized governance model to ensure that the network is governed by the community.",
    "vicuna-7b_fact_raw": "1. TOPAZ1 is a cryptocurrency that was created in 2017.\n2. TOPAZ1 uses a technology called \"Zero Knowledge Proofs\" for enhanced privacy and security.\n3. The Zerocoin protocol, which TOPAZ1 is based on, was developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.\n4. TOPAZ1 allows for private transactions without the need for a trusted third party.\n5. TOPAZ1 employs a decentralized governance model with community members known as \"stewards\" making decisions about the network's development.",
    "vicuna-7b_fact": [
      "TOPAZ1 is a cryptocurrency that was created in 2017.",
      "TOPAZ1 uses a technology called \"Zero Knowledge Proofs\" for enhanced privacy and security.",
      "The Zerocoin protocol, which TOPAZ1 is based on, was developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.",
      "TOPAZ1 allows for private transactions without the need for a trusted third party.",
      "TOPAZ1 employs a decentralized governance model with community members known as \"stewards\" making decisions about the network's development."
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "vicuna-7b_response": "GATA-1 is a transcription factor that plays a crucial role in the development and function of various cell types, including hematopoietic cells. GATA-1 isoforms are generated by alternative splicing of the GATA-1 mRNA, which results in the production of different protein isoforms with distinct functions.\nThe gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself. The GATA-1 gene is located on chromosome X and consists of 17 exons that are spliced together to produce the GATA-1 mRNA. The alternative splicing of the GATA-1 mRNA results in the production of different isoforms of GATA-1, each with a unique combination of exons.\nThe specific splicing events that give rise to the different GATA-1 isoforms are regulated by a complex network of transcription factors and cofactors, as well as by the presence of specific regulatory elements in the GATA-1 gene promoter. Some of the transcription factors that have been shown to regulate GATA-1 splicing include the splicing factors SF1 and SC35, as well as the transcription factor GATA-2.\nIn summary, the gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself, and the specific splicing events that give rise to the different isoforms are regulated by a complex network of transcription factors and cofactors.",
    "vicuna-7b_fact_raw": "1. GATA-1 is a transcription factor important for the development and function of various cell types, including hematopoietic cells.\n2. GATA-1 isoforms are generated by alternative splicing of the GATA-1 mRNA.\n3. The GATA-1 gene is located on chromosome X.\n4. The GATA-1 gene consists of 17 exons that are spliced together to produce GATA-1 mRNA.\n5. The splicing factors SF1 and SC35, as well as the transcription factor GATA-2, are involved in regulating GATA-1 splicing.",
    "vicuna-7b_fact": [
      "GATA-1 is a transcription factor important for the development and function of various cell types, including hematopoietic cells.",
      "GATA-1 isoforms are generated by alternative splicing of the GATA-1 mRNA.",
      "The GATA-1 gene is located on chromosome X.",
      "The GATA-1 gene consists of 17 exons that are spliced together to produce GATA-1 mRNA.",
      "The splicing factors SF1 and SC35, as well as the transcription factor GATA-2, are involved in regulating GATA-1 splicing."
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "vicuna-7b_response": "MIRA-seq (Mutation Identification by Deep Sequencing) is a powerful technique used to identify somatic mutations in a genome. It is a high-throughput sequencing-based approach that involves capturing and sequencing the entire exome (all protein-coding genes) of a sample, followed by a targeted sequencing of the remaining genome.\nThe exome capture step uses a specific set of probes to enrich for the coding regions of the genome, while the remaining genome is sequenced using a targeted sequencing approach. This allows for the identification of both coding and non-coding mutations, including single nucleotide variants (SNVs), insertions and deletions (indels), and copy number variations (CNVs).\nMIRA-seq is particularly useful for studying somatic mutations, which are mutations that occur in cells other than the germline cells (sperm or egg cells). These mutations can be caused by various factors, such as environmental exposures, aging, or genetic predisposition, and can lead to the development of cancer or other diseases.\nBy using MIRA-seq, researchers can identify somatic mutations in a genome and study their impact on the development and progression of diseases. This technique has been used to study a wide range of diseases, including cancer, neurological disorders, and genetic diseases.\nIn summary, MIRA-seq is a powerful technique used to identify somatic mutations in a genome, which can provide valuable insights into the development and progression of diseases.",
    "vicuna-7b_fact_raw": "1. MIRA-seq stands for Mutation Identification by Deep Sequencing.\n2. MIRA-seq is a technique used to identify somatic mutations in a genome.\n3. The technique involves capturing and sequencing the entire exome of a sample.\n4. MIRA-seq uses a specific set of probes to enrich for the coding regions of the genome.\n5. MIRA-seq has been used to study diseases such as cancer, neurological disorders, and genetic diseases.",
    "vicuna-7b_fact": [
      "MIRA-seq stands for Mutation Identification by Deep Sequencing.",
      "MIRA-seq is a technique used to identify somatic mutations in a genome.",
      "The technique involves capturing and sequencing the entire exome of a sample.",
      "MIRA-seq uses a specific set of probes to enrich for the coding regions of the genome.",
      "MIRA-seq has been used to study diseases such as cancer, neurological disorders, and genetic diseases."
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "vicuna-7b_response": "ARCALYST is a biologic drug that is used to treat cryopyrin-associated periodic syndromes (CAPS), a rare genetic disorder characterized by periodic fever, skin rash, and inflammation. It is given as an injection under the skin (subcutaneous injection) and is typically administered every 4 weeks.\nThe drug works by targeting and inhibiting the activity of a protein called interleukin-1 beta (IL-1β), which is involved in the inflammatory response. By reducing the production of IL-1β, ARCALYST helps to reduce the symptoms of CAPS, such as fever, skin rash, and joint pain.\nIt is important to note that ARCALYST is not a cure for CAPS, and it is not effective in treating all cases of the disorder. It is also not recommended for use in people with certain medical conditions, such as a history of infections or certain types of cancer.\nIf you have been prescribed ARCALYST and have questions about its use, it is important to discuss them with your healthcare provider. They can provide you with more information about the drug and help you determine if it is right for you.",
    "vicuna-7b_fact_raw": "1. ARCALYST is used to treat cryopyrin-associated periodic syndromes (CAPS).\n2. CAPS is characterized by periodic fever, skin rash, and inflammation.\n3. ARCALYST is administered as a subcutaneous injection every 4 weeks.\n4. The drug ARCALYST targets and inhibits the activity of interleukin-1 beta (IL-1β).\n5. ARCALYST is not a cure for CAPS.",
    "vicuna-7b_fact": [
      "ARCALYST is used to treat cryopyrin-associated periodic syndromes (CAPS).",
      "CAPS is characterized by periodic fever, skin rash, and inflammation.",
      "ARCALYST is administered as a subcutaneous injection every 4 weeks.",
      "The drug ARCALYST targets and inhibits the activity of interleukin-1 beta (IL-1β).",
      "ARCALYST is not a cure for CAPS."
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "vicuna-7b_response": "Robertsonian translocation is a type of chromosomal abnormality that occurs when two acrocentric chromosomes (chromosomes 13 and 14 in humans) fuse together, resulting in the formation of a derivative chromosome. The derivative chromosome is typically made up of the telomeric regions of the two acrocentric chromosomes that fused, and the centromere of one of the acrocentric chromosomes.\nThe human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13 and 14. The fusion of these two chromosomes results in the formation of a derivative chromosome that contains the telomeric regions of chromosomes 13 and 14, as well as the centromere of one of the acrocentric chromosomes. The derivative chromosome is typically shortened and has a unique genetic makeup, which can lead to a variety of health problems.",
    "vicuna-7b_fact_raw": "1. Robertsonian translocation is a chromosomal abnormality involving the fusion of two acrocentric chromosomes.\n2. In humans, chromosomes 13 and 14 can be involved in Robertsonian translocation.\n3. The derivative chromosome formed from Robertsonian translocation contains the telomeric regions of the two fused acrocentric chromosomes.\n4. The derivative chromosome also contains the centromere of one of the acrocentric chromosomes.\n5. The derivative chromosome resulting from a Robertsonian translocation is typically shortened.",
    "vicuna-7b_fact": [
      "Robertsonian translocation is a chromosomal abnormality involving the fusion of two acrocentric chromosomes.",
      "In humans, chromosomes 13 and 14 can be involved in Robertsonian translocation.",
      "The derivative chromosome formed from Robertsonian translocation contains the telomeric regions of the two fused acrocentric chromosomes.",
      "The derivative chromosome also contains the centromere of one of the acrocentric chromosomes.",
      "The derivative chromosome resulting from a Robertsonian translocation is typically shortened."
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "vicuna-7b_response": "There are several R packages that can be used for the identification of pediatric brain tumors, including:\n1. Brain-Tumor-Classifier: This package uses machine learning algorithms to classify brain tumors into different categories, including pediatric brain tumors.\n2. R-CNN: This package is a deep learning framework that can be used for object detection, including the detection of brain tumors in pediatric MRI scans.\n3. TensorFlow: This is a popular deep learning framework that can be used for a variety of tasks, including image classification and object detection.\n4. H2O.ai: This package is a machine learning platform that can be used for a variety of tasks, including the identification of pediatric brain tumors.\n5. Caret: This package is a collection of functions for planning, fitting, and assessing machine learning models, including those used for the identification of pediatric brain tumors.\nIt's important to note that the choice of package will depend on the specific task and the data that is available. It's also important to consult with a medical professional before using any package for diagnostic purposes.",
    "vicuna-7b_fact_raw": "1. The Brain-Tumor-Classifier R package uses machine learning algorithms to classify brain tumors.\n2. The R-CNN package is a deep learning framework for object detection that can be applied to detecting brain tumors in pediatric MRI scans.\n3. TensorFlow is a deep learning framework that can be used for tasks such as image classification and object detection.\n4. H2O.ai is a machine learning platform that can be utilized for identifying pediatric brain tumors.\n5. The Caret package in R provides functions for planning, fitting, and assessing machine learning models, including those for identifying pediatric brain tumors.",
    "vicuna-7b_fact": [
      "The Brain-Tumor-Classifier R package uses machine learning algorithms to classify brain tumors.",
      "The R-CNN package is a deep learning framework for object detection that can be applied to detecting brain tumors in pediatric MRI scans.",
      "TensorFlow is a deep learning framework that can be used for tasks such as image classification and object detection.",
      "H2O.ai is a machine learning platform that can be utilized for identifying pediatric brain tumors.",
      "The Caret package in R provides functions for planning, fitting, and assessing machine learning models, including those for identifying pediatric brain tumors."
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "vicuna-7b_response": "Yes, Nemo is a zinc finger protein. Zinc finger proteins are proteins that contain a zinc ion in their structure and are involved in regulating gene expression. Nemo is a zinc finger protein that is involved in the regulation of gene expression in the nervous system. It is a transcription factor that binds to specific DNA sequences and regulates the expression of genes involved in the development and function of the nervous system. Nemo is also involved in the regulation of stress response in the nervous system.",
    "vicuna-7b_fact_raw": "1. Nemo is a zinc finger protein.\n2. Zinc finger proteins contain a zinc ion in their structure.\n3. Zinc finger proteins are involved in regulating gene expression.\n4. Nemo regulates gene expression in the nervous system.\n5. Nemo is involved in the regulation of stress response in the nervous system.",
    "vicuna-7b_fact": [
      "Nemo is a zinc finger protein.",
      "Zinc finger proteins contain a zinc ion in their structure.",
      "Zinc finger proteins are involved in regulating gene expression.",
      "Nemo regulates gene expression in the nervous system.",
      "Nemo is involved in the regulation of stress response in the nervous system."
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "vicuna-7b_response": "TFIIS (Transcription Factor IIS) is a transcriptional elongation factor that plays a critical role in the initiation and elongation of RNA polymerase II transcription. TFIIS interacts with the RNA polymerase II holoenzyme and helps to recruit and stabilize the transcription elongation factor EF-1α.\nIn terms of nucleosome positioning, TFIIS does not directly affect nucleosome positioning. Nucleosomes are composed of histone proteins that are arranged around DNA in a way that compacts the DNA and allows it to be more easily packaged into the cell's nucleus. Nucleosomes are typically found at the core of the chromatin fiber, and their positioning is determined by the interactions between the histone tails and the DNA.\nHowever, TFIIS can indirectly affect nucleosome positioning by influencing the transcriptional elongation process. For example, TFIIS can help to recruit the transcription elongation factor EF-1α to the promoter region, which can lead to the disassembly of nucleosomes and the opening up of the chromatin structure. This can allow for the transcriptional machinery to access the DNA and initiate transcription.\nIn summary, while TFIIS does not directly affect nucleosome positioning, it can indirectly influence nucleosome positioning by influencing the transcriptional elongation process.",
    "vicuna-7b_fact_raw": "1. TFIIS is a transcriptional elongation factor that plays a role in the initiation and elongation of RNA polymerase II transcription.\n2. TFIIS interacts with the RNA polymerase II holoenzyme.\n3. TFIIS helps to recruit and stabilize the transcription elongation factor EF-1α.\n4. Nucleosomes are composed of histone proteins and are involved in compacting DNA for packaging into the cell's nucleus.\n5. TFIIS can indirectly affect nucleosome positioning by influencing the transcriptional elongation process.",
    "vicuna-7b_fact": [
      "TFIIS is a transcriptional elongation factor that plays a role in the initiation and elongation of RNA polymerase II transcription.",
      "TFIIS interacts with the RNA polymerase II holoenzyme.",
      "TFIIS helps to recruit and stabilize the transcription elongation factor EF-1α.",
      "Nucleosomes are composed of histone proteins and are involved in compacting DNA for packaging into the cell's nucleus.",
      "TFIIS can indirectly affect nucleosome positioning by influencing the transcriptional elongation process."
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "vicuna-7b_response": "The origins of replication close to yeast centromeres fire early.\nCentromeres are the regions of the chromosome where the two sister chromatids are joined during cell division, and they are also the sites where the replication originates. In yeast, the origins of replication are located close to the centromeres, and they fire early during the S phase of the cell cycle.\nThis is in contrast to origins located far from the centromeres, which fire later in the S phase. The early firing of origins close to the centromeres ensures that replication occurs before the chromosomes are separated during cell division, ensuring that each daughter cell receives an exact copy of the genetic material.\nOverall, the timing of replication origin firing is critical for maintaining genetic stability and ensuring proper cell division.",
    "vicuna-7b_fact_raw": "1. Origins of replication close to yeast centromeres fire early during the S phase of the cell cycle.\n2. Centromeres are regions where the two sister chromatids are joined during cell division.\n3. In yeast, the origins of replication are located close to the centromeres.\n4. Origins of replication located far from the centromeres fire later in the S phase.\n5. Early firing of origins close to the centromeres is important for ensuring that each daughter cell receives an exact copy of the genetic material.",
    "vicuna-7b_fact": [
      "Origins of replication close to yeast centromeres fire early during the S phase of the cell cycle.",
      "Centromeres are regions where the two sister chromatids are joined during cell division.",
      "In yeast, the origins of replication are located close to the centromeres.",
      "Origins of replication located far from the centromeres fire later in the S phase.",
      "Early firing of origins close to the centromeres is important for ensuring that each daughter cell receives an exact copy of the genetic material."
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "vicuna-7b_response": "Mammalian GA-sequences are a type of non-coding RNA that are found in the nuclei of mammalian cells. They are characterized by the presence of a specific sequence called the GA-sequence, which is composed of the nucleotides guanine, adenine, and cytosine.\nIn addition to the GA-sequence, mammalian GA-sequences also contain a specific type of modification called N6-methyladenosine (m6A). This modification is thought to play a role in regulating the expression of genes and is involved in a variety of cellular processes, including development, differentiation, and cellular metabolism.\nMammalian GA-sequences are found in a variety of tissues and cell types, and their expression is regulated by a complex network of transcription factors, epigenetic modifications, and other regulatory mechanisms.\nOverall, mammalian GA-sequences are an important class of non-coding RNA that play a critical role in regulating gene expression and cellular processes in mammalian cells.",
    "vicuna-7b_fact_raw": "1. Mammalian GA-sequences are a type of non-coding RNA found in the nuclei of mammalian cells.\n2. The GA-sequence is composed of the nucleotides guanine, adenine, and cytosine.\n3. Mammalian GA-sequences contain a modification called N6-methyladenosine (m6A).\n4. This m6A modification is involved in regulating gene expression and various cellular processes including development, differentiation, and cellular metabolism.\n5. The expression of mammalian GA-sequences is regulated by transcription factors, epigenetic modifications, and other regulatory mechanisms.",
    "vicuna-7b_fact": [
      "Mammalian GA-sequences are a type of non-coding RNA found in the nuclei of mammalian cells.",
      "The GA-sequence is composed of the nucleotides guanine, adenine, and cytosine.",
      "Mammalian GA-sequences contain a modification called N6-methyladenosine (m6A).",
      "This m6A modification is involved in regulating gene expression and various cellular processes including development, differentiation, and cellular metabolism.",
      "The expression of mammalian GA-sequences is regulated by transcription factors, epigenetic modifications, and other regulatory mechanisms."
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "vicuna-7b_response": "The number of Groucho-related genes (GRG) in the mouse genome is not a fixed number, as the genome is constantly evolving and new genes are being discovered. However, as of the latest mouse genome assembly (mm10), there are 10 known Groucho-related genes (GRG1-GRG10) that have been identified. These genes are also known as the Groucho family of genes, and they play a role in regulating the expression of other genes.",
    "vicuna-7b_fact_raw": "1. The mouse genome contains 10 known Groucho-related genes (GRG1-GRG10).\n2. These genes are identified in the latest mouse genome assembly (mm10).\n3. Groucho-related genes are also known as the Groucho family of genes.\n4. Groucho-related genes play a role in regulating the expression of other genes.",
    "vicuna-7b_fact": [
      "The mouse genome contains 10 known Groucho-related genes (GRG1-GRG10).",
      "These genes are identified in the latest mouse genome assembly (mm10).",
      "Groucho-related genes are also known as the Groucho family of genes.",
      "Groucho-related genes play a role in regulating the expression of other genes."
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "vicuna-7b_response": "RNA polymerase II is a complex enzyme that is responsible for transcribing DNA into RNA. It is composed of several subunits, and one of these subunits, Rpb11, carries RNA cleavage activity.\nRpb11 is one of the largest subunits of RNA polymerase II and is involved in the process of transcription elongation. It is responsible for recognizing and binding to the template strand of the DNA molecule, as well as the transcribed strand of RNA.\nIn addition to its role in transcription elongation, Rpb11 also carries RNA cleavage activity. This activity is thought to be involved in the regulation of transcription, as it allows the enzyme to cleave RNA molecules at specific sites. This can lead to the production of mature, functional RNA molecules, or it can result in the degradation of RNA that is not needed.\nOverall, Rpb11 is an important subunit of RNA polymerase II that plays a key role in the process of transcription. Its ability to carry RNA cleavage activity is just one of the many functions that it performs in this complex process.",
    "vicuna-7b_fact_raw": "1. RNA polymerase II is responsible for transcribing DNA into RNA.\n2. Rpb11 is a subunit of RNA polymerase II.\n3. Rpb11 carries RNA cleavage activity.\n4. Rpb11 is involved in the process of transcription elongation.\n5. Rpb11's RNA cleavage activity is involved in the regulation of transcription.",
    "vicuna-7b_fact": [
      "RNA polymerase II is responsible for transcribing DNA into RNA.",
      "Rpb11 is a subunit of RNA polymerase II.",
      "Rpb11 carries RNA cleavage activity.",
      "Rpb11 is involved in the process of transcription elongation.",
      "Rpb11's RNA cleavage activity is involved in the regulation of transcription."
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "vicuna-7b_response": "Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features such as a broad nasal bridge, low-set ears, and a small jaw. The genetic basis of Ohdo syndrome is caused by mutations in the PHF8 gene.\nPHF8 is a protein-coding gene that plays a critical role in the development of the brain and nervous system. Mutations in the PHF8 gene can lead to disruptions in the normal function of the gene, resulting in the development of Ohdo syndrome.\nThe PHF8 gene is located on the long (q) arm of chromosome 1 at position 13.1 and spans approximately 200 kilobases. The gene contains 21 exons that code for a protein with multiple domains, including a zinc finger domain, a PHD finger domain, and a KRAB repression domain.\nMutations in the PHF8 gene can result in a variety of clinical features, including intellectual disability, developmental delay, and distinctive facial features. The severity of the symptoms can vary depending on the specific mutation and the presence of other genetic factors.\nIn summary, the genetic basis of Ohdo syndrome is caused by mutations in the PHF8 gene, which plays a critical role in the development of the brain and nervous system. Mutations in the PHF8 gene can lead to disruptions in the normal function of the gene, resulting in the development of Ohdo syndrome.",
    "vicuna-7b_fact_raw": "1. Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features.\n2. Mutations in the PHF8 gene cause Ohdo syndrome.\n3. The PHF8 gene is located on the long (q) arm of chromosome 1 at position 13.1.\n4. The PHF8 gene spans approximately 200 kilobases and contains 21 exons.\n5. The PHF8 gene codes for a protein with multiple domains, including a zinc finger domain, a PHD finger domain, and a KRAB repression domain.",
    "vicuna-7b_fact": [
      "Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features.",
      "Mutations in the PHF8 gene cause Ohdo syndrome.",
      "The PHF8 gene is located on the long (q) arm of chromosome 1 at position 13.1.",
      "The PHF8 gene spans approximately 200 kilobases and contains 21 exons.",
      "The PHF8 gene codes for a protein with multiple domains, including a zinc finger domain, a PHD finger domain, and a KRAB repression domain."
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "vicuna-7b_response": "One R/Bioconductor package that has been developed for the analysis of psychiatric disease genes is the \"HumanMethylation27\" package. This package provides tools for analyzing DNA methylation data from the Illumina 450K methylation array, which is commonly used to study epigenetic changes in psychiatric disease.\nThe package provides functions for processing and analyzing methylation data, including functions for quality control, normalization, and statistical analysis. It also includes functions for visualizing methylation data using various plots and heatmaps.\nAnother package that can be used for the analysis of psychiatric disease genes is the \"limma\" package. This package provides tools for linear models for microarray data analysis, which can be used to analyze gene expression data from psychiatric disease patients.\nIt's worth noting that there are many other R/Bioconductor packages that can be used for the analysis of psychiatric disease genes, depending on the specific research question and the type of data being analyzed.",
    "vicuna-7b_fact_raw": "1. The \"HumanMethylation27\" package is an R/Bioconductor package developed for the analysis of psychiatric disease genes.\n2. The \"HumanMethylation27\" package provides tools for analyzing DNA methylation data from the Illumina 450K methylation array.\n3. The \"HumanMethylation27\" package includes functions for quality control, normalization, and statistical analysis of methylation data.\n4. The \"limma\" package is another R/Bioconductor package that can be used for the analysis of psychiatric disease genes.\n5. The \"limma\" package provides tools for linear models for microarray data analysis.",
    "vicuna-7b_fact": [
      "The \"HumanMethylation27\" package is an R/Bioconductor package developed for the analysis of psychiatric disease genes.",
      "The \"HumanMethylation27\" package provides tools for analyzing DNA methylation data from the Illumina 450K methylation array.",
      "The \"HumanMethylation27\" package includes functions for quality control, normalization, and statistical analysis of methylation data.",
      "The \"limma\" package is another R/Bioconductor package that can be used for the analysis of psychiatric disease genes.",
      "The \"limma\" package provides tools for linear models for microarray data analysis."
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "vicuna-7b_response": "Intracerebral hemorrhage, also known as a stroke, is a medical emergency that occurs when there is bleeding within the brain. The swirl sign is a radiological finding that is seen on CT scans of the brain in patients with intracerebral hemorrhage.\nThe swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain. This pattern is caused by the movement of blood within the brain, which can cause the brain tissue to become distorted and twisted. The swirl sign is often seen in the early stages of intracerebral hemorrhage, and it can help doctors to diagnose the condition and determine the severity of the bleeding.\nThe swirl sign is not always present in all cases of intracerebral hemorrhage, and it is not a specific diagnostic indicator. However, it can be a useful tool for doctors to help diagnose and manage this serious medical condition.\nIn summary, the swirl sign is a radiological finding that is seen on CT scans of the brain in patients with intracerebral hemorrhage. It is characterized by a swirling pattern of blood within the affected hemisphere of the brain, and it can help doctors to diagnose and manage this serious medical condition.",
    "vicuna-7b_fact_raw": "1. Intracerebral hemorrhage is a medical emergency characterized by bleeding within the brain.\n2. The swirl sign is a radiological finding observed on CT scans in patients with intracerebral hemorrhage.\n3. The swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain.\n4. The swirl sign is often seen in the early stages of intracerebral hemorrhage.\n5. The swirl sign can assist doctors in diagnosing the condition and determining the severity of the bleeding.",
    "vicuna-7b_fact": [
      "Intracerebral hemorrhage is a medical emergency characterized by bleeding within the brain.",
      "The swirl sign is a radiological finding observed on CT scans in patients with intracerebral hemorrhage.",
      "The swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain.",
      "The swirl sign is often seen in the early stages of intracerebral hemorrhage.",
      "The swirl sign can assist doctors in diagnosing the condition and determining the severity of the bleeding."
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "vicuna-7b_response": "ROF1, also known as RNA polymerase II factor 1, is a transcription factor that plays a crucial role in the regulation of gene expression in Arabidopsis thaliana. ROF1 is a component of the general transcription factor TFIIF, which is responsible for the recruitment of RNA polymerase II to promoters and the initiation of transcription.\nROF1 is inducible and its expression can be regulated by various stimuli, including light, temperature, and stress conditions. For example, exposure to high light intensity can induce ROF1 expression in Arabidopsis, as well as other plant species. This is thought to be a mechanism for protecting the plant from photooxidative stress, as ROF1 is involved in the regulation of genes involved in the response to oxidative stress.\nIn addition to light, ROF1 expression can also be induced by various abiotic stress conditions, such as drought, salt, and cold. This suggests that ROF1 plays a role in the plant's response to a wide range of environmental stimuli.\nIt is worth noting that ROF1 expression can also be regulated by various hormones, such as auxin and cytokinin. For example, auxin has been shown to induce ROF1 expression in Arabidopsis, which may be involved in the regulation of cell elongation and growth.\nIn summary, ROF1 expression can be induced by various stimuli, including light, temperature, and stress conditions, as well as hormones such as auxin and cytokinin. This suggests that ROF1 plays a crucial role in the regulation of gene expression in response to a wide range of environmental stimuli in Arabidopsis.",
    "vicuna-7b_fact_raw": "1. ROF1, also known as RNA polymerase II factor 1, is a transcription factor in Arabidopsis thaliana.\n2. ROF1 is a component of the general transcription factor TFIIF.\n3. High light intensity can induce ROF1 expression in Arabidopsis and other plant species.\n4. ROF1 expression can be induced by abiotic stress conditions such as drought, salt, and cold.\n5. Auxin, a plant hormone, has been shown to induce ROF1 expression in Arabidopsis.",
    "vicuna-7b_fact": [
      "ROF1, also known as RNA polymerase II factor 1, is a transcription factor in Arabidopsis thaliana.",
      "ROF1 is a component of the general transcription factor TFIIF.",
      "High light intensity can induce ROF1 expression in Arabidopsis and other plant species.",
      "ROF1 expression can be induced by abiotic stress conditions such as drought, salt, and cold.",
      "Auxin, a plant hormone, has been shown to induce ROF1 expression in Arabidopsis."
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "vicuna-7b_response": "Hereditary renal amyloidosis is a rare genetic disorder characterized by the accumulation of an abnormal protein called amyloid in the kidneys. The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR).\nTTR is a plasma protein that is produced in the liver and transported to various tissues in the body, including the heart, brain, and kidneys. In people with hereditary renal amyloidosis caused by TTR, the protein is abnormally folded and accumulates in the kidneys, leading to progressive damage and dysfunction of the renal tubules.\nOther less common causes of hereditary renal amyloidosis include the proteins alpha-synuclein, apolipoprotein A-1, and lysozyme. However, TTR is the most common cause of hereditary renal amyloidosis, and it is estimated that about 90% of cases are caused by TTR mutations.\nIt is important to note that hereditary renal amyloidosis is a genetic disorder that can be inherited from an affected parent. If you have a family history of hereditary renal amyloidosis, it is important to speak with a healthcare provider about genetic testing and counseling.",
    "vicuna-7b_fact_raw": "1. Hereditary renal amyloidosis is a genetic disorder characterized by the accumulation of amyloid in the kidneys.\n2. The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR).\n3. Transthyretin is a plasma protein produced in the liver.\n4. About 90% of hereditary renal amyloidosis cases are caused by TTR mutations.\n5. Hereditary renal amyloidosis can be inherited from an affected parent.",
    "vicuna-7b_fact": [
      "Hereditary renal amyloidosis is a genetic disorder characterized by the accumulation of amyloid in the kidneys.",
      "The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR).",
      "Transthyretin is a plasma protein produced in the liver.",
      "About 90% of hereditary renal amyloidosis cases are caused by TTR mutations.",
      "Hereditary renal amyloidosis can be inherited from an affected parent."
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "vicuna-7b_response": "Yes, the proteome of mouse hippocampus has been analyzed. The hippocampus is a brain structure involved in learning and memory, and its proteome, or the set of all proteins expressed in a particular cell or tissue type, has been studied extensively in mice.\nSeveral studies have used proteomic techniques, such as two-dimensional gel electrophoresis and mass spectrometry, to identify and quantify the proteins expressed in the mouse hippocampus. These studies have identified thousands of proteins, including both protein-coding genes and non-coding RNAs, as well as proteins involved in various biological processes such as neurotransmission, synaptic plasticity, and cellular metabolism.\nOne study published in the journal Molecular and Cellular Proteomics in 2012 used a combination of mass spectrometry and bioinformatics approaches to identify over 7,000 proteins in the mouse hippocampus. Another study published in the journal Neuroscience Letters in 2016 used two-dimensional gel electrophoresis to identify over 1,000 proteins in the mouse hippocampus, including proteins involved in synaptic plasticity and neuronal signaling.\nOverall, the proteome of mouse hippocampus has been extensively studied, and these studies have provided important insights into the biology of this brain structure and the mechanisms underlying learning and memory.",
    "vicuna-7b_fact_raw": "1. The proteome of mouse hippocampus has been analyzed.\n2. Proteomic techniques such as two-dimensional gel electrophoresis and mass spectrometry have been used to study the mouse hippocampus.\n3. Studies have identified thousands of proteins in the mouse hippocampus.\n4. A study published in Molecular and Cellular Proteomics in 2012 identified over 7,000 proteins in the mouse hippocampus.\n5. A study published in Neuroscience Letters in 2016 identified over 1,000 proteins in the mouse hippocampus.",
    "vicuna-7b_fact": [
      "The proteome of mouse hippocampus has been analyzed.",
      "Proteomic techniques such as two-dimensional gel electrophoresis and mass spectrometry have been used to study the mouse hippocampus.",
      "Studies have identified thousands of proteins in the mouse hippocampus.",
      "A study published in Molecular and Cellular Proteomics in 2012 identified over 7,000 proteins in the mouse hippocampus.",
      "A study published in Neuroscience Letters in 2016 identified over 1,000 proteins in the mouse hippocampus."
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "vicuna-7b_response": "No, mouse chromosomes are not acrocentric. Acrocentric chromosomes are a type of chromosome that have their centromeres located at the ends of the chromosome, whereas mouse chromosomes have their centromeres located in the middle of the chromosome.",
    "vicuna-7b_fact_raw": "1. Mouse chromosomes are not acrocentric.\n2. Acrocentric chromosomes have their centromeres located at the ends of the chromosome.\n3. Mouse chromosomes have their centromeres located in the middle of the chromosome.",
    "vicuna-7b_fact": [
      "Mouse chromosomes are not acrocentric.",
      "Acrocentric chromosomes have their centromeres located at the ends of the chromosome.",
      "Mouse chromosomes have their centromeres located in the middle of the chromosome."
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "vicuna-7b_response": "One example of an siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer is GEN-1.\nGEN-1 is an siRNA drug that targets the Hedgehog signaling pathway, which is known to play a role in the development and progression of pancreatic cancer. By inhibiting the Hedgehog pathway, GEN-1 has been shown to reduce the growth and proliferation of pancreatic cancer cells in preclinical studies.\nGEN-1 is currently being studied in a phase 1b/2 clinical trial in patients with advanced pancreatic cancer. The trial is evaluating the safety and efficacy of GEN-1 in combination with chemotherapy and is expected to enroll up to 100 patients.\nIt's important to note that siRNA-based drugs are still in the early stages of development and more research is needed to fully understand their safety and efficacy. However, siRNA-based drugs like GEN-1 have the potential to offer a new and targeted approach to the treatment of pancreatic cancer.",
    "vicuna-7b_fact_raw": "1. GEN-1 is an siRNA-based drug currently in clinical trials for the treatment of pancreatic cancer.\n2. GEN-1 targets the Hedgehog signaling pathway, which is involved in the development and progression of pancreatic cancer.\n3. Preclinical studies have shown that GEN-1 can reduce the growth and proliferation of pancreatic cancer cells.\n4. GEN-1 is being studied in a phase 1b/2 clinical trial with advanced pancreatic cancer patients.\n5. The clinical trial of GEN-1 is expected to enroll up to 100 patients.",
    "vicuna-7b_fact": [
      "GEN-1 is an siRNA-based drug currently in clinical trials for the treatment of pancreatic cancer.",
      "GEN-1 targets the Hedgehog signaling pathway, which is involved in the development and progression of pancreatic cancer.",
      "Preclinical studies have shown that GEN-1 can reduce the growth and proliferation of pancreatic cancer cells.",
      "GEN-1 is being studied in a phase 1b/2 clinical trial with advanced pancreatic cancer patients.",
      "The clinical trial of GEN-1 is expected to enroll up to 100 patients."
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "vicuna-7b_response": "The HPG pore is a type of protein channel that is found in the plasma membrane of certain types of cells, including neurons and endocrine cells. It is also known as the high-affinity potassium channel or the tetrameric potassium channel.\nThe HPG pore is a complex structure that is composed of four identical subunits, each of which contains six transmembrane domains. These domains form a pore that is selective for potassium ions, allowing them to pass through the channel while blocking the passage of other ions.\nThe HPG pore plays an important role in regulating the flow of potassium ions across the plasma membrane, which is essential for a variety of cellular processes, including electrical signaling, muscle contraction, and hormone secretion.\nIn addition to its role in potassium ion transport, the HPG pore has also been implicated in a number of other cellular processes, including cell proliferation, differentiation, and apoptosis.\nOverall, the HPG pore is a complex and important structure that plays a critical role in the function of many different types of cells.",
    "vicuna-7b_fact_raw": "1. The HPG pore is found in the plasma membrane of certain types of cells, including neurons and endocrine cells.\n2. It is also known as the high-affinity potassium channel or the tetrameric potassium channel.\n3. The HPG pore is composed of four identical subunits, each containing six transmembrane domains.\n4. The HPG pore is selective for potassium ions, allowing them to pass through while blocking other ions.\n5. The HPG pore is involved in cellular processes such as electrical signaling, muscle contraction, and hormone secretion.",
    "vicuna-7b_fact": [
      "The HPG pore is found in the plasma membrane of certain types of cells, including neurons and endocrine cells.",
      "It is also known as the high-affinity potassium channel or the tetrameric potassium channel.",
      "The HPG pore is composed of four identical subunits, each containing six transmembrane domains.",
      "The HPG pore is selective for potassium ions, allowing them to pass through while blocking other ions.",
      "The HPG pore is involved in cellular processes such as electrical signaling, muscle contraction, and hormone secretion."
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "vicuna-7b_response": "The 959 Nematode Genomes initiative is a large-scale project aimed at sequencing and analyzing the genomes of 959 species of roundworms, also known as nematodes. Nematodes are a diverse group of parasitic and free-living organisms that play important roles in many ecosystems, including as model organisms for biological research.\nThe 959 Nematode Genomes initiative is a collaborative effort between researchers from around the world, with the goal of generating a comprehensive understanding of the genetic diversity and evolutionary history of nematodes. By sequencing and analyzing the genomes of a large number of nematode species, researchers hope to gain insights into the genetic basis of nematode biology, evolution, and ecology, as well as to identify new targets for the development of drugs and other interventions to control nematode-transmitted diseases.\nThe 959 Nematode Genomes initiative is an ambitious project that will require significant resources and expertise, but it has the potential to revolutionize our understanding of nematode biology and to lead to important advances in biotechnology and medicine.",
    "vicuna-7b_fact_raw": "1. The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of roundworms.\n2. Nematodes are a diverse group of organisms that include both parasitic and free-living species.\n3. The initiative is a collaborative effort involving researchers from around the world.\n4. One of the goals of the initiative is to understand the genetic diversity and evolutionary history of nematodes.\n5. The project seeks to identify new targets for drug development and interventions to control diseases transmitted by nematodes.",
    "vicuna-7b_fact": [
      "The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of roundworms.",
      "Nematodes are a diverse group of organisms that include both parasitic and free-living species.",
      "The initiative is a collaborative effort involving researchers from around the world.",
      "One of the goals of the initiative is to understand the genetic diversity and evolutionary history of nematodes.",
      "The project seeks to identify new targets for drug development and interventions to control diseases transmitted by nematodes."
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "vicuna-7b_response": "There are several R packages that have been developed for analyzing Non-invasive prenatal testing (NIPT) data. Some of the popular R packages for NIPT analysis include:\n1. \"nipstest\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n2. \"nipstools\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\n3. \"nipstestR\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n4. \"nipstoolsR\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\n5. \"nipstest.r\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n6. \"nipstools.r\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\nIt's worth noting that these packages are not the only ones available, and new packages may be developed in the future. It's always a good idea to check the package documentation and examples before using it for your specific analysis.",
    "vicuna-7b_fact_raw": "1. The \"nipstest\" R package provides functions for analyzing and interpreting Non-invasive prenatal testing (NIPT) data.\n2. The \"nipstools\" R package provides functions for processing, analyzing, and visualizing NIPT data.\n3. The \"nipstestR\" R package provides functions for analyzing and interpreting NIPT data.\n4. The \"nipstoolsR\" R package provides functions for processing, analyzing, and visualizing NIPT data.\n5. The \"nipstest.r\" and \"nipstools.r\" are mentioned as R packages for NIPT data analysis.",
    "vicuna-7b_fact": [
      "The \"nipstest\" R package provides functions for analyzing and interpreting Non-invasive prenatal testing (NIPT) data.",
      "The \"nipstools\" R package provides functions for processing, analyzing, and visualizing NIPT data.",
      "The \"nipstestR\" R package provides functions for analyzing and interpreting NIPT data.",
      "The \"nipstoolsR\" R package provides functions for processing, analyzing, and visualizing NIPT data.",
      "The \"nipstest.r\" and \"nipstools.r\" are mentioned as R packages for NIPT data analysis."
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbach’s syndrome.",
    "vicuna-7b_response": "Achenbach's syndrome, also known as \"painful heel syndrome,\" is a condition characterized by pain in the heel of the foot. The pain is typically worse when standing or walking and may be accompanied by swelling and redness in the heel. The exact cause of Achenbach's syndrome is not known, but it is thought to be related to overuse or injury to the heel.\nSymptoms of Achenbach's syndrome may include:\n* Pain in the heel of the foot, usually worse in the morning or after rest\n* Swelling and redness in the heel\n* Pain that worsens with standing or walking\n* Pain that improves with rest\nTreatment for Achenbach's syndrome typically includes rest, ice, and over-the-counter pain medications. In some cases, physical therapy or orthotics may be recommended to help alleviate symptoms. In severe cases, surgery may be necessary.\nIt is important to see a healthcare provider if you are experiencing persistent heel pain, as there may be an underlying condition that requires treatment.",
    "vicuna-7b_fact_raw": "1. Achenbach's syndrome is characterized by pain in the heel of the foot.\n2. Symptoms of Achenbach's syndrome can include swelling and redness in the heel.\n3. The pain associated with Achenbach's syndrome typically worsens with standing or walking.\n4. Treatment for Achenbach's syndrome may involve rest, ice, and over-the-counter pain medications.\n5. In some cases of Achenbach's syndrome, physical therapy or orthotics may be recommended.",
    "vicuna-7b_fact": [
      "Achenbach's syndrome is characterized by pain in the heel of the foot.",
      "Symptoms of Achenbach's syndrome can include swelling and redness in the heel.",
      "The pain associated with Achenbach's syndrome typically worsens with standing or walking.",
      "Treatment for Achenbach's syndrome may involve rest, ice, and over-the-counter pain medications.",
      "In some cases of Achenbach's syndrome, physical therapy or orthotics may be recommended."
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "vicuna-7b_response": "Long repeat expansions are a type of genetic mutation that can cause a variety of diseases, including Huntington's disease, myotonic dystrophy, and fragile X syndrome. There are several algorithms that can be used to detect long repeat expansions, including:\n1. PCR-based methods: These methods use polymerase chain reaction (PCR) to amplify specific regions of the genome and then sequence the amplified regions. PCR can be used to detect repeat expansions by amplifying a specific region of the genome and then sequencing the amplified region to identify repeat expansions.\n2. Sequencing-based methods: These methods use next-generation sequencing (NGS) to sequence the entire genome or specific regions of the genome. Sequencing can be used to detect repeat expansions by identifying repeat expansions in the sequenced regions.\n3. Microarray-based methods: These methods use microarrays to detect repeat expansions by comparing the expression of specific genes to a reference genome. Microarrays can be used to detect repeat expansions by identifying genes that are differentially expressed between individuals with and without repeat expansions.\n4. Bioinformatics-based methods: These methods use bioinformatics tools to analyze genomic data and identify repeat expansions. Bioinformatics tools can be used to detect repeat expansions by identifying repeat expansions in genomic data using algorithms such as repeat masking and repeat element identification.\nOverall, the choice of algorithm for detecting long repeat expansions will depend on the specific application and the type of data available.",
    "vicuna-7b_fact_raw": "1. PCR-based methods can detect repeat expansions by amplifying and sequencing specific regions of the genome.\n2. Sequencing-based methods involve using next-generation sequencing to identify repeat expansions in the genome.\n3. Microarray-based methods detect repeat expansions by comparing gene expression to a reference genome.\n4. Bioinformatics-based methods analyze genomic data to identify repeat expansions using algorithms like repeat masking.\n5. Long repeat expansions are genetic mutations associated with diseases such as Huntington's disease, myotonic dystrophy, and fragile X syndrome.",
    "vicuna-7b_fact": [
      "PCR-based methods can detect repeat expansions by amplifying and sequencing specific regions of the genome.",
      "Sequencing-based methods involve using next-generation sequencing to identify repeat expansions in the genome.",
      "Microarray-based methods detect repeat expansions by comparing gene expression to a reference genome.",
      "Bioinformatics-based methods analyze genomic data to identify repeat expansions using algorithms like repeat masking.",
      "Long repeat expansions are genetic mutations associated with diseases such as Huntington's disease, myotonic dystrophy, and fragile X syndrome."
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "vicuna-7b_response": "Neuroligin-3 is a protein that is involved in the development and function of synapses, the connections between neurons. While neuroligin-3 has been shown to play a role in the development and maintenance of some types of brain tumors, it is not clear whether it promotes the growth of specific brain tumors.\nResearch has shown that neuroligin-3 is overexpressed in some types of brain tumors, including glioblastoma and ependymoma. However, the exact role that neuroligin-3 plays in the development and progression of these tumors is not well understood. Some studies have suggested that neuroligin-3 may promote the growth and survival of tumor cells, while other studies have found that it may have a more complex role in tumor development.\nIt is important to note that the role of neuroligin-3 in brain tumors is still an area of active research, and more studies are needed to fully understand its role in the development and progression of these tumors. If you have concerns about your own health or the health of a loved one, it is always best to consult with a medical professional.",
    "vicuna-7b_fact_raw": "1. Neuroligin-3 is involved in the development and function of synapses in the brain.\n2. Neuroligin-3 has been shown to play a role in the development and maintenance of some types of brain tumors.\n3. Neuroligin-3 is overexpressed in some types of brain tumors, including glioblastoma and ependymoma.\n4. Research on the role of neuroligin-3 in brain tumors is still ongoing and not fully understood.\n5. The exact role of neuroligin-3 in the development and progression of brain tumors like glioblastoma and ependymoma is not well understood.",
    "vicuna-7b_fact": [
      "Neuroligin-3 is involved in the development and function of synapses in the brain.",
      "Neuroligin-3 has been shown to play a role in the development and maintenance of some types of brain tumors.",
      "Neuroligin-3 is overexpressed in some types of brain tumors, including glioblastoma and ependymoma.",
      "Research on the role of neuroligin-3 in brain tumors is still ongoing and not fully understood.",
      "The exact role of neuroligin-3 in the development and progression of brain tumors like glioblastoma and ependymoma is not well understood."
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "vicuna-7b_response": "Gas vesicles are small, gas-filled organelles found in some bacteria, such as cyanobacteria. They are typically about 100-200 nanometers in diameter, which is about the same size as a red blood cell. Gas vesicles are responsible for the buoyancy of cyanobacteria, allowing them to float on water or other liquid environments. They are also involved in photosynthesis, as they contain chlorophyll and other pigments that absorb light energy and convert it into chemical energy.",
    "vicuna-7b_fact_raw": "1. Gas vesicles are typically about 100-200 nanometers in diameter.\n2. Gas vesicles are found in some bacteria, including cyanobacteria.\n3. The size of gas vesicles is comparable to that of a red blood cell.\n4. Gas vesicles contribute to the buoyancy of cyanobacteria.\n5. Gas vesicles are involved in photosynthesis and contain chlorophyll and other pigments.",
    "vicuna-7b_fact": [
      "Gas vesicles are typically about 100-200 nanometers in diameter.",
      "Gas vesicles are found in some bacteria, including cyanobacteria.",
      "The size of gas vesicles is comparable to that of a red blood cell.",
      "Gas vesicles contribute to the buoyancy of cyanobacteria.",
      "Gas vesicles are involved in photosynthesis and contain chlorophyll and other pigments."
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "vicuna-7b_response": "BET (Bromodomain and Extra-terminal domain) proteins are a family of proteins that contain bromodomains and extra-terminal domains. Bromodomains are protein recognition modules that bind to acetylated lysine residues, while extra-terminal domains are involved in regulating the activity of bromodomains.\nThere are several subfamilies of BET proteins, including BET bromodomains, BET tandem bromodomains, BET-like proteins, and BET-specific proteins. BET bromodomains are the most well-known subfamily and are involved in regulating the transcription of genes involved in cell growth and differentiation.\nBET proteins play a role in a variety of cellular processes, including transcriptional regulation, chromatin remodeling, and protein-protein interactions. Dysregulation of BET proteins has been implicated in a number of diseases, including cancer, neurodegeneration, and immune disorders.\nSome examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2. BRD4 is one of the best-studied BET proteins and has been shown to play a role in the transcriptional regulation of genes involved in cell growth and differentiation. BRDT is a BET protein that is involved in the regulation of the circadian rhythm. BAP1, BAP3, BAPL1, and BAPL2 are BET proteins that are involved in the regulation of cellular processes such as DNA repair and cell cycle progression.",
    "vicuna-7b_fact_raw": "1. BET proteins are a family of proteins that contain bromodomains and extra-terminal domains.\n2. Bromodomains bind to acetylated lysine residues.\n3. Extra-terminal domains are involved in regulating the activity of bromodomains.\n4. Dysregulation of BET proteins has been implicated in diseases such as cancer, neurodegeneration, and immune disorders.\n5. Examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2.",
    "vicuna-7b_fact": [
      "BET proteins are a family of proteins that contain bromodomains and extra-terminal domains.",
      "Bromodomains bind to acetylated lysine residues.",
      "Extra-terminal domains are involved in regulating the activity of bromodomains.",
      "Dysregulation of BET proteins has been implicated in diseases such as cancer, neurodegeneration, and immune disorders.",
      "Examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2."
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "vicuna-7b_response": "One algorithm that has been developed for prediction of protein subcellular localization using deep learning is called DeepLoc.\nDeepLoc is a deep learning-based method that uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to predict the subcellular localization of proteins. The method was developed by researchers from the University of California, San Francisco (UCSF) and was published in the journal Nature Biotechnology in 2018.\nDeepLoc uses a large dataset of protein sequences and their corresponding subcellular localization information to train its deep learning models. The models are trained to predict the subcellular localization of proteins based on their amino acid sequences, using features such as the presence of certain amino acid residues, the presence of certain motifs, and the conservation of certain patterns across different species.\nDeepLoc has been shown to be highly accurate in predicting the subcellular localization of proteins, with an accuracy of over 90%. The method has been applied to predict the subcellular localization of proteins from a variety of organisms, including bacteria, archaea, and eukaryotes.\nOverall, DeepLoc is a powerful tool for predicting the subcellular localization of proteins using deep learning, and it has the potential to significantly improve our understanding of protein function and cellular processes.",
    "vicuna-7b_fact_raw": "1. DeepLoc is an algorithm developed for predicting protein subcellular localization using deep learning.\n2. DeepLoc combines convolutional neural networks (CNNs) and recurrent neural networks (RNNs) for its predictions.\n3. The algorithm was developed by researchers from the University of California, San Francisco (UCSF).\n4. DeepLoc was published in the journal Nature Biotechnology in 2018.\n5. DeepLoc has demonstrated an accuracy of over 90% in predicting the subcellular localization of proteins.",
    "vicuna-7b_fact": [
      "DeepLoc is an algorithm developed for predicting protein subcellular localization using deep learning.",
      "DeepLoc combines convolutional neural networks (CNNs) and recurrent neural networks (RNNs) for its predictions.",
      "The algorithm was developed by researchers from the University of California, San Francisco (UCSF).",
      "DeepLoc was published in the journal Nature Biotechnology in 2018.",
      "DeepLoc has demonstrated an accuracy of over 90% in predicting the subcellular localization of proteins."
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "vicuna-7b_response": "MULTOVL is a cryptocurrency that is built on the MULTOS platform. MULTOS is a multi-application operating system that is designed to provide secure storage for a wide range of applications, including cryptocurrencies.\nMULTOVL is a digital currency that uses the MULTOS platform to provide a secure and flexible platform for the issuance and management of digital tokens. It is designed to be a decentralized and secure alternative to traditional fiat currencies, and it offers a number of advantages over traditional cryptocurrencies, including improved security, privacy, and flexibility.\nOne of the key features of MULTOVL is its use of advanced security technologies, such as biometric authentication and advanced encryption algorithms, to ensure the security and privacy of transactions. This makes it an attractive option for individuals and organizations looking for a secure and reliable way to store and transfer value online.\nIn addition to its security features, MULTOVL also offers a number of other benefits, including fast and reliable transactions, low transaction fees, and a wide range of integration options, making it a versatile and flexible choice for a wide range of applications.\nOverall, MULTOVL is a promising new cryptocurrency that is built on the MULTOS platform and offers a number of advantages over traditional cryptocurrencies, including improved security, privacy, and flexibility.",
    "vicuna-7b_fact_raw": "1. MULTOVL is a cryptocurrency built on the MULTOS platform.\n2. MULTOS is a multi-application operating system designed to provide secure storage for various applications, including cryptocurrencies.\n3. MULTOVL uses advanced security technologies such as biometric authentication and advanced encryption algorithms.\n4. MULTOVL aims to offer improved security, privacy, and flexibility over traditional fiat currencies and cryptocurrencies.\n5. MULTOVL is designed to provide fast and reliable transactions with low transaction fees.",
    "vicuna-7b_fact": [
      "MULTOVL is a cryptocurrency built on the MULTOS platform.",
      "MULTOS is a multi-application operating system designed to provide secure storage for various applications, including cryptocurrencies.",
      "MULTOVL uses advanced security technologies such as biometric authentication and advanced encryption algorithms.",
      "MULTOVL aims to offer improved security, privacy, and flexibility over traditional fiat currencies and cryptocurrencies.",
      "MULTOVL is designed to provide fast and reliable transactions with low transaction fees."
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "vicuna-7b_response": "GDF15, also known as growth differentiation factor 15, is a protein that has been studied as a potential biomarker for various conditions, including cancer, cardiovascular disease, and diabetes. Metformin is a medication that is commonly used to treat type 2 diabetes, and some studies have suggested that metformin may have anti-cancer effects by reducing the levels of GDF15 in the body.\nHowever, the relationship between metformin treatment and GDF15 levels is not straightforward, and more research is needed to fully understand the role of GDF15 as a biomarker for metformin treatment. Some studies have found that metformin treatment is associated with decreased levels of GDF15 in patients with type 2 diabetes, while others have found no association or have reported conflicting results.\nIt is also important to note that GDF15 is a complex and multifaceted protein with many potential functions, and its role in metformin treatment may depend on various factors, such as the individual's underlying health status, the dose and duration of metformin treatment, and other medications or lifestyle factors that may affect GDF15 levels.\nIn summary, while GDF15 has been studied as a potential biomarker for metformin treatment, the relationship between the two is not yet fully understood, and more research is needed to clarify their relationship.",
    "vicuna-7b_fact_raw": "1. GDF15, also known as growth differentiation factor 15, is a protein that has been studied as a potential biomarker for various conditions, including cancer, cardiovascular disease, and diabetes.\n2. Metformin is a medication commonly used to treat type 2 diabetes.\n3. Some studies have suggested that metformin may have anti-cancer effects by reducing the levels of GDF15 in the body.\n4. Research on the relationship between metformin treatment and GDF15 levels has produced conflicting results.\n5. The role of GDF15 in metformin treatment may be influenced by factors such as the individual's health status, the dose and duration of metformin treatment, and other medications or lifestyle factors.",
    "vicuna-7b_fact": [
      "GDF15, also known as growth differentiation factor 15, is a protein that has been studied as a potential biomarker for various conditions, including cancer, cardiovascular disease, and diabetes.",
      "Metformin is a medication commonly used to treat type 2 diabetes.",
      "Some studies have suggested that metformin may have anti-cancer effects by reducing the levels of GDF15 in the body.",
      "Research on the relationship between metformin treatment and GDF15 levels has produced conflicting results.",
      "The role of GDF15 in metformin treatment may be influenced by factors such as the individual's health status, the dose and duration of metformin treatment, and other medications or lifestyle factors."
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "vicuna-7b_response": "Recursive splicing is a process in which a small RNA molecule called a microRNA (miRNA) binds to the messenger RNA (mRNA) of a target gene and then recruits other proteins to cleave the mRNA into smaller pieces, leading to the degradation of the target gene. Recursive splicing can occur in both short and long introns.\nIntrons are the non-coding regions of the genome that are present between the exons, which are the coding regions. Introns can be either short or long. Short introns are those that are less than 1 kilobase (kb) in length, while long introns are those that are greater than 1 kb in length.\nRecursive splicing can occur in both short and long introns. In the case of short introns, recursive splicing can be more common because the small size of these introns makes them more accessible to the miRNA molecule. This is because the small size of the intron means that the miRNA molecule can bind to the intron more easily, leading to a higher probability of recursive splicing occurring.\nIn contrast, long introns are less accessible to the miRNA molecule because they are larger and more difficult to bind to. This means that recursive splicing is less likely to occur in long introns. However, it is important to note that the likelihood of recursive splicing occurring in a particular intron depends on a variety of factors, including the specific miRNA molecule involved, the target gene, and the cellular context in which the process is occurring.\nIn summary, recursive splicing can occur in both short and long introns, but it is more common in short introns because the small size of these introns makes them more accessible to the miRNA molecule.",
    "vicuna-7b_fact_raw": "1. Recursive splicing is a process where a microRNA (miRNA) binds to the messenger RNA (mRNA) of a target gene and recruits proteins to cleave the mRNA.\n2. Introns are non-coding regions of the genome present between exons.\n3. Short introns are defined as being less than 1 kilobase (kb) in length.\n4. Long introns are defined as being greater than 1 kb in length.\n5. Recursive splicing is more common in short introns due to their small size making them more accessible to the miRNA molecule.",
    "vicuna-7b_fact": [
      "Recursive splicing is a process where a microRNA (miRNA) binds to the messenger RNA (mRNA) of a target gene and recruits proteins to cleave the mRNA.",
      "Introns are non-coding regions of the genome present between exons.",
      "Short introns are defined as being less than 1 kilobase (kb) in length.",
      "Long introns are defined as being greater than 1 kb in length.",
      "Recursive splicing is more common in short introns due to their small size making them more accessible to the miRNA molecule."
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "vicuna-7b_response": "The TALE-iD method is a technique used to identify and characterize specific regions of the genome, known as transposable elements (TEs). TE's are DNA sequences that can move and copy themselves within the genome, and they make up a significant portion of the human genome. The TALE-iD method uses a combination of computational and experimental approaches to identify and characterize specific TEs in the human genome.\nThe TALE-iD method is based on the use of transposase enzymes, which are proteins that can move TEs within the genome. By using transposase enzymes to move specific TEs in the genome, the TALE-iD method can identify the specific regions of the genome that are targeted by these enzymes. This information can then be used to identify and characterize specific TEs in the genome.\nThe TALE-iD method has a number of potential applications, including the identification of TEs that may be involved in disease, the study of the evolution of the human genome, and the development of new tools for genome engineering. Overall, the TALE-iD method is a powerful tool for understanding the role of TEs in the human genome and for studying the mechanisms that govern their movement and activity.",
    "vicuna-7b_fact_raw": "1. The TALE-iD method is used to identify and characterize specific regions of the genome known as transposable elements (TEs).\n2. Transposable elements are DNA sequences that can move and copy themselves within the genome.\n3. A significant portion of the human genome is made up of transposable elements.\n4. The TALE-iD method uses transposase enzymes to move specific TEs within the genome.\n5. The TALE-iD method has potential applications in identifying TEs involved in disease, studying human genome evolution, and developing genome engineering tools.",
    "vicuna-7b_fact": [
      "The TALE-iD method is used to identify and characterize specific regions of the genome known as transposable elements (TEs).",
      "Transposable elements are DNA sequences that can move and copy themselves within the genome.",
      "A significant portion of the human genome is made up of transposable elements.",
      "The TALE-iD method uses transposase enzymes to move specific TEs within the genome.",
      "The TALE-iD method has potential applications in identifying TEs involved in disease, studying human genome evolution, and developing genome engineering tools."
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "vicuna-7b_response": "There are several Lisp frameworks that have been developed for image processing, including:\n1. Common Lisp Image Processing (CLIP): CLIP is a library for image processing in Common Lisp. It provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n2. Lisp-based Image Processing System (LIPS): LIPS is a Lisp-based image processing system that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n3. Lisp-based Image Processing Library (LIP): LIP is a Lisp-based image processing library that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n4. Lisp-based Image Processing System (LIPS): LIPS is a Lisp-based image processing system that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n5. Lisp-based Image Processing Library (LIP): LIP is a Lisp-based image processing library that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\nIt's worth noting that these frameworks are not the only ones available, and there are many other libraries and frameworks that can be used for image processing in Lisp.",
    "vicuna-7b_fact_raw": "1. Common Lisp Image Processing (CLIP) is a library for image processing in Common Lisp.\n2. Lisp-based Image Processing System (LIPS) is a Lisp-based image processing system.\n3. Lisp-based Image Processing Library (LIP) is a Lisp-based image processing library.\n4. CLIP, LIPS, and LIP provide a range of image processing functions, including filtering, thresholding, and morphological operations.\n5. There are multiple libraries and frameworks available for image processing in Lisp.",
    "vicuna-7b_fact": [
      "Common Lisp Image Processing (CLIP) is a library for image processing in Common Lisp.",
      "Lisp-based Image Processing System (LIPS) is a Lisp-based image processing system.",
      "Lisp-based Image Processing Library (LIP) is a Lisp-based image processing library.",
      "CLIP, LIPS, and LIP provide a range of image processing functions, including filtering, thresholding, and morphological operations.",
      "There are multiple libraries and frameworks available for image processing in Lisp."
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "vicuna-7b_response": "The genome of Saccharomyces cerevisiae, also known as baker's yeast, underwent an ancient whole genome duplication event approximately 100 million years ago, which resulted in the formation of a pair of homologous chromosomes. This event led to the duplication of approximately 90% of the yeast genes, with each duplicate gene being present on one of the two homologous chromosomes.\nThe duplication event had a profound impact on the evolution of the yeast genome, leading to the expansion of gene families, the emergence of new functions, and the adaptation of the organism to its environment. The duplicated genes have been subject to various forms of evolutionary change, including gene loss, functional divergence, and neo-functionalization, which has contributed to the complexity and diversity of the yeast genome.\nIn summary, approximately 90% of the genes in the genome of Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.",
    "vicuna-7b_fact_raw": "1. The genome of Saccharomyces cerevisiae underwent an ancient whole genome duplication event approximately 100 million years ago.\n2. The whole genome duplication event resulted in the formation of a pair of homologous chromosomes in Saccharomyces cerevisiae.\n3. Approximately 90% of the genes in Saccharomyces cerevisiae are the result of the ancient whole genome duplication event.\n4. The duplication event led to the expansion of gene families in Saccharomyces cerevisiae.\n5. The duplicated genes in Saccharomyces cerevisiae have undergone evolutionary changes such as gene loss, functional divergence, and neo-functionalization.",
    "vicuna-7b_fact": [
      "The genome of Saccharomyces cerevisiae underwent an ancient whole genome duplication event approximately 100 million years ago.",
      "The whole genome duplication event resulted in the formation of a pair of homologous chromosomes in Saccharomyces cerevisiae.",
      "Approximately 90% of the genes in Saccharomyces cerevisiae are the result of the ancient whole genome duplication event.",
      "The duplication event led to the expansion of gene families in Saccharomyces cerevisiae.",
      "The duplicated genes in Saccharomyces cerevisiae have undergone evolutionary changes such as gene loss, functional divergence, and neo-functionalization."
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "vicuna-7b_response": "Estrogen-related receptor β (Esrrb) is a nuclear receptor that is primarily expressed in the brain and testis. It is a member of the nuclear receptor superfamily and belongs to the estrogen receptor (ER) family of transcription factors. Esrrb is activated by the steroid hormone estrogen and plays a role in the regulation of various biological processes, including cell proliferation, differentiation, and survival.\nThere are several compounds that are known to bind to Esrrb and modulate its activity. These include estrogens, such as estradiol and estrone, as well as synthetic estrogen agonists and antagonists, such as tamoxifen and raloxifene. Additionally, some non-steroidal compounds, such as the selective estrogen receptor modulators (SERMs) and the anti-androgens, have been shown to bind to and modulate the activity of Esrrb.\nOverall, Esrrb is bound by a variety of compounds that act as ligands and modulate its activity as a transcription factor.",
    "vicuna-7b_fact_raw": "1. Estrogen-related receptor β (Esrrb) is primarily expressed in the brain and testis.\n2. Esrrb is a member of the nuclear receptor superfamily.\n3. Esrrb belongs to the estrogen receptor (ER) family of transcription factors.\n4. Estradiol and estrone are estrogens known to bind to Esrrb.\n5. Tamoxifen and raloxifene are synthetic estrogen agonists and antagonists that bind to Esrrb.",
    "vicuna-7b_fact": [
      "Estrogen-related receptor β (Esrrb) is primarily expressed in the brain and testis.",
      "Esrrb is a member of the nuclear receptor superfamily.",
      "Esrrb belongs to the estrogen receptor (ER) family of transcription factors.",
      "Estradiol and estrone are estrogens known to bind to Esrrb.",
      "Tamoxifen and raloxifene are synthetic estrogen agonists and antagonists that bind to Esrrb."
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "vicuna-7b_response": "ZCCHC17 is a protein that plays a role in the regulation of the cell cycle. Specifically, it is a member of the Zinc Finger CCCH Zinc Finger Proteins family, which are known to be involved in the regulation of various cellular processes, including cell cycle progression.\nThe exact function of ZCCHC17 is not fully understood, but it is thought to be involved in the regulation of the G1 phase of the cell cycle. This is achieved through its ability to bind to specific DNA sequences and regulate the expression of genes involved in cell cycle progression.\nAdditionally, ZCCHC17 has been shown to play a role in the regulation of the immune response, and has been implicated in the development of certain types of cancer. However, further research is needed to fully understand the role of ZCCHC17 in these processes.",
    "vicuna-7b_fact_raw": "1. ZCCHC17 is a protein that is involved in the regulation of the cell cycle.\n2. It is a member of the Zinc Finger CCCH Zinc Finger Proteins family.\n3. ZCCHC17 is thought to be involved in the regulation of the G1 phase of the cell cycle.\n4. ZCCHC17 has the ability to bind to specific DNA sequences and regulate the expression of genes involved in cell cycle progression.\n5. ZCCHC17 has been implicated in the development of certain types of cancer.",
    "vicuna-7b_fact": [
      "ZCCHC17 is a protein that is involved in the regulation of the cell cycle.",
      "It is a member of the Zinc Finger CCCH Zinc Finger Proteins family.",
      "ZCCHC17 is thought to be involved in the regulation of the G1 phase of the cell cycle.",
      "ZCCHC17 has the ability to bind to specific DNA sequences and regulate the expression of genes involved in cell cycle progression.",
      "ZCCHC17 has been implicated in the development of certain types of cancer."
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "vicuna-7b_response": "The nuclear pore basket is a complex structure that forms a channel in the nuclear envelope, which separates the nucleus from the cytoplasm. The nuclear pore basket is composed of multiple proteins, including FG repeat proteins, such as FG repeat-containing protein 1 (FGCP1) and FG repeat-containing protein 2 (FGCP2), and SC32, a protein that is involved in the assembly of the nuclear pore complex. Other proteins that have been identified as components of the nuclear pore basket include nucleoporins, such as Nup153 and Nup205, and the transmembrane protein Tpr.",
    "vicuna-7b_fact_raw": "1. The nuclear pore basket is a structure that forms a channel in the nuclear envelope.\n2. FG repeat proteins are components of the nuclear pore basket.\n3. FG repeat-containing protein 1 (FGCP1) and FG repeat-containing protein 2 (FGCP2) are specific proteins that form part of the nuclear pore basket.\n4. SC32 is a protein involved in the assembly of the nuclear pore complex.\n5. Nucleoporins, such as Nup153 and Nup205, and the transmembrane protein Tpr have been identified as components of the nuclear pore basket.",
    "vicuna-7b_fact": [
      "The nuclear pore basket is a structure that forms a channel in the nuclear envelope.",
      "FG repeat proteins are components of the nuclear pore basket.",
      "FG repeat-containing protein 1 (FGCP1) and FG repeat-containing protein 2 (FGCP2) are specific proteins that form part of the nuclear pore basket.",
      "SC32 is a protein involved in the assembly of the nuclear pore complex.",
      "Nucleoporins, such as Nup153 and Nup205, and the transmembrane protein Tpr have been identified as components of the nuclear pore basket."
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "vicuna-7b_response": "Gepotidacin is a type of topoisomerase inhibitor called a \"topoisomerase I inhibitor.\" It works by binding to and inhibiting the activity of topoisomerase I, an enzyme that is involved in the replication of DNA. This can lead to the formation of DNA breaks and the accumulation of DNA damage, ultimately resulting in cell death. Gepotidacin is being studied as a potential treatment for various types of cancer.",
    "vicuna-7b_fact_raw": "1. Gepotidacin is a topoisomerase inhibitor.\n2. It is classified as a \"topoisomerase I inhibitor.\"\n3. Gepotidacin binds to and inhibits the activity of the enzyme topoisomerase I.\n4. The inhibition of topoisomerase I by gepotidacin can lead to DNA breaks and accumulation of DNA damage.\n5. Gepotidacin is being studied as a potential treatment for various types of cancer.",
    "vicuna-7b_fact": [
      "Gepotidacin is a topoisomerase inhibitor.",
      "It is classified as a \"topoisomerase I inhibitor.\"",
      "Gepotidacin binds to and inhibits the activity of the enzyme topoisomerase I.",
      "The inhibition of topoisomerase I by gepotidacin can lead to DNA breaks and accumulation of DNA damage.",
      "Gepotidacin is being studied as a potential treatment for various types of cancer."
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "vicuna-7b_response": "Sure, I'd be happy to describe Canvas SPW!\nCanvas SPW, or Canvas Special Purpose Word, is a type of Canvas that is designed to handle specific types of data. It is typically used in situations where the data is too complex or too large to be stored in a regular Canvas, but still needs to be processed and analyzed.\nCanvas SPW is similar to a regular Canvas in that it is a container for data that can be manipulated and analyzed using the same tools and techniques as a regular Canvas. However, unlike a regular Canvas, a Canvas SPW is not limited to a specific type of data or a specific number of dimensions.\nOne of the key benefits of using a Canvas SPW is that it allows you to process and analyze large amounts of data without having to worry about running out of memory or storage. This is because the data is stored in a specialized format that is optimized for processing and analysis, rather than in a format that is optimized for storage.\nCanvas SPW is also highly customizable, which means that you can tailor it to your specific needs and requirements. This can be especially useful if you are working with data that is highly complex or variable, as it allows you to create a Canvas that is specifically designed to handle your data.\nOverall, Canvas SPW is a powerful tool that can help you to process and analyze large and complex datasets, and is particularly useful in situations where traditional data storage and processing methods are not sufficient.",
    "vicuna-7b_fact_raw": "NO FACTS",
    "vicuna-7b_fact": []
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "vicuna-7b_response": "STING (Stimulator of Interferon Genes) agonists are a class of drugs that activate the STING pathway, which plays a crucial role in the immune system's response to viral infections. STING agonists have been shown to have potent antiviral effects and have been studied for the treatment of various viral infections, including influenza, SARS-CoV-2 (the virus that causes COVID-19), and Ebola virus.\nSome examples of STING agonists include:\n1. MK-8628: This is a small molecule STING agonist that has been shown to be effective against a wide range of viruses, including influenza, SARS-CoV-2, and Ebola virus.\n2. GS-9620: This is another small molecule STING agonist that has been shown to be effective against SARS-CoV-2 in animal models.\n3. CX804: This is a STING agonist that has been shown to be effective against influenza in animal models.\n4. TLR7 agonists: TLR7 (Toll-like receptor 7) agonists, which include imiquimod and resiquimod, have been shown to activate the STING pathway and have antiviral effects.\nIt's important to note that while STING agonists show promise as antiviral drugs, they are still in the early stages of development and more research is needed to fully understand their safety and efficacy.",
    "vicuna-7b_fact_raw": "1. STING agonists activate the STING pathway, which is involved in the immune response to viral infections.\n2. MK-8628 is a small molecule STING agonist that has been shown to be effective against influenza, SARS-CoV-2, and Ebola virus.\n3. GS-9620 is a small molecule STING agonist that has been shown to be effective against SARS-CoV-2 in animal models.\n4. CX804 is a STING agonist that has been shown to be effective against influenza in animal models.\n5. TLR7 agonists, such as imiquimod and resiquimod, can activate the STING pathway and have antiviral effects.",
    "vicuna-7b_fact": [
      "STING agonists activate the STING pathway, which is involved in the immune response to viral infections.",
      "MK-8628 is a small molecule STING agonist that has been shown to be effective against influenza, SARS-CoV-2, and Ebola virus.",
      "GS-9620 is a small molecule STING agonist that has been shown to be effective against SARS-CoV-2 in animal models.",
      "CX804 is a STING agonist that has been shown to be effective against influenza in animal models.",
      "TLR7 agonists, such as imiquimod and resiquimod, can activate the STING pathway and have antiviral effects."
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "vicuna-7b_response": "SLIC-CAGE is a method for analyzing and classifying the structure of proteins. It stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".\nThe SLIC-CAGE method uses a combination of sequence information and structural information to predict the contact and geometry information of a protein. It does this by first analyzing the amino acid sequence of the protein, and then using this information to predict the contact and geometry information.\nThe SLIC-CAGE method is based on the idea that the contact and geometry information of a protein is determined by the sequence of amino acids in the protein. This is because the sequence of amino acids in a protein determines the shape of the protein, and the shape of the protein determines the interactions between the protein and other molecules.\nThe SLIC-CAGE method is a powerful tool for analyzing and classifying the structure of proteins. It has been used to study the structure and function of a wide range of proteins, including enzymes, receptors, and transporters.\nOverall, SLIC-CAGE is a useful tool for understanding the structure and function of proteins, and it has many potential applications in fields such as biotechnology and medicine.",
    "vicuna-7b_fact_raw": "1. SLIC-CAGE is a method for analyzing and classifying the structure of proteins.\n2. SLIC-CAGE stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".\n3. The method uses a combination of sequence information and structural information to predict protein contact and geometry information.\n4. SLIC-CAGE is based on the principle that the sequence of amino acids in a protein determines its shape and interactions with other molecules.\n5. SLIC-CAGE has been used to study the structure and function of various proteins, including enzymes, receptors, and transporters.",
    "vicuna-7b_fact": [
      "SLIC-CAGE is a method for analyzing and classifying the structure of proteins.",
      "SLIC-CAGE stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".",
      "The method uses a combination of sequence information and structural information to predict protein contact and geometry information.",
      "SLIC-CAGE is based on the principle that the sequence of amino acids in a protein determines its shape and interactions with other molecules.",
      "SLIC-CAGE has been used to study the structure and function of various proteins, including enzymes, receptors, and transporters."
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "vicuna-7b_response": "LEM-3, also known as Leucine-rich repeat-containing protein 3, is a protein that plays a role in various cellular processes. The specific roles of LEM-3 are not well understood, but it is thought to be involved in regulating cell growth and division, as well as in the development of certain diseases.\nOne of the functions of LEM-3 is to regulate the activity of the CDK2/cyclin A1 complex, which is involved in cell division. This complex is responsible for phosphorylating and activating the CDK2 kinase, which then phosphorylates and activates other proteins involved in cell division. LEM-3 has been shown to bind to the CDK2/cyclin A1 complex and to inhibit its activity, suggesting that it plays a role in regulating cell division.\nIn addition to its role in cell division, LEM-3 has also been implicated in the development of certain diseases. For example, it has been shown to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer. This suggests that LEM-3 may play a role in the development and progression of these diseases.\nOverall, while the specific roles of LEM-3 are not well understood, it is clear that it plays a role in regulating cell growth and division, and may be involved in the development of certain diseases. Further research is needed to fully understand the functions of LEM-3 and its potential as a therapeutic target.",
    "vicuna-7b_fact_raw": "1. LEM-3 is thought to be involved in regulating cell growth and division.\n2. LEM-3 is known to regulate the activity of the CDK2/cyclin A1 complex, which is involved in cell division.\n3. The CDK2/cyclin A1 complex is responsible for phosphorylating and activating the CDK2 kinase.\n4. LEM-3 has been shown to bind to the CDK2/cyclin A1 complex and inhibit its activity.\n5. LEM-3 has been found to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer.",
    "vicuna-7b_fact": [
      "LEM-3 is thought to be involved in regulating cell growth and division.",
      "LEM-3 is known to regulate the activity of the CDK2/cyclin A1 complex, which is involved in cell division.",
      "The CDK2/cyclin A1 complex is responsible for phosphorylating and activating the CDK2 kinase.",
      "LEM-3 has been shown to bind to the CDK2/cyclin A1 complex and inhibit its activity.",
      "LEM-3 has been found to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer."
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "vicuna-7b_response": "tmVar is a software package for managing and visualizing temporal data. It is developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna. Here is a list of the releases of tmVar:\n1. tmVar 1.0: This was the first release of tmVar, which was released in 2012. It was primarily designed for the analysis of RNA-seq data.\n2. tmVar 1.1: This release was released in 2013 and included several new features, including the ability to analyze ChIP-seq data and the ability to visualize the results of the analysis using interactive heatmaps.\n3. tmVar 1.2: This release was released in 2014 and included several new features, including the ability to analyze single-cell RNA-seq data and the ability to perform batch processing of large datasets.\n4. tmVar 1.3: This release was released in 2015 and included several new features, including the ability to perform differential expression analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n5. tmVar 1.4: This release was released in 2016 and included several new features, including the ability to perform functional enrichment analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n6. tmVar 1.5: This release was released in 2017 and included several new features, including the ability to perform clustering analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n7. tmVar 1.6: This release was released in 2018 and included several new features, including the ability to perform network analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n8. tmVar 1.7: This release was released in 2019 and included several new features, including the ability to perform batch processing of large datasets and the ability to visualize the results of the analysis using interactive heatmaps.\n9. tmVar 1.8: This release was released in 2020 and included several new features, including the ability to perform batch processing of large datasets and the ability to visualize the results of the analysis using interactive heatmaps.\n10. tmVar 1.9:",
    "vicuna-7b_fact_raw": "1. tmVar is a software package developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna.\n2. tmVar 1.0 was the first release of tmVar, and it was released in 2012.\n3. tmVar 1.1 was released in 2013 and included the ability to analyze ChIP-seq data.\n4. tmVar 1.2 was released in 2014 and introduced the ability to analyze single-cell RNA-seq data.\n5. tmVar 1.6 was released in 2018 and introduced the ability to perform network analysis.",
    "vicuna-7b_fact": [
      "tmVar is a software package developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna.",
      "tmVar 1.0 was the first release of tmVar, and it was released in 2012.",
      "tmVar 1.1 was released in 2013 and included the ability to analyze ChIP-seq data.",
      "tmVar 1.2 was released in 2014 and introduced the ability to analyze single-cell RNA-seq data.",
      "tmVar 1.6 was released in 2018 and introduced the ability to perform network analysis."
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "vicuna-7b_response": "There are several databases that contain information on somatic mutations in normal cells. Here are a few examples:\n1. The Cancer Genome Atlas (TCGA) database: This database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.\n2. The International Cancer Genome Consortium (ICGC) database: This database contains genomic data on a variety of cancer types, including information on somatic mutations.\n3. The National Cancer Institute's (NCI) SEQUENOM database: This database contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.\n4. The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB): This database contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.\nThese are just a few examples of databases that contain information on somatic mutations in normal cells. There are many other databases available, and the specific database that is most relevant to a particular question will depend on the type of information being sought.",
    "vicuna-7b_fact_raw": "1. The Cancer Genome Atlas (TCGA) database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.\n2. The International Cancer Genome Consortium (ICGC) database contains genomic data on a variety of cancer types, including information on somatic mutations.\n3. The National Cancer Institute's (NCI) SEQUENOM database contains information on somatic mutations in normal and cancer cells.\n4. The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB) contains information on somatic mutations in normal and cancer cells.\n5. The SEQUENOM and SMDB databases include mutations in genes involved in DNA replication, repair, and cell cycle control.",
    "vicuna-7b_fact": [
      "The Cancer Genome Atlas (TCGA) database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.",
      "The International Cancer Genome Consortium (ICGC) database contains genomic data on a variety of cancer types, including information on somatic mutations.",
      "The National Cancer Institute's (NCI) SEQUENOM database contains information on somatic mutations in normal and cancer cells.",
      "The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB) contains information on somatic mutations in normal and cancer cells.",
      "The SEQUENOM and SMDB databases include mutations in genes involved in DNA replication, repair, and cell cycle control."
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "vicuna-7b_response": "Yes, there are several graph kernel libraries available implemented in Java. Some of the popular ones include:\n1. JUNG: JUNG is a Java library for working with graph data structures. It provides a set of tools for creating, manipulating, and analyzing graphs. JUNG is a popular choice for graph processing in Java.\n2. igraph: igraph is a C++ library for working with graphs. It provides a set of tools for creating, manipulating, and analyzing graphs. igraph also has a Java wrapper library called Jigraph that allows Java developers to use igraph from Java.\n3. Gephi: Gephi is a popular open-source graph visualization and analysis tool. It provides a Java API that allows developers to create custom plugins and integrate Gephi with other Java applications.\n4. GraphX: GraphX is a distributed graph processing framework for Apache Spark. It provides a set of tools for creating, manipulating, and analyzing graphs in Apache Spark. GraphX is a popular choice for graph processing in big data applications.\nThese are just a few examples of the graph kernel libraries available implemented in Java. The choice of library will depend on the specific requirements of the application and the type of graph processing tasks that need to be performed.",
    "vicuna-7b_fact_raw": "1. JUNG is a Java library designed for working with graph data structures.\n2. igraph is a C++ library with a Java wrapper called Jigraph.\n3. Gephi is an open-source graph visualization and analysis tool with a Java API.\n4. GraphX is a distributed graph processing framework for Apache Spark.\n5. The choice of graph kernel library in Java depends on the application's specific requirements and graph processing tasks.",
    "vicuna-7b_fact": [
      "JUNG is a Java library designed for working with graph data structures.",
      "igraph is a C++ library with a Java wrapper called Jigraph.",
      "Gephi is an open-source graph visualization and analysis tool with a Java API.",
      "GraphX is a distributed graph processing framework for Apache Spark.",
      "The choice of graph kernel library in Java depends on the application's specific requirements and graph processing tasks."
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "vicuna-7b_response": "The SHERLOCKv2 platform is a comprehensive platform that integrates four key advances to provide a more accurate and efficient analysis of biological data. These four advances are:\n1. Deep learning algorithms: SHERLOCKv2 uses deep learning algorithms to analyze large amounts of biological data and identify patterns and relationships that are not easily detectable by traditional methods.\n2. High-quality reference genomes: SHERLOCKv2 uses high-quality reference genomes to provide a more accurate analysis of genomic data. This allows the platform to identify variations and mutations that may be relevant to disease.\n3. Integration of multiple data types: SHERLOCKv2 integrates multiple data types, including genomic, transcriptomic, and epigenomic data, to provide a more comprehensive analysis of biological data.\n4. Real-time analysis: SHERLOCKv2 provides real-time analysis of biological data, allowing users to quickly and easily identify potential biomarkers and targets for drug development.\nOverall, the integration of these four advances into the SHERLOCKv2 platform provides a powerful tool for analyzing biological data and identifying potential targets for drug development.",
    "vicuna-7b_fact_raw": "1. SHERLOCKv2 uses deep learning algorithms to analyze biological data.\n2. The platform employs high-quality reference genomes for genomic data analysis.\n3. SHERLOCKv2 integrates multiple types of data, including genomic, transcriptomic, and epigenomic data.\n4. It offers real-time analysis of biological data.\n5. SHERLOCKv2 is designed to identify potential biomarkers and targets for drug development.",
    "vicuna-7b_fact": [
      "SHERLOCKv2 uses deep learning algorithms to analyze biological data.",
      "The platform employs high-quality reference genomes for genomic data analysis.",
      "SHERLOCKv2 integrates multiple types of data, including genomic, transcriptomic, and epigenomic data.",
      "It offers real-time analysis of biological data.",
      "SHERLOCKv2 is designed to identify potential biomarkers and targets for drug development."
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "vicuna-7b_response": "The bartender algorithm is a simple algorithm used in artificial intelligence and machine learning to solve a variety of problems. It is called the \"bartender algorithm\" because it is often used to solve problems that involve finding the shortest path between two points in a graph.\nThe algorithm works by starting at a random point in the graph and then moving to the nearest unvisited point. It then moves to the nearest unvisited point from that point, and so on, until it reaches a goal state. The algorithm uses a priority queue to keep track of the most promising moves, and it also maintains a graph of the current state of the search.\nThe bartender algorithm is a greedy algorithm, which means that it makes the locally optimal choice at each step. This can make it very efficient for solving problems with a large number of possible solutions, as it is able to quickly converge on the optimal solution.\nThe bartender algorithm is often used in conjunction with other search algorithms, such as depth-first search and breadth-first search, to solve more complex problems. It is also used in a variety of other applications, such as scheduling and resource allocation.\nOverall, the bartender algorithm is a simple but powerful algorithm that is widely used in artificial intelligence and machine learning.",
    "vicuna-7b_fact_raw": "1. The bartender algorithm is used in artificial intelligence and machine learning.\n2. It is designed to find the shortest path between two points in a graph.\n3. The algorithm starts at a random point and moves to the nearest unvisited point until it reaches a goal state.\n4. It uses a priority queue to track the most promising moves.\n5. The bartender algorithm is a greedy algorithm.",
    "vicuna-7b_fact": [
      "The bartender algorithm is used in artificial intelligence and machine learning.",
      "It is designed to find the shortest path between two points in a graph.",
      "The algorithm starts at a random point and moves to the nearest unvisited point until it reaches a goal state.",
      "It uses a priority queue to track the most promising moves.",
      "The bartender algorithm is a greedy algorithm."
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "vicuna-7b_response": "There are several web-based pedigree editors available that allow users to create and manage their family trees online. Some popular options include:\n1. Ancestry.com: This is a widely-used genealogy website that offers a range of tools for creating and managing family trees, including a web-based pedigree editor.\n2. MyHeritage: This is another popular genealogy website that offers a web-based pedigree editor, as well as a range of other tools for researching and managing family trees.\n3. Geni.com: This is a free online genealogy platform that allows users to create and manage their family trees, as well as collaborate with others on their research.\n4. WeRelate.org: This is a free, open-source genealogy website that offers a web-based pedigree editor, as well as a range of other tools for researching and managing family trees.\n5. FamilySearch.org: This is a free genealogy website that is run by The Church of Jesus Christ of Latter-day Saints. It offers a web-based pedigree editor, as well as a range of other tools for researching and managing family trees.\nThese are just a few examples of the many web-based pedigree editors available. It's worth noting that some of these platforms may offer different levels of functionality or require a subscription or payment to access certain features.",
    "vicuna-7b_fact_raw": "1. Ancestry.com is a genealogy website that offers a web-based pedigree editor.\n2. MyHeritage is a genealogy website that provides a web-based pedigree editor.\n3. Geni.com is a free online genealogy platform with a web-based pedigree editor.\n4. WeRelate.org is a free, open-source genealogy website that includes a web-based pedigree editor.\n5. FamilySearch.org is a free genealogy website operated by The Church of Jesus Christ of Latter-day Saints and offers a web-based pedigree editor.",
    "vicuna-7b_fact": [
      "Ancestry.com is a genealogy website that offers a web-based pedigree editor.",
      "MyHeritage is a genealogy website that provides a web-based pedigree editor.",
      "Geni.com is a free online genealogy platform with a web-based pedigree editor.",
      "WeRelate.org is a free, open-source genealogy website that includes a web-based pedigree editor.",
      "FamilySearch.org is a free genealogy website operated by The Church of Jesus Christ of Latter-day Saints and offers a web-based pedigree editor."
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "vicuna-7b_response": "There are several curated databases that exist for spider venom toxins. Here are a few examples:\n1. SpiderTox: SpiderTox is a database of spider venom toxins that was developed by researchers at the University of Melbourne. It contains information on the toxins found in over 50 species of spiders, including details on their structure, function, and effects on human cells.\n2. SpiderVenomDB: SpiderVenomDB is a database of spider venom toxins that was developed by researchers at the University of California, San Diego. It contains information on the toxins found in over 20 species of spiders, including details on their structure, function, and effects on human cells.\n3. Spider Venom Database: The Spider Venom Database is a database of spider venom toxins that was developed by researchers at the University of Melbourne. It contains information on the toxins found in over 50 species of spiders, including details on their structure, function, and effects on human cells.\n4. Spider Venom Toxins Database: The Spider Venom Toxins Database is a database of spider venom toxins that was developed by researchers at the University of California, Los Angeles. It contains information on the toxins found in over 20 species of spiders, including details on their structure, function, and effects on human cells.\n5. Spider Venom Database: The Spider Venom Database is a database of spider venom toxins that was developed by researchers at the University of Melbourne. It contains information on the toxins found in over 50 species of spiders, including details on their structure, function, and effects on human cells.\nThese databases are valuable resources for researchers studying spider venom toxins, as they provide detailed information on the toxins and their effects on human cells. They also provide a useful starting point for researchers looking to identify potential therapeutic targets for spider venom toxins.",
    "vicuna-7b_fact_raw": "1. SpiderTox is a database developed by researchers at the University of Melbourne containing information on spider venom toxins from over 50 species of spiders.\n2. SpiderVenomDB is a database developed by researchers at the University of California, San Diego with information on spider venom toxins from over 20 species of spiders.\n3. The Spider Venom Database is mentioned as a resource developed by researchers at the University of Melbourne with toxin information from over 50 spider species.\n4. The Spider Venom Toxins Database is mentioned as being developed by researchers at the University of California, Los Angeles, containing toxin information from over 20 spider species.\n5. These databases provide details on the structure, function, and effects of spider venom toxins on human cells.",
    "vicuna-7b_fact": [
      "SpiderTox is a database developed by researchers at the University of Melbourne containing information on spider venom toxins from over 50 species of spiders.",
      "SpiderVenomDB is a database developed by researchers at the University of California, San Diego with information on spider venom toxins from over 20 species of spiders.",
      "The Spider Venom Database is mentioned as a resource developed by researchers at the University of Melbourne with toxin information from over 50 spider species.",
      "The Spider Venom Toxins Database is mentioned as being developed by researchers at the University of California, Los Angeles, containing toxin information from over 20 spider species.",
      "These databases provide details on the structure, function, and effects of spider venom toxins on human cells."
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "vicuna-7b_response": "Axitinib is a targeted therapy drug that is used to treat advanced renal cell carcinoma and advanced melanoma. It is not approved for the treatment of pancreatic cancer.\nThere have been some studies that have looked at the use of axitinib in combination with other drugs in the treatment of pancreatic cancer, but the results have been mixed and more research is needed to determine its effectiveness in this setting.\nIt's important to note that the prognosis for pancreatic cancer is generally poor, and the majority of patients do not survive for more than a year after diagnosis. There is currently no cure for pancreatic cancer, and treatment options are focused on prolonging survival and improving quality of life.\nIf you have been diagnosed with pancreatic cancer and are considering treatment with axitinib, it is important to speak with your oncologist about the potential benefits and risks of this treatment, as well as other options that may be available to you.",
    "vicuna-7b_fact_raw": "1. Axitinib is used to treat advanced renal cell carcinoma and advanced melanoma.\n2. Axitinib is not approved for the treatment of pancreatic cancer.\n3. Studies on the use of axitinib in combination with other drugs for pancreatic cancer have yielded mixed results.\n4. The prognosis for pancreatic cancer patients is generally poor, with the majority not surviving more than a year after diagnosis.\n5. There is currently no cure for pancreatic cancer.",
    "vicuna-7b_fact": [
      "Axitinib is used to treat advanced renal cell carcinoma and advanced melanoma.",
      "Axitinib is not approved for the treatment of pancreatic cancer.",
      "Studies on the use of axitinib in combination with other drugs for pancreatic cancer have yielded mixed results.",
      "The prognosis for pancreatic cancer patients is generally poor, with the majority not surviving more than a year after diagnosis.",
      "There is currently no cure for pancreatic cancer."
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "vicuna-7b_response": "MLP (Mechano Growth Factor-Induced Protein) is a protein that plays a role in regulating F-actin dynamics, which are the dynamics of the actin cytoskeleton. MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex, which is a key regulator of actin polymerization.\nThe Arp2/3 complex is a complex of proteins that catalyzes the formation of branched actin filaments, which are essential for the dynamic reorganization of the actin cytoskeleton. MLP binds to the Arp2/3 complex and inhibits its activity, thereby regulating the formation of branched actin filaments and the dynamic reorganization of the actin cytoskeleton.\nIn this way, MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex, which is a key regulator of actin polymerization. This interaction is an important mechanism by which MLP regulates the dynamic reorganization of the actin cytoskeleton and contributes to its role in cellular processes such as cell growth, migration, and differentiation.",
    "vicuna-7b_fact_raw": "1. MLP (Mechano Growth Factor-Induced Protein) regulates F-actin dynamics.\n2. MLP interacts with the Arp2/3 complex to regulate F-actin dynamics.\n3. The Arp2/3 complex is a key regulator of actin polymerization.\n4. MLP binds to the Arp2/3 complex and inhibits its activity.\n5. The interaction between MLP and the Arp2/3 complex contributes to the dynamic reorganization of the actin cytoskeleton.",
    "vicuna-7b_fact": [
      "MLP (Mechano Growth Factor-Induced Protein) regulates F-actin dynamics.",
      "MLP interacts with the Arp2/3 complex to regulate F-actin dynamics.",
      "The Arp2/3 complex is a key regulator of actin polymerization.",
      "MLP binds to the Arp2/3 complex and inhibits its activity.",
      "The interaction between MLP and the Arp2/3 complex contributes to the dynamic reorganization of the actin cytoskeleton."
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "vicuna-7b_response": "There are 51 pseudokinases in the human kinome.",
    "vicuna-7b_fact_raw": "1. There are 51 pseudokinases in the human kinome.",
    "vicuna-7b_fact": [
      "There are 51 pseudokinases in the human kinome."
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "vicuna-7b_response": "ApoE mimetics are molecules that mimic the structure and function of the apoE protein, which is a major protein component of low-density lipoprotein (LDL) in the blood. ApoE mimetics have been studied as potential therapeutic agents for the treatment of various diseases, including Alzheimer's disease, atherosclerosis, and other conditions related to lipid metabolism. Here are three examples of apoE mimetics:\n1. Apolipoprotein E (apoE) mimetic peptides: These are short peptides that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal Nature Medicine in 2012 found that a specific apoE mimetic peptide called PPMI-111 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.\n2. Apolipoprotein E (apoE) mimetic small molecules: These are small molecules that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal Nature in 2018 found that a specific apoE mimetic small molecule called CNP (cyanopeptide) improved memory and learning in mice with Alzheimer's disease.\n3. Apolipoprotein E (apoE) mimetic nanoparticles: These are nanoparticles that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal ACS Nano in 2019 found that a specific apoE mimetic nanoparticle called NP-205 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.\nIt's important to note that while apoE mimetics have shown promise in preclinical studies, their efficacy and safety in humans have yet to be fully established. Further research is needed to fully understand the potential benefits and risks of these molecules",
    "vicuna-7b_fact_raw": "1. Apolipoprotein E (apoE) mimetic peptides are short peptides designed to mimic the structure of the apoE protein.\n2. A study published in Nature Medicine in 2012 reported that an apoE mimetic peptide called PPMI-111 reduced beta-amyloid plaque accumulation in Alzheimer's disease mice.\n3. Apolipoprotein E (apoE) mimetic small molecules are designed to mimic the structure of the apoE protein.\n4. A study published in Nature in 2018 found that an apoE mimetic small molecule called CNP improved memory and learning in mice with Alzheimer's disease.\n5. A study published in ACS Nano in 2019 reported that an apoE mimetic nanoparticle called NP-205 reduced beta-amyloid plaque accumulation in the brains of Alzheimer's disease mice.",
    "vicuna-7b_fact": [
      "Apolipoprotein E (apoE) mimetic peptides are short peptides designed to mimic the structure of the apoE protein.",
      "A study published in Nature Medicine in 2012 reported that an apoE mimetic peptide called PPMI-111 reduced beta-amyloid plaque accumulation in Alzheimer's disease mice.",
      "Apolipoprotein E (apoE) mimetic small molecules are designed to mimic the structure of the apoE protein.",
      "A study published in Nature in 2018 found that an apoE mimetic small molecule called CNP improved memory and learning in mice with Alzheimer's disease.",
      "A study published in ACS Nano in 2019 reported that an apoE mimetic nanoparticle called NP-205 reduced beta-amyloid plaque accumulation in the brains of Alzheimer's disease mice."
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "vicuna-7b_response": "SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells. There are sex differences in SAMHD1 activity that have been observed in various studies.\nOne study published in the journal Cell in 2015 found that SAMHD1 activity is higher in women than in men. The study suggested that this difference may contribute to the lower viral load observed in women compared to men.\nAnother study published in the journal Nature Medicine in 2016 found that SAMHD1 activity is lower in women than in men. The study suggested that this difference may contribute to the higher susceptibility of women to HIV-1 infection.\nIt is important to note that these studies were conducted in different populations and under different experimental conditions, and more research is needed to fully understand the sex differences in SAMHD1 activity.\nIn summary, there are sex differences in SAMHD1 activity that have been observed in various studies, with higher activity in women and lower activity in men. These differences may contribute to the observed differences in viral load and susceptibility to HIV-1 infection between men and women.",
    "vicuna-7b_fact_raw": "1. SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells.\n2. A study published in the journal Cell in 2015 found that SAMHD1 activity is higher in women than in men.\n3. The same study from Cell in 2015 suggested that higher SAMHD1 activity in women may contribute to their lower viral load compared to men.\n4. A study published in the journal Nature Medicine in 2016 found that SAMHD1 activity is lower in women than in men.\n5. The study from Nature Medicine in 2016 suggested that lower SAMHD1 activity in women may contribute to their higher susceptibility to HIV-1 infection.",
    "vicuna-7b_fact": [
      "SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells.",
      "A study published in the journal Cell in 2015 found that SAMHD1 activity is higher in women than in men.",
      "The same study from Cell in 2015 suggested that higher SAMHD1 activity in women may contribute to their lower viral load compared to men.",
      "A study published in the journal Nature Medicine in 2016 found that SAMHD1 activity is lower in women than in men.",
      "The study from Nature Medicine in 2016 suggested that lower SAMHD1 activity in women may contribute to their higher susceptibility to HIV-1 infection."
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "vicuna-7b_response": "RUNX2 is a transcription factor that plays a crucial role in the development and differentiation of various cell types, including astrocytes. While the exact effect of RUNX2 on astrocyte differentiation is complex and depends on various factors, including the stage of differentiation, the presence of other signaling molecules, and the cellular context, studies have shown that RUNX2 can inhibit astrocyte differentiation in some cases.\nOne study published in the journal Molecular and Cellular Biology found that RUNX2 expression was decreased during the differentiation of neural stem cells into astrocytes, suggesting that RUNX2 may play a role in regulating the differentiation of these cells (1). Another study published in the journal Glia found that overexpression of RUNX2 in astrocyte progenitor cells inhibited their differentiation into mature astrocytes, while knockdown of RUNX2 in these cells promoted differentiation (2).\nHowever, it is important to note that the effects of RUNX2 on astrocyte differentiation are not always consistent, and other studies have found that RUNX2 can promote astrocyte differentiation under certain conditions. For example, a study published in the journal Neurochemistry International found that RUNX2 overexpression in astrocyte progenitor cells promoted their differentiation into mature astrocytes, while knockdown of RUNX2 inhibited differentiation (3).\nIn summary, while the effects of RUNX2 on astrocyte differentiation are complex and depend on various factors, studies have shown that RUNX2 can inhibit astrocyte differentiation in some cases. However, the exact role of RUNX2 in regulating astrocyte differentiation is still an area of active research, and further studies are needed to fully understand its effects on this process.",
    "vicuna-7b_fact_raw": "1. RUNX2 is a transcription factor involved in the development and differentiation of various cell types, including astrocytes.\n2. A study in the journal Molecular and Cellular Biology reported that RUNX2 expression decreased during the differentiation of neural stem cells into astrocytes.\n3. Research published in the journal Glia found that overexpression of RUNX2 inhibited the differentiation of astrocyte progenitor cells into mature astrocytes.\n4. The same study from the journal Glia indicated that knockdown of RUNX2 promoted the differentiation of astrocyte progenitor cells.\n5. A study in Neurochemistry International suggested that RUNX2 overexpression promoted the differentiation of astrocyte progenitor cells into mature astrocytes, while its knockdown inhibited differentiation.",
    "vicuna-7b_fact": [
      "RUNX2 is a transcription factor involved in the development and differentiation of various cell types, including astrocytes.",
      "A study in the journal Molecular and Cellular Biology reported that RUNX2 expression decreased during the differentiation of neural stem cells into astrocytes.",
      "Research published in the journal Glia found that overexpression of RUNX2 inhibited the differentiation of astrocyte progenitor cells into mature astrocytes.",
      "The same study from the journal Glia indicated that knockdown of RUNX2 promoted the differentiation of astrocyte progenitor cells.",
      "A study in Neurochemistry International suggested that RUNX2 overexpression promoted the differentiation of astrocyte progenitor cells into mature astrocytes, while its knockdown inhibited differentiation."
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "vicuna-7b_response": "The Cobb-Stainsby excision arthroplasty is a surgical procedure that is typically performed on the knee joint. It is used to treat osteochondritis dissecans, a condition in which a piece of cartilage and bone in the joint becomes detached from the underlying bone.\nThe Cobb-Stainsby excision arthroplasty involves making an incision over the affected knee joint and removing the damaged cartilage and bone. The joint is then stabilized using a graft of healthy cartilage and bone, or a metal or plastic implant.\nThe procedure is typically performed on an outpatient basis, which means that the patient can go home on the same day as the surgery. The recovery time for the Cobb-Stainsby excision arthroplasty can vary depending on the specifics of the procedure and the patient's overall health, but most people are able to resume normal activities within a few weeks to a few months.",
    "vicuna-7b_fact_raw": "1. The Cobb-Stainsby excision arthroplasty is a surgical procedure performed on the knee joint.\n2. It is used to treat osteochondritis dissecans, a condition where a piece of cartilage and bone becomes detached from the underlying bone in a joint.\n3. The procedure involves removing the damaged cartilage and bone from the knee joint.\n4. The knee joint is stabilized using a graft of healthy cartilage and bone, or a metal or plastic implant after the removal of damaged parts.\n5. The Cobb-Stainsby excision arthroplasty is typically performed on an outpatient basis.",
    "vicuna-7b_fact": [
      "The Cobb-Stainsby excision arthroplasty is a surgical procedure performed on the knee joint.",
      "It is used to treat osteochondritis dissecans, a condition where a piece of cartilage and bone becomes detached from the underlying bone in a joint.",
      "The procedure involves removing the damaged cartilage and bone from the knee joint.",
      "The knee joint is stabilized using a graft of healthy cartilage and bone, or a metal or plastic implant after the removal of damaged parts.",
      "The Cobb-Stainsby excision arthroplasty is typically performed on an outpatient basis."
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "vicuna-7b_response": "Yes, GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).\nEMT is a crucial process in embryonic development, tissue repair, and cancer progression. It involves the loss of epithelial cell polarity and the acquisition of a mesenchymal phenotype, characterized by the expression of mesenchymal markers and the ability to migrate and proliferate in a three-dimensional environment.\nGRHL2 is a transcription factor that plays a crucial role in regulating cellular processes, including cell proliferation, differentiation, and migration. Studies have shown that over-expression of GRHL2 in various cell types, including epithelial cells, can lead to EMT. This is achieved by activating a set of genes that are involved in the mesenchymal phenotype, such as N-cadherin, vimentin, and fibronectin.\nIn addition, GRHL2 has also been shown to regulate the expression of other genes that are involved in EMT, such as Snail and Slug. These genes are known to play a crucial role in the regulation of E-cadherin, a key epithelial marker, and the downregulation of mesenchymal markers.\nOverall, GRHL2 over-expression leads to EMT by activating a set of genes that are involved in the mesenchymal phenotype and downregulating genes that are involved in the epithelial phenotype. This process is crucial for various biological processes, including embryonic development, tissue repair, and cancer progression.",
    "vicuna-7b_fact_raw": "1. GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).\n2. EMT involves the loss of epithelial cell polarity and the acquisition of a mesenchymal phenotype.\n3. GRHL2 is a transcription factor that regulates cellular processes such as cell proliferation, differentiation, and migration.\n4. Over-expression of GRHL2 activates genes involved in the mesenchymal phenotype, such as N-cadherin, vimentin, and fibronectin.\n5. GRHL2 regulates the expression of genes like Snail and Slug, which are involved in the regulation of E-cadherin and the downregulation of mesenchymal markers.",
    "vicuna-7b_fact": [
      "GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).",
      "EMT involves the loss of epithelial cell polarity and the acquisition of a mesenchymal phenotype.",
      "GRHL2 is a transcription factor that regulates cellular processes such as cell proliferation, differentiation, and migration.",
      "Over-expression of GRHL2 activates genes involved in the mesenchymal phenotype, such as N-cadherin, vimentin, and fibronectin.",
      "GRHL2 regulates the expression of genes like Snail and Slug, which are involved in the regulation of E-cadherin and the downregulation of mesenchymal markers."
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "vicuna-7b_response": "T-UCRs, or Tumor-Associated Antigens, are proteins or carbohydrates that are expressed on the surface of cancer cells and can be recognized by the immune system. Some T-UCRs that have been implicated in lung cancer include:\n* TAG-72: This T-UCR is expressed in a variety of cancers, including lung cancer, and can be targeted by immunotherapy.\n* MUC1: This T-UCR is a mucin protein that is expressed in many types of cancer, including lung cancer, and can be targeted by immunotherapy.\n* CEA: This T-UCR is a carcinoembryonic antigen that is expressed in many types of cancer, including lung cancer, and can be targeted by immunotherapy.\n* RAGE: This T-UCR is a receptor for advanced glycation end products and is expressed in many types of cancer, including lung cancer, and can be targeted by immunotherapy.\n* MAGE: This T-UCR is a group of proteins that are expressed in many types of cancer, including lung cancer, and can be targeted by immunotherapy.\n* NY-ESO-1: This T-UCR is a cancer/testis antigen that is expressed in many types of cancer, including lung cancer, and can be targeted by immunotherapy.\nIt's important to note that these are just a few examples of T-UCRs that have been implicated in lung cancer, and there are many other T-UCRs that can be targeted by immunotherapy. Additionally, the specific T-UCRs that are most effective in treating lung cancer may vary depending on the individual patient and the specific characteristics of their cancer.",
    "vicuna-7b_fact_raw": "1. TAG-72 is a Tumor-Associated Antigen (T-UCR) expressed in various cancers, including lung cancer.\n2. MUC1 is a mucin protein T-UCR that is expressed in many types of cancer, including lung cancer.\n3. CEA is a carcinoembryonic antigen T-UCR that is expressed in many types of cancer, including lung cancer.\n4. RAGE is a receptor for advanced glycation end products T-UCR that is expressed in many types of cancer, including lung cancer.\n5. NY-ESO-1 is a cancer/testis antigen T-UCR that is expressed in many types of cancer, including lung cancer.",
    "vicuna-7b_fact": [
      "TAG-72 is a Tumor-Associated Antigen (T-UCR) expressed in various cancers, including lung cancer.",
      "MUC1 is a mucin protein T-UCR that is expressed in many types of cancer, including lung cancer.",
      "CEA is a carcinoembryonic antigen T-UCR that is expressed in many types of cancer, including lung cancer.",
      "RAGE is a receptor for advanced glycation end products T-UCR that is expressed in many types of cancer, including lung cancer.",
      "NY-ESO-1 is a cancer/testis antigen T-UCR that is expressed in many types of cancer, including lung cancer."
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "vicuna-7b_response": "GPR151 is a G protein-coupled receptor that has been identified as an orphan receptor, meaning that it has not been shown to bind to any known ligands. However, recent studies have suggested that GPR151 may play a role in the regulation of metabolic processes, including glucose and lipid metabolism.\nOne study published in the journal Molecular Endocrinology in 2012 found that GPR151 is expressed in various tissues, including the liver, adipose tissue, and skeletal muscle, and that it is involved in the regulation of glucose and lipid metabolism. The study also found that GPR151 is activated by a variety of compounds, including fatty acids and bile acids, which suggests that it may play a role in the regulation of lipid metabolism.\nAnother study published in the journal Diabetes in 2014 found that GPR151 is expressed in pancreatic beta cells and that it is involved in the regulation of insulin secretion. The study found that activation of GPR151 by fatty acids increased insulin secretion in pancreatic beta cells, suggesting that it may play a role in the regulation of glucose metabolism.\nOverall, while more research is needed to fully understand the function of GPR151, recent studies have suggested that it may play a role in the regulation of metabolic processes, including glucose and lipid metabolism.",
    "vicuna-7b_fact_raw": "1. GPR151 is a G protein-coupled receptor identified as an orphan receptor.\n2. A study published in Molecular Endocrinology in 2012 reported that GPR151 is expressed in the liver, adipose tissue, and skeletal muscle.\n3. The same study suggested that GPR151 is involved in the regulation of glucose and lipid metabolism.\n4. A study published in the journal Diabetes in 2014 found that GPR151 is expressed in pancreatic beta cells.\n5. The 2014 study indicated that activation of GPR151 by fatty acids increased insulin secretion in pancreatic beta cells.",
    "vicuna-7b_fact": [
      "GPR151 is a G protein-coupled receptor identified as an orphan receptor.",
      "A study published in Molecular Endocrinology in 2012 reported that GPR151 is expressed in the liver, adipose tissue, and skeletal muscle.",
      "The same study suggested that GPR151 is involved in the regulation of glucose and lipid metabolism.",
      "A study published in the journal Diabetes in 2014 found that GPR151 is expressed in pancreatic beta cells.",
      "The 2014 study indicated that activation of GPR151 by fatty acids increased insulin secretion in pancreatic beta cells."
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "vicuna-7b_response": "Fluzone intradermal quadrivalent vaccine contains attenuated live viruses of four strains: influenza virus type A (H1N1), influenza virus type A (H3N2), influenza virus type B (Yamagata), and influenza virus type B (Victoria).",
    "vicuna-7b_fact_raw": "NO FACTS",
    "vicuna-7b_fact": []
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "vicuna-7b_response": "The TNFR2 gene, also known as the tumor necrosis factor receptor 2 gene, is a gene that encodes for a protein called TNF receptor 2. This protein is a receptor for the TNF-alpha cytokine, which plays a role in the immune response and inflammation.\nThere are several variations or polymorphisms in the TNFR2 gene that have been associated with an increased risk of developing Systemic Lupus Erythematosus (SLE), an autoimmune disease that causes inflammation throughout the body. One of these variations is a single nucleotide polymorphism (SNP) called rs1143679.\nThis SNP is located in the 3' untranslated region of the TNFR2 gene and results in the substitution of a single nucleotide (C for T). This variation has been found to be associated with an increased risk of developing SLE in several studies, including a study of over 1,000 patients with SLE and over 1,000 healthy controls.\nIn summary, the TNFR2 gene and its rs1143679 SNP are genetically associated with an increased risk of developing Systemic Lupus Erythematosus.",
    "vicuna-7b_fact_raw": "1. The TNFR2 gene encodes for a protein called TNF receptor 2.\n2. TNF receptor 2 is a receptor for the TNF-alpha cytokine.\n3. Variations in the TNFR2 gene have been associated with an increased risk of developing Systemic Lupus Erythematosus (SLE).\n4. A single nucleotide polymorphism (SNP) in the TNFR2 gene, known as rs1143679, is associated with an increased risk of SLE.\n5. The rs1143679 SNP results in the substitution of a single nucleotide (C for T) in the 3' untranslated region of the TNFR2 gene.",
    "vicuna-7b_fact": [
      "The TNFR2 gene encodes for a protein called TNF receptor 2.",
      "TNF receptor 2 is a receptor for the TNF-alpha cytokine.",
      "Variations in the TNFR2 gene have been associated with an increased risk of developing Systemic Lupus Erythematosus (SLE).",
      "A single nucleotide polymorphism (SNP) in the TNFR2 gene, known as rs1143679, is associated with an increased risk of SLE.",
      "The rs1143679 SNP results in the substitution of a single nucleotide (C for T) in the 3' untranslated region of the TNFR2 gene."
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "vicuna-7b_response": "Yes, there is a vaccine for peanut allergy. It is called the AR101 vaccine and it is the first and only FDA-approved vaccine for the prevention of peanut allergy in children.\nThe AR101 vaccine is administered in two doses, with the first dose given at 4-6 years of age and the second dose given 6-12 months later. The vaccine is designed to gradually increase the body's tolerance to peanut protein, which can help prevent the development of peanut allergy.\nIt is important to note that the vaccine is not a cure for peanut allergy and it does not eliminate the risk of an allergic reaction to peanuts. However, it can significantly reduce the risk of developing a peanut allergy and can provide long-term protection against the allergy.\nIt is also important to note that the vaccine is not recommended for individuals who have a severe allergy to peanuts or any other ingredients in the vaccine.\nIt is important to consult with a healthcare provider to determine if the vaccine is appropriate for you or your child.",
    "vicuna-7b_fact_raw": "1. The AR101 vaccine is FDA-approved for the prevention of peanut allergy in children.\n2. The AR101 vaccine is administered in two doses.\n3. The first dose of the AR101 vaccine is given at 4-6 years of age.\n4. The second dose of the AR101 vaccine is given 6-12 months after the first dose.\n5. The AR101 vaccine is not recommended for individuals with a severe allergy to peanuts or any other ingredients in the vaccine.",
    "vicuna-7b_fact": [
      "The AR101 vaccine is FDA-approved for the prevention of peanut allergy in children.",
      "The AR101 vaccine is administered in two doses.",
      "The first dose of the AR101 vaccine is given at 4-6 years of age.",
      "The second dose of the AR101 vaccine is given 6-12 months after the first dose.",
      "The AR101 vaccine is not recommended for individuals with a severe allergy to peanuts or any other ingredients in the vaccine."
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "vicuna-7b_response": "The mouse Fxy gene is located on chromosome 10 at position 10.10. The gene is composed of 10 exons and spans approximately 100 kilobases. The Fxy gene encodes for a protein that is involved in the regulation of cell growth and differentiation. The gene has been shown to be expressed in a variety of tissues, including the brain, heart, and testis. The Fxy gene has also been implicated in the development of certain diseases, such as cancer and neurological disorders.",
    "vicuna-7b_fact_raw": "1. The mouse Fxy gene is located on chromosome 10 at position 10.10.\n2. The Fxy gene is composed of 10 exons.\n3. The Fxy gene spans approximately 100 kilobases.\n4. The Fxy gene encodes for a protein involved in the regulation of cell growth and differentiation.\n5. The Fxy gene is expressed in a variety of tissues, including the brain, heart, and testis.",
    "vicuna-7b_fact": [
      "The mouse Fxy gene is located on chromosome 10 at position 10.10.",
      "The Fxy gene is composed of 10 exons.",
      "The Fxy gene spans approximately 100 kilobases.",
      "The Fxy gene encodes for a protein involved in the regulation of cell growth and differentiation.",
      "The Fxy gene is expressed in a variety of tissues, including the brain, heart, and testis."
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "vicuna-7b_response": "Methidiumpropyl-EDTA (MPE) sequencing is a method used to sequence DNA molecules by using MPE as a primer for DNA amplification. MPE is a modified nucleotide analog that contains a methidium group, which is a derivative of psoralen, and a propyl group. The methidium group allows MPE to bind to DNA through its intercalating properties, while the propyl group enhances the stability of the MPE-DNA complex.\nThe MPE-seq method involves the following steps:\n1. MPE is added to the DNA sample to make the MPE-DNA complex.\n2. The complex is denatured to separate the DNA strands.\n3. The denatured DNA is then amplified using PCR, with MPE as the primer.\n4. The amplified product is then sequenced using standard DNA sequencing techniques, such as capillary electrophoresis or Sanger sequencing.\nThe MPE-seq method has several advantages over other sequencing methods, such as its ability to sequence long DNA molecules, its high sensitivity and specificity, and its ability to sequence both DNA and RNA. However, it also has some limitations, such as the potential for cross-linking to other nucleic acids and the need for specialized equipment and expertise.\nOverall, the MPE-seq method is a powerful tool for DNA sequencing, particularly for studying complex genomes and transcriptomes.",
    "vicuna-7b_fact_raw": "1. Methidiumpropyl-EDTA (MPE) sequencing uses MPE as a primer for DNA amplification.\n2. MPE contains a methidium group, which is a derivative of psoralen, and a propyl group.\n3. The methidium group allows MPE to bind to DNA through intercalating properties.\n4. The MPE-seq method includes steps such as adding MPE to DNA, denaturing the complex, amplifying the DNA using PCR with MPE as the primer, and sequencing the amplified product.\n5. The MPE-seq method can sequence both DNA and RNA.",
    "vicuna-7b_fact": [
      "Methidiumpropyl-EDTA (MPE) sequencing uses MPE as a primer for DNA amplification.",
      "MPE contains a methidium group, which is a derivative of psoralen, and a propyl group.",
      "The methidium group allows MPE to bind to DNA through intercalating properties.",
      "The MPE-seq method includes steps such as adding MPE to DNA, denaturing the complex, amplifying the DNA using PCR with MPE as the primer, and sequencing the amplified product.",
      "The MPE-seq method can sequence both DNA and RNA."
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "vicuna-7b_response": "GWAR is a web-based game development platform that allows users to create and share their own games. It is built using a combination of technologies, including HTML, CSS, JavaScript, and a few other web technologies.\nHTML (Hypertext Markup Language) is used to define the structure and content of a web page. It provides a way to define the different elements of a web page, such as headings, paragraphs, images, and links.\nCSS (Cascading Style Sheets) is used to define the visual style of a web page, such as colors, fonts, and layout. It allows developers to create a consistent look and feel for their web pages.\nJavaScript is used to add interactive elements to a web page. It allows developers to add animations, interactions, and other dynamic effects to their web pages.\nGWAR also uses a few other web technologies, such as WebGL (Web Graphics Library) for 3D graphics, and WebRTC (Web Real-Time Communication) for real-time communication between users.\nOverall, GWAR is built using a combination of web technologies that allow developers to create and share their own games on the web.",
    "vicuna-7b_fact_raw": "1. GWAR is a web-based game development platform.\n2. GWAR is built using HTML, CSS, and JavaScript among other web technologies.\n3. HTML is used in GWAR to define the structure and content of web pages.\n4. CSS is used in GWAR to define the visual style of web pages.\n5. JavaScript is used in GWAR to add interactive elements to web pages.",
    "vicuna-7b_fact": [
      "GWAR is a web-based game development platform.",
      "GWAR is built using HTML, CSS, and JavaScript among other web technologies.",
      "HTML is used in GWAR to define the structure and content of web pages.",
      "CSS is used in GWAR to define the visual style of web pages.",
      "JavaScript is used in GWAR to add interactive elements to web pages."
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "vicuna-7b_response": "Xaliproden is a drug that has been studied for its potential to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. However, the evidence regarding the effectiveness of xaliproden in improving the prognosis of ALS is limited and inconclusive.\nXaliproden is a selective agonist of the melanocortin-4 receptor (MC4R), which is a receptor that is involved in the regulation of appetite, metabolism, and inflammation. Some studies have suggested that xaliproden may have neuroprotective effects and may slow the progression of ALS in animal models of the disease. However, these studies have not been replicated in clinical trials in humans.\nThere have been two clinical trials of xaliproden in patients with ALS, but both of these trials were small and had limited power to detect a difference in the progression of the disease. The first trial found that xaliproden was well-tolerated and had no significant effect on the progression of the disease, while the second trial found that xaliproden was associated with a slight delay in the decline of respiratory function, but again, the study was not large enough to determine whether this was statistically significant.\nOverall, while xaliproden may have some potential as a treatment for ALS, the evidence regarding its effectiveness in improving the prognosis of the disease is limited and inconclusive. Further research is needed to determine the safety and efficacy of xaliproden in treating ALS.",
    "vicuna-7b_fact_raw": "1. Xaliproden has been studied for its potential to treat amyotrophic lateral sclerosis (ALS).\n2. Xaliproden is a selective agonist of the melanocortin-4 receptor (MC4R).\n3. Some studies have suggested that xaliproden may have neuroprotective effects and may slow the progression of ALS in animal models.\n4. There have been two clinical trials of xaliproden in patients with ALS.\n5. The first clinical trial found that xaliproden had no significant effect on the progression of ALS, while the second trial found a slight delay in the decline of respiratory function.",
    "vicuna-7b_fact": [
      "Xaliproden has been studied for its potential to treat amyotrophic lateral sclerosis (ALS).",
      "Xaliproden is a selective agonist of the melanocortin-4 receptor (MC4R).",
      "Some studies have suggested that xaliproden may have neuroprotective effects and may slow the progression of ALS in animal models.",
      "There have been two clinical trials of xaliproden in patients with ALS.",
      "The first clinical trial found that xaliproden had no significant effect on the progression of ALS, while the second trial found a slight delay in the decline of respiratory function."
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "vicuna-7b_response": "The LiPS-A3S line is a transgenic line that was created by inserting the A3S promoter upstream of the luciferase gene. The A3S promoter is a constitutive promoter that is active in all tissues and cell types, and it is commonly used to drive the expression of genes in transgenic animals.\nIn the case of the LiPS-A3S line, the A3S promoter was used to drive the expression of the luciferase gene, which is a reporter gene that encodes an enzyme that catalyzes the conversion of a substrate (luciferin) to light. The luciferase gene was inserted into the genome of the mouse embryonic stem cells that were used to create the LiPS-A3S line, and the A3S promoter was used to drive the expression of the luciferase gene in these cells.\nThe luciferase gene was inserted into the genome of the LiPS-A3S line using a technique called gene targeting. In this technique, a small piece of DNA that contains the luciferase gene is inserted into the genome of the mouse embryonic stem cells at a specific location, using a special enzyme called a recombinase. The recombinase is used to cut the DNA at a specific site, and then the luciferase gene is inserted into the resulting gap in the DNA. The A3S promoter is then used to drive the expression of the luciferase gene in the cells that contain the transgene.\nIn summary, the LiPS-A3S line was created by inserting the A3S promoter upstream of the luciferase gene, and the A3S promoter was used to drive the expression of the luciferase gene in the mouse embryonic stem cells that were used to create the line. The luciferase gene was inserted into the genome of the LiPS-A3S line using a technique called gene targeting, and the A3S promoter was used to drive the expression of the luciferase gene in these cells.",
    "vicuna-7b_fact_raw": "1. The LiPS-A3S line is a transgenic line where the A3S promoter is used to drive the expression of the luciferase gene.\n2. The A3S promoter is a constitutive promoter active in all tissues and cell types.\n3. The luciferase gene encodes an enzyme that catalyzes the conversion of luciferin to light.\n4. The luciferase gene was inserted into the genome of mouse embryonic stem cells to create the LiPS-A3S line.\n5. Gene targeting, which involves using a recombinase enzyme, was the technique used to insert the luciferase gene into the LiPS-A3S line's genome.",
    "vicuna-7b_fact": [
      "The LiPS-A3S line is a transgenic line where the A3S promoter is used to drive the expression of the luciferase gene.",
      "The A3S promoter is a constitutive promoter active in all tissues and cell types.",
      "The luciferase gene encodes an enzyme that catalyzes the conversion of luciferin to light.",
      "The luciferase gene was inserted into the genome of mouse embryonic stem cells to create the LiPS-A3S line.",
      "Gene targeting, which involves using a recombinase enzyme, was the technique used to insert the luciferase gene into the LiPS-A3S line's genome."
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "vicuna-7b_response": "There are several tools and frameworks available for predicting drug synergy with deep learning. Some of the popular ones include:\n1. DeepDrug: This is a deep learning-based drug discovery platform that can predict the potential of drug combinations based on molecular interactions.\n2. DrugBank: This is a public database of drugs and drug targets that includes information on drug interactions and synergy. It can be used as a source of data for deep learning models.\n3. GATORnet: This is a web-based platform that uses deep learning to predict the activity of drugs against various disease targets.\n4. DeepChem: This is a deep learning framework for drug discovery that can predict the activity of drugs against various targets and also predict the potential of drug combinations.\n5. DrugSynth: This is a deep learning-based platform for drug discovery that can predict the potential of drug combinations based on molecular interactions.\nThese are just a few examples of the tools and frameworks available for predicting drug synergy with deep learning. The choice of tool will depend on the specific requirements of the user and the nature of the data being used.",
    "vicuna-7b_fact_raw": "1. DeepDrug is a deep learning-based drug discovery platform that predicts the potential of drug combinations based on molecular interactions.\n2. DrugBank is a public database that includes information on drug interactions and synergy.\n3. GATORnet is a web-based platform that uses deep learning to predict the activity of drugs against various disease targets.\n4. DeepChem is a deep learning framework for drug discovery that can predict drug activity against various targets and drug combinations.\n5. DrugSynth is a deep learning-based platform for drug discovery that predicts the potential of drug combinations based on molecular interactions.",
    "vicuna-7b_fact": [
      "DeepDrug is a deep learning-based drug discovery platform that predicts the potential of drug combinations based on molecular interactions.",
      "DrugBank is a public database that includes information on drug interactions and synergy.",
      "GATORnet is a web-based platform that uses deep learning to predict the activity of drugs against various disease targets.",
      "DeepChem is a deep learning framework for drug discovery that can predict drug activity against various targets and drug combinations.",
      "DrugSynth is a deep learning-based platform for drug discovery that predicts the potential of drug combinations based on molecular interactions."
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "vicuna-7b_response": "There are several cloud-based platforms that have been developed for comparing genome-wide association studies (GWAS). Some examples include:\n1. GWAS Central: This is a cloud-based platform that provides a centralized repository for storing and analyzing GWAS data. It allows researchers to upload their data and perform analyses using a variety of statistical methods.\n2. The Global Alliance for Genomics and Health (GA4GH): This is a cloud-based platform that provides tools and resources for sharing and analyzing genomic data. It includes a variety of tools for comparing GWAS data, such as the GWAS Catalog and the Variant Effect Predictor.\n3. The National Center for Biotechnology Information (NCBI): This is a cloud-based platform that provides a variety of tools for analyzing GWAS data, including the dbGaP database.\n4. The European Bioinformatics Institute (EBI): This is a cloud-based platform that provides a variety of tools for analyzing GWAS data, including the European Genome-Phenome Archive (EGA).\nThese are just a few examples of cloud-based platforms that have been developed for comparing GWAS data. There are many other platforms available, and the best one for a particular researcher will depend on their specific needs and goals.",
    "vicuna-7b_fact_raw": "1. GWAS Central is a cloud-based platform designed for storing and analyzing GWAS data.\n2. The Global Alliance for Genomics and Health provides tools for sharing and analyzing genomic data, including tools for comparing GWAS data.\n3. The National Center for Biotechnology Information offers a cloud-based platform with tools for analyzing GWAS data, such as the dbGaP database.\n4. The European Bioinformatics Institute provides a cloud-based platform with tools for analyzing GWAS data, including the European Genome-Phenome Archive.\n5. The GWAS Catalog and the Variant Effect Predictor are tools included in the GA4GH platform for comparing GWAS data.",
    "vicuna-7b_fact": [
      "GWAS Central is a cloud-based platform designed for storing and analyzing GWAS data.",
      "The Global Alliance for Genomics and Health provides tools for sharing and analyzing genomic data, including tools for comparing GWAS data.",
      "The National Center for Biotechnology Information offers a cloud-based platform with tools for analyzing GWAS data, such as the dbGaP database.",
      "The European Bioinformatics Institute provides a cloud-based platform with tools for analyzing GWAS data, including the European Genome-Phenome Archive.",
      "The GWAS Catalog and the Variant Effect Predictor are tools included in the GA4GH platform for comparing GWAS data."
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "vicuna-7b_response": "CMB305 is a monoclonal antibody that targets the CD33 protein, which is expressed on the surface of certain cancer cells, including acute myeloid leukemia (AML) cells. CMB305 has been shown to have potential in the treatment of AML, and it is currently being studied in clinical trials for the treatment of other types of cancer as well, including sarcomas.\nSarcomas are a type of cancer that develops from the soft tissues of the body, such as muscle, fat, bone, and connective tissue. They are rare cancers, and they can occur in both adults and children. The CD33 protein is expressed on the surface of some sarcoma cells, so CMB305 may have potential in the treatment of sarcomas as well.\nHowever, it is important to note that CMB305 has not been specifically approved for the treatment of sarcomas by the FDA, and its efficacy in treating sarcomas is still being studied. Additionally, sarcomas are a diverse group of cancers, and the response to treatment can vary depending on the specific type of sarcoma and other individual factors. Therefore, it is important to consult with a healthcare professional to determine the best treatment options for a specific case of sarcoma.",
    "vicuna-7b_fact_raw": "1. CMB305 is a monoclonal antibody that targets the CD33 protein.\n2. The CD33 protein is expressed on the surface of certain cancer cells, including acute myeloid leukemia (AML) cells.\n3. CMB305 is currently being studied in clinical trials for the treatment of sarcomas.\n4. Sarcomas are cancers that develop from soft tissues of the body.\n5. CMB305 has not been specifically approved by the FDA for the treatment of sarcomas.",
    "vicuna-7b_fact": [
      "CMB305 is a monoclonal antibody that targets the CD33 protein.",
      "The CD33 protein is expressed on the surface of certain cancer cells, including acute myeloid leukemia (AML) cells.",
      "CMB305 is currently being studied in clinical trials for the treatment of sarcomas.",
      "Sarcomas are cancers that develop from soft tissues of the body.",
      "CMB305 has not been specifically approved by the FDA for the treatment of sarcomas."
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "vicuna-7b_response": "The Saint's Triad is a concept in Christian theology that refers to the three persons of the Trinity: the Father, the Son, and the Holy Spirit. The manifestations of the Saint's Triad are the ways in which these three persons are revealed and experienced in the world.\nThe Father is often revealed through creation, as the creator of the universe and all that exists within it. The Son is revealed through the person of Jesus Christ, who is believed to be the Son of God and the savior of humanity. The Holy Spirit is revealed through the work of the Holy Spirit, which includes the guidance of believers, the empowerment of the church, and the conviction of sinners.\nIn addition to these primary manifestations, the Saint's Triad is also revealed in the sacraments, such as baptism and communion, and in the lives of believers who are filled with the Holy Spirit and live in accordance with God's will.\nOverall, the manifestations of the Saint's Triad are diverse and multifaceted, and they are experienced in a variety of ways by different people.",
    "vicuna-7b_fact_raw": "NO FACTS",
    "vicuna-7b_fact": []
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "vicuna-7b_response": "LY6K, also known as Ly6K or CD272, is a protein that is expressed on the surface of immune cells, including T cells, B cells, and natural killer cells. It is also expressed on some cancer cells, including non-small cell lung cancer (NSCLC) cells.\nThere is limited research on the relationship between LY6K expression and prognosis in NSCLC patients. However, some studies have suggested that overexpression of LY6K in cancer cells may be associated with better prognosis.\nFor example, one study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC. The study suggested that LY6K may play a role in regulating the immune response to cancer and may be a potential target for immunotherapy in NSCLC.\nAnother study published in the journal Clinical Cancer Research in 2018 found that high levels of LY6K expression were associated with improved survival in patients with advanced NSCLC who had undergone surgery. The study suggested that LY6K may be a potential biomarker for identifying patients who are likely to benefit from immunotherapy.\nHowever, it is important to note that these studies are limited and more research is needed to fully understand the role of LY6K in NSCLC and its potential as a prognostic biomarker. Additionally, the prognosis of NSCLC patients can be influenced by many factors, including the stage and grade of the cancer, the presence of certain genetic mutations, and the overall health of the patient.\nIn summary, while some studies have suggested that overexpression of LY6K may be associated with better prognosis in NSCLC patients, more research is needed to fully understand the role of LY6K in cancer prognosis and to determine its potential as a prognostic biomarker in NSCLC.",
    "vicuna-7b_fact_raw": "1. LY6K is a protein expressed on the surface of immune cells such as T cells, B cells, and natural killer cells.\n2. LY6K is also expressed on some cancer cells, including non-small cell lung cancer (NSCLC) cells.\n3. A study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.\n4. A study published in the journal Clinical Cancer Research in 2018 found that high levels of LY6K expression were associated with improved survival in patients with advanced NSCLC who had undergone surgery.\n5. The studies suggest that LY6K may be a potential target for immunotherapy in NSCLC and a potential biomarker for identifying patients who may benefit from immunotherapy.",
    "vicuna-7b_fact": [
      "LY6K is a protein expressed on the surface of immune cells such as T cells, B cells, and natural killer cells.",
      "LY6K is also expressed on some cancer cells, including non-small cell lung cancer (NSCLC) cells.",
      "A study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.",
      "A study published in the journal Clinical Cancer Research in 2018 found that high levels of LY6K expression were associated with improved survival in patients with advanced NSCLC who had undergone surgery.",
      "The studies suggest that LY6K may be a potential target for immunotherapy in NSCLC and a potential biomarker for identifying patients who may benefit from immunotherapy."
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "vicuna-7b_response": "During cytokinesis, the CDK (Cyclin-dependent kinase) targets specific phosphorylation sites on proteins to regulate their activity. The dephosphorylation of these targets is important for the completion of cytokinesis. Here are some of the CDK targets that are dephosphorylated during cytokinesis:\n1. Plk1 (Polo-like kinase 1) - Plk1 is dephosphorylated by Cdc28 during anaphase onset, which allows it to activate the separation of sister chromatids.\n2. Cdc14 - Cdc14 is dephosphorylated by Cdc28 during anaphase onset, which allows it to promote the degradation of securin, a protein that inhibits the separation of sister chromatids.\n3. Cdc20 - Cdc20 is dephosphorylated by Cdc28 during anaphase onset, which allows it to promote the degradation of other proteins involved in the completion of cytokinesis.\n4. BubR1 - BubR1 is dephosphorylated by Cdc28 during anaphase onset, which allows it to promote the separation of sister chromatids.\n5. Aurora B - Aurora B is dephosphorylated by Cdc20 during anaphase onset, which allows it to activate the separation of sister chromatids.\nThese are just a few examples of the CDK targets that are dephosphorylated during cytokinesis. The specific targets that are dephosphorylated can vary depending on the cell type and the stage of the cell cycle.",
    "vicuna-7b_fact_raw": "1. Plk1 is dephosphorylated by Cdc28 during anaphase onset.\n2. Cdc14 is dephosphorylated by Cdc28 during anaphase onset.\n3. Cdc20 is dephosphorylated by Cdc28 during anaphase onset.\n4. BubR1 is dephosphorylated by Cdc28 during anaphase onset.\n5. Aurora B is dephosphorylated by Cdc20 during anaphase onset.",
    "vicuna-7b_fact": [
      "Plk1 is dephosphorylated by Cdc28 during anaphase onset.",
      "Cdc14 is dephosphorylated by Cdc28 during anaphase onset.",
      "Cdc20 is dephosphorylated by Cdc28 during anaphase onset.",
      "BubR1 is dephosphorylated by Cdc28 during anaphase onset.",
      "Aurora B is dephosphorylated by Cdc20 during anaphase onset."
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "vicuna-7b_response": "Xanamem is a drug that is used to treat the symptoms of Alzheimer's disease. It is a type of drug called a cholinesterase inhibitor, which works by increasing the levels of a chemical in the brain called acetylcholine. Acetylcholine is important for memory and cognitive function, and decreased levels of this chemical are associated with Alzheimer's disease.\nXanamem is specifically designed to target the \"nuclear\" form of the acetylcholinesterase enzyme, which is more difficult to inhibit than the \"cytosolic\" form. This allows Xanamem to have a more potent effect on acetylcholine levels in the brain, and may make it more effective at treating the symptoms of Alzheimer's disease than other cholinesterase inhibitors.\nXanamem is typically taken as a pill, usually once daily. It is important to note that Xanamem is not a cure for Alzheimer's disease, but it can help to improve symptoms such as memory loss, confusion, and disorientation. It is important to work with a healthcare provider to determine the best treatment plan for an individual with Alzheimer's disease.",
    "vicuna-7b_fact_raw": "1. Xanamem is used to treat symptoms of Alzheimer's disease.\n2. Xanamem is a type of drug known as a cholinesterase inhibitor.\n3. Xanamem works by increasing levels of acetylcholine in the brain.\n4. Xanamem targets the \"nuclear\" form of the acetylcholinesterase enzyme.\n5. Xanamem is typically administered in pill form, usually once daily.",
    "vicuna-7b_fact": [
      "Xanamem is used to treat symptoms of Alzheimer's disease.",
      "Xanamem is a type of drug known as a cholinesterase inhibitor.",
      "Xanamem works by increasing levels of acetylcholine in the brain.",
      "Xanamem targets the \"nuclear\" form of the acetylcholinesterase enzyme.",
      "Xanamem is typically administered in pill form, usually once daily."
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "vicuna-7b_response": "The Hof1-Cyk3 interaction plays a crucial role in the regulation of the cytochrome c oxidase (COX) complex in yeast. The COX complex is responsible for generating ATP from the oxidation of molecular oxygen in the mitochondria of the cell.\nHof1 is a component of the COX complex and is responsible for the transfer of electrons from the cytochrome c protein to the copper centers of the complex. Cyk3 is a protein that interacts with Hof1 and is involved in the regulation of the COX complex.\nThe Hof1-Cyk3 interaction is important for the proper functioning of the COX complex, as it helps to maintain the proper conformation of Hof1 and ensures that it is in close proximity to the copper centers of the complex. This interaction is also important for the proper assembly of the COX complex and for the regulation of its activity.\nIn summary, the Hof1-Cyk3 interaction plays a critical role in the regulation of the cytochrome c oxidase complex in yeast, ensuring that it is properly assembled and functioning properly.",
    "vicuna-7b_fact_raw": "1. The Hof1-Cyk3 interaction regulates the cytochrome c oxidase (COX) complex in yeast.\n2. The COX complex is responsible for generating ATP from the oxidation of molecular oxygen in the mitochondria.\n3. Hof1 is a component of the COX complex and transfers electrons from the cytochrome c protein to the copper centers of the complex.\n4. Cyk3 interacts with Hof1 and is involved in the regulation of the COX complex.\n5. The Hof1-Cyk3 interaction is important for the proper assembly and activity regulation of the COX complex.",
    "vicuna-7b_fact": [
      "The Hof1-Cyk3 interaction regulates the cytochrome c oxidase (COX) complex in yeast.",
      "The COX complex is responsible for generating ATP from the oxidation of molecular oxygen in the mitochondria.",
      "Hof1 is a component of the COX complex and transfers electrons from the cytochrome c protein to the copper centers of the complex.",
      "Cyk3 interacts with Hof1 and is involved in the regulation of the COX complex.",
      "The Hof1-Cyk3 interaction is important for the proper assembly and activity regulation of the COX complex."
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "vicuna-7b_response": "T-UCRs, or Tumor-Associated Urokinase-Type Plasminogen Activator Receptor, have been implicated in gastric cancer.\nGastric cancer is a type of cancer that develops in the stomach. T-UCRs are a type of protein that plays a role in the development and progression of cancer. Research has shown that high levels of T-UCRs can promote the growth and spread of cancer cells, including those in the stomach.\nSeveral studies have identified specific T-UCRs that have been implicated in gastric cancer. For example, a study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1, a specific type of T-UCR, were associated with poor outcomes in patients with gastric cancer. Another study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2, another type of T-UCR, were associated with poor survival in patients with gastric cancer.\nOverall, while more research is needed to fully understand the role of T-UCRs in gastric cancer, there is evidence to suggest that high levels of certain T-UCRs can promote the growth and spread of cancer cells in the stomach.",
    "vicuna-7b_fact_raw": "1. T-UCRs, or Tumor-Associated Urokinase-Type Plasminogen Activator Receptor, have been implicated in gastric cancer.\n2. High levels of T-UCRs can promote the growth and spread of cancer cells, including those in the stomach.\n3. A study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1 were associated with poor outcomes in patients with gastric cancer.\n4. Another study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2 were associated with poor survival in patients with gastric cancer.",
    "vicuna-7b_fact": [
      "T-UCRs, or Tumor-Associated Urokinase-Type Plasminogen Activator Receptor, have been implicated in gastric cancer.",
      "High levels of T-UCRs can promote the growth and spread of cancer cells, including those in the stomach.",
      "A study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1 were associated with poor outcomes in patients with gastric cancer.",
      "Another study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2 were associated with poor survival in patients with gastric cancer."
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "vicuna-7b_response": "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), an autoimmune disease that can affect various parts of the body. The LSI is a simple, easy-to-use tool that helps healthcare providers to assess the overall health status of patients with SLE.\nThe LSI is a composite score that is based on the presence and severity of 11 different organ systems that can be affected by SLE, such as the skin, joints, kidneys, and heart. Each organ system is assigned a score based on the degree of involvement, ranging from 0 to 3. The scores for each organ system are then added together to obtain the total LSI score, which ranges from 0 to 33.\nThe LSI score can be used to monitor the disease activity and response to treatment in patients with SLE. A higher LSI score indicates more severe disease activity, while a lower score indicates less severe disease activity. The LSI can also be used to identify patients who are at high risk of disease complications, such as kidney damage or blood clots.\nIt is important to note that the LSI is just one tool that can be used to assess the severity of SLE. Other tools, such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or the British Isles Lupus Assessment Group (BILAG) index, may be used in addition to or instead of the LSI.\nIn summary, the Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), an autoimmune disease that can affect various parts of the body. The LSI is a simple, easy-to-use tool that helps healthcare providers to assess the overall health status of patients with SLE. The LSI score can be used to monitor the disease activity and response to treatment in patients with SLE, and it can also be used to identify patients who are at high risk of disease complications.",
    "vicuna-7b_fact_raw": "1. The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).\n2. The LSI evaluates the presence and severity of symptoms in 11 different organ systems affected by SLE.\n3. Each organ system in the LSI is assigned a score from 0 to 3, based on the degree of involvement.\n4. The total LSI score ranges from 0 to 33, with higher scores indicating more severe disease activity.\n5. The LSI can be used to monitor disease activity, response to treatment, and identify patients at high risk of complications from SLE.",
    "vicuna-7b_fact": [
      "The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).",
      "The LSI evaluates the presence and severity of symptoms in 11 different organ systems affected by SLE.",
      "Each organ system in the LSI is assigned a score from 0 to 3, based on the degree of involvement.",
      "The total LSI score ranges from 0 to 33, with higher scores indicating more severe disease activity.",
      "The LSI can be used to monitor disease activity, response to treatment, and identify patients at high risk of complications from SLE."
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "vicuna-7b_response": "ZSWIM6 is a gene that has been associated with several disorders caused by de novo mutations. Here are some of the disorders that have been linked to ZSWIM6 mutations:\n1. Schinzel-Giedion syndrome (SGS): SGS is a rare genetic disorder that is caused by mutations in the ZWS6 gene. It is characterized by intellectual disability, developmental delays, and abnormalities in the skull and facial bones.\n2. Cerebral palsy: Cerebral palsy is a group of disorders that affect movement and posture. Some studies have suggested that ZWS6 mutations may be associated with cerebral palsy, but more research is needed to confirm this link.\n3. Autism spectrum disorder (ASD): ASD is a neurodevelopmental disorder that affects communication and social interaction. Some studies have suggested that ZWS6 mutations may be associated with ASD, but more research is needed to confirm this link.\n4. Microcephaly: Microcephaly is a condition where a child's head is smaller than expected for their age. Some studies have suggested that ZWS6 mutations may be associated with microcephaly, but more research is needed to confirm this link.\nIt's important to note that these associations are still being studied and more research is needed to confirm the link between ZWS6 mutations and these disorders.",
    "vicuna-7b_fact_raw": "1. Schinzel-Giedion syndrome (SGS) is caused by mutations in the ZSWIM6 gene.\n2. ZSWIM6 mutations have been suggested to be associated with cerebral palsy.\n3. ZSWIM6 mutations may be associated with autism spectrum disorder (ASD).\n4. ZSWIM6 mutations may be associated with microcephaly.\n5. The associations between ZSWIM6 mutations and the mentioned disorders are still being researched for confirmation.",
    "vicuna-7b_fact": [
      "Schinzel-Giedion syndrome (SGS) is caused by mutations in the ZSWIM6 gene.",
      "ZSWIM6 mutations have been suggested to be associated with cerebral palsy.",
      "ZSWIM6 mutations may be associated with autism spectrum disorder (ASD).",
      "ZSWIM6 mutations may be associated with microcephaly.",
      "The associations between ZSWIM6 mutations and the mentioned disorders are still being researched for confirmation."
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "vicuna-7b_response": "The Koos Classification is a system used to classify diseases of the musculoskeletal system, including the joints, muscles, bones, and tendons. Some examples of diseases that can be classified using the Koos Classification include:\n* Osteoarthritis: a degenerative joint disease that affects the cartilage that cushions the ends of bones and allows them to move smoothly.\n* Rheumatoid arthritis: an autoimmune disease that causes inflammation in the joints and can lead to joint damage and loss of function.\n* Osteoporosis: a condition in which the bones become weak and brittle, leading to an increased risk of fractures.\n* Tendinitis: inflammation of a tendon, which can cause pain and stiffness in the affected area.\n* Bursitis: inflammation of a bursa, which is a small, fluid-filled sac that acts as a cushion between bones, muscles, and tendons.\nThese are just a few examples of the many diseases that can be classified using the Koos Classification. If you have a specific question about a disease or condition, please let me know and I will do my best to provide you with more information.",
    "vicuna-7b_fact_raw": "1. The Koos Classification is used to classify diseases of the musculoskeletal system.\n2. Osteoarthritis is a disease that can be classified using the Koos Classification and affects the cartilage of joints.\n3. Rheumatoid arthritis, which can be classified using the Koos Classification, is an autoimmune disease that causes inflammation in the joints.\n4. Osteoporosis, a condition that leads to weak and brittle bones, can be classified using the Koos Classification.\n5. Tendinitis and bursitis, both inflammations of different parts of the musculoskeletal system, can be classified using the Koos Classification.",
    "vicuna-7b_fact": [
      "The Koos Classification is used to classify diseases of the musculoskeletal system.",
      "Osteoarthritis is a disease that can be classified using the Koos Classification and affects the cartilage of joints.",
      "Rheumatoid arthritis, which can be classified using the Koos Classification, is an autoimmune disease that causes inflammation in the joints.",
      "Osteoporosis, a condition that leads to weak and brittle bones, can be classified using the Koos Classification.",
      "Tendinitis and bursitis, both inflammations of different parts of the musculoskeletal system, can be classified using the Koos Classification."
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "vicuna-7b_response": "AZD8601 is a small molecule inhibitor of the enzyme phosphoinositide-3-kinase (PI3K) delta. PI3K delta is a subunit of the PI3K enzyme complex, which plays a key role in regulating cell growth, survival, and metabolism.\nIn vivo studies have shown that AZD8601 can effectively inhibit the PI3K delta pathway in various types of cancer cells, leading to decreased cell proliferation, migration, and invasion. Additionally, AZD8601 has been shown to induce apoptosis (programmed cell death) in cancer cells, which can lead to a reduction in tumor size and growth.\nAZD8601 has also been shown to have anti-angiogenic effects, which means it can inhibit the formation of new blood vessels that tumors need to grow. This can lead to a reduction in the supply of oxygen and nutrients to the tumor, further reducing its growth and progression.\nOverall, AZD8601 has shown promising in vivo effects in preclinical studies and is currently being evaluated in clinical trials for the treatment of various types of cancer.",
    "vicuna-7b_fact_raw": "1. AZD8601 is a small molecule inhibitor of the enzyme phosphoinositide-3-kinase (PI3K) delta.\n2. In vivo studies have indicated that AZD8601 can inhibit the PI3K delta pathway in various types of cancer cells.\n3. AZD8601 has been observed to decrease cell proliferation, migration, and invasion in cancer cells.\n4. AZD8601 can induce apoptosis in cancer cells.\n5. AZD8601 has anti-angiogenic effects, which can inhibit the formation of new blood vessels in tumors.",
    "vicuna-7b_fact": [
      "AZD8601 is a small molecule inhibitor of the enzyme phosphoinositide-3-kinase (PI3K) delta.",
      "In vivo studies have indicated that AZD8601 can inhibit the PI3K delta pathway in various types of cancer cells.",
      "AZD8601 has been observed to decrease cell proliferation, migration, and invasion in cancer cells.",
      "AZD8601 can induce apoptosis in cancer cells.",
      "AZD8601 has anti-angiogenic effects, which can inhibit the formation of new blood vessels in tumors."
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "vicuna-7b_response": "SAHFS, or Secure Access to Healthcare Facilities and Services, are created through a process known as \"community-based primary healthcare (CBPHC)\". CBPHC is a holistic approach to healthcare that focuses on building strong relationships between communities and healthcare providers.\nThe process of creating SAHFS typically involves several steps:\n1. Community engagement: The first step in creating SAHFS is to engage with the local community to understand their healthcare needs and priorities. This involves conducting surveys, holding focus groups, and meeting with community leaders and stakeholders.\n2. Health needs assessment: Based on the community engagement, a health needs assessment is conducted to identify the specific healthcare needs of the community. This assessment helps to determine the types of services that are required to address the community's healthcare needs.\n3. Service development: Based on the health needs assessment, the next step is to develop the services that will be provided through the SAHFS. This may involve building new healthcare facilities, recruiting and training healthcare providers, and developing policies and procedures for the delivery of healthcare services.\n4. Implementation: Once the services have been developed, the SAHFS is implemented. This involves setting up the necessary infrastructure, such as healthcare facilities and equipment, and training healthcare providers on how to deliver the services.\n5. Monitoring and evaluation: Finally, the SAHFS is monitored and evaluated to ensure that it is meeting the healthcare needs of the community and to identify areas for improvement.\nOverall, creating SAHFS requires a collaborative effort between communities, healthcare providers, and government agencies. It is a process that involves building strong relationships and working together to improve access to healthcare services for all.",
    "vicuna-7b_fact_raw": "1. Secure Access to Healthcare Facilities and Services (SAHFS) are created through a process known as \"community-based primary healthcare (CBPHC)\".\n2. The first step in creating SAHFS involves engaging with the local community to understand their healthcare needs and priorities.\n3. A health needs assessment is conducted to identify the specific healthcare needs of the community as part of the SAHFS creation process.\n4. The development of services provided through SAHFS may include building new healthcare facilities and recruiting and training healthcare providers.\n5. The SAHFS process includes monitoring and evaluation to ensure it meets the community's healthcare needs and to identify areas for improvement.",
    "vicuna-7b_fact": [
      "Secure Access to Healthcare Facilities and Services (SAHFS) are created through a process known as \"community-based primary healthcare (CBPHC)\".",
      "The first step in creating SAHFS involves engaging with the local community to understand their healthcare needs and priorities.",
      "A health needs assessment is conducted to identify the specific healthcare needs of the community as part of the SAHFS creation process.",
      "The development of services provided through SAHFS may include building new healthcare facilities and recruiting and training healthcare providers.",
      "The SAHFS process includes monitoring and evaluation to ensure it meets the community's healthcare needs and to identify areas for improvement."
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "vicuna-7b_response": "The PDZ domain is a protein interaction domain that plays a role in regulating the localization and stability of proteins. The SATB1 protein, also known as special AT-rich sequence binding protein 1, is a nuclear protein that is involved in the regulation of chromatin structure and transcription. The PDZ domain in SATB1 is thought to interact with other proteins and play a role in the regulation of SATB1's function. For example, the PDZ domain in SATB1 has been shown to interact with the protein hDlg, which is involved in the regulation of chromatin structure and transcription. Additionally, the PDZ domain in SATB1 has been shown to interact with the protein CASZ1, which is involved in the regulation of chromatin structure and transcription. Overall, the PDZ domain in SATB1 is thought to play a role in the regulation of SATB1's function by interacting with other proteins and modulating the localization and stability of SATB1.",
    "vicuna-7b_fact_raw": "1. The PDZ domain is a protein interaction domain involved in regulating the localization and stability of proteins.\n2. SATB1, or special AT-rich sequence binding protein 1, is a nuclear protein that regulates chromatin structure and transcription.\n3. The PDZ domain in SATB1 is believed to interact with other proteins to regulate SATB1's function.\n4. The PDZ domain in SATB1 has been shown to interact with the protein hDlg.\n5. The PDZ domain in SATB1 has also been shown to interact with the protein CASZ1.",
    "vicuna-7b_fact": [
      "The PDZ domain is a protein interaction domain involved in regulating the localization and stability of proteins.",
      "SATB1, or special AT-rich sequence binding protein 1, is a nuclear protein that regulates chromatin structure and transcription.",
      "The PDZ domain in SATB1 is believed to interact with other proteins to regulate SATB1's function.",
      "The PDZ domain in SATB1 has been shown to interact with the protein hDlg.",
      "The PDZ domain in SATB1 has also been shown to interact with the protein CASZ1."
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "vicuna-7b_response": "The BLISS technique is based on the principles of behaviorism, specifically on the idea that behavior is acquired through learning and can be shaped and changed through reinforcement and punishment. The BLISS technique is a type of behavioral therapy that aims to help individuals overcome specific phobias by gradually exposing them to the feared stimulus in a systematic and controlled way.\nThe BLISS technique stands for:\nB - Break the phobia down into smaller parts\nL - Learn the relaxation response\nI - Identify and challenge the negative thoughts and beliefs that contribute to the phobia\nS - Strengthen the positive responses to the feared stimulus\nS - Sustain the new responses through repetition and practice\nThe therapist will work with the individual to identify the specific fears and anxieties associated with the phobia, and then help them to gradually confront these fears through a series of exposure exercises. The therapist will also teach the individual relaxation techniques to help them manage their anxiety during exposure.\nThe BLISS technique is a form of cognitive-behavioral therapy, which is a type of psychotherapy that focuses on changing the individual's thoughts, beliefs, and behaviors in order to improve their mental health. The BLISS technique is a specific type of cognitive-behavioral therapy that is designed to help individuals overcome specific phobias.\nIt's important to note that the BLISS technique is not suitable for everyone and it's important to consult with a licensed therapist or psychologist to determine the best course of treatment for your specific needs.",
    "vicuna-7b_fact_raw": "1. The BLISS technique is based on the principles of behaviorism.\n2. The BLISS technique is a type of behavioral therapy aimed at helping individuals overcome specific phobias.\n3. The BLISS technique involves gradual exposure to the feared stimulus in a systematic and controlled way.\n4. The BLISS technique is a form of cognitive-behavioral therapy.\n5. The BLISS technique includes teaching relaxation techniques to manage anxiety during exposure.",
    "vicuna-7b_fact": [
      "The BLISS technique is based on the principles of behaviorism.",
      "The BLISS technique is a type of behavioral therapy aimed at helping individuals overcome specific phobias.",
      "The BLISS technique involves gradual exposure to the feared stimulus in a systematic and controlled way.",
      "The BLISS technique is a form of cognitive-behavioral therapy.",
      "The BLISS technique includes teaching relaxation techniques to manage anxiety during exposure."
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "vicuna-7b_response": "NK3R antagonists are drugs that block the action of the NK3 receptor, which is a type of receptor found on cells in the nervous system. Here are three examples of NK3R antagonists:\n1. APD334: APD334 is a selective NK3R antagonist that is being developed for the treatment of pain. It has been shown to be effective in reducing pain in animal models and has been tested in clinical trials for the treatment of chronic pain.\n2. Tegoprazan: Tegoprazan is another selective NK3R antagonist that is used to treat acute and chronic pain. It has been shown to be effective in reducing pain in animal models and has been approved for use in several countries for the treatment of acute pain.\n3. SB-277011: SB-277011 is a selective NK3R antagonist that is being developed for the treatment of chronic pain. It has been shown to be effective in reducing pain in animal models and has been tested in clinical trials for the treatment of chronic pain.",
    "vicuna-7b_fact_raw": "1. APD334 is a selective NK3R antagonist being developed for the treatment of pain.\n2. Tegoprazan is a selective NK3R antagonist used to treat acute and chronic pain.\n3. SB-277011 is a selective NK3R antagonist being developed for the treatment of chronic pain.",
    "vicuna-7b_fact": [
      "APD334 is a selective NK3R antagonist being developed for the treatment of pain.",
      "Tegoprazan is a selective NK3R antagonist used to treat acute and chronic pain.",
      "SB-277011 is a selective NK3R antagonist being developed for the treatment of chronic pain."
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "vicuna-7b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is known as dronabinol. It is a synthetic cannabinoid that acts as an inverse agonist at the ghrelin receptor, which is a G protein-coupled receptor that plays a role in regulating appetite and metabolism. Dronabinol has been studied for its potential therapeutic effects in various conditions, including appetite stimulation in cancer patients undergoing chemotherapy, and it has been approved for medical use in several countries for the treatment of nausea and vomiting associated with cancer chemotherapy, as well as for the treatment of anorexia associated with AIDS.",
    "vicuna-7b_fact_raw": "1. Dronabinol is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. Dronabinol acts as an inverse agonist at the ghrelin receptor.\n3. The ghrelin receptor is a G protein-coupled receptor involved in regulating appetite and metabolism.\n4. Dronabinol has been studied for appetite stimulation in cancer patients undergoing chemotherapy.\n5. Dronabinol has been approved for medical use in several countries for treating nausea and vomiting associated with cancer chemotherapy and anorexia associated with AIDS.",
    "vicuna-7b_fact": [
      "Dronabinol is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "Dronabinol acts as an inverse agonist at the ghrelin receptor.",
      "The ghrelin receptor is a G protein-coupled receptor involved in regulating appetite and metabolism.",
      "Dronabinol has been studied for appetite stimulation in cancer patients undergoing chemotherapy.",
      "Dronabinol has been approved for medical use in several countries for treating nausea and vomiting associated with cancer chemotherapy and anorexia associated with AIDS."
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "vicuna-7b_response": "Vaxchora is a vaccine that is approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older. The vaccine is administered as a single dose and is estimated to provide protection against cholera for up to 5 years.\nThe efficacy of Vaxchora against moderate to severe cholera has been demonstrated in clinical trials. In a randomized, double-blind, placebo-controlled trial, Vaxchora was found to be 77.3% effective in preventing symptomatic cholera caused by serogroup Ogawa. The vaccine was also found to be 92.3% effective in preventing severe cholera, defined as cholera requiring hospitalization or resulting in death.\nIt is important to note that while Vaxchora is effective in preventing cholera caused by serogroup Ogawa, it does not provide protection against other serogroups of cholera, such as serogroup El Tor. Therefore, individuals traveling to areas with cholera outbreaks caused by these other serogroups should still take precautions to avoid exposure to contaminated food and water.\nIn summary, Vaxchora is an effective vaccine against moderate to severe cholera caused by serogroup Ogawa, with estimates of protection ranging from 5 to 7 years. However, it is important to note that the vaccine does not provide protection against other serogroups of cholera, and individuals traveling to areas with cholera outbreaks should still take precautions to avoid exposure to contaminated food and water.",
    "vicuna-7b_fact_raw": "1. Vaxchora is approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older.\n2. Vaxchora is administered as a single dose and is estimated to provide protection against cholera for up to 5 years.\n3. In a clinical trial, Vaxchora was found to be 77.3% effective in preventing symptomatic cholera caused by serogroup Ogawa.\n4. The vaccine was also found to be 92.3% effective in preventing severe cholera, defined as cholera requiring hospitalization or resulting in death.\n5. Vaxchora does not provide protection against other serogroups of cholera, such as serogroup El Tor.",
    "vicuna-7b_fact": [
      "Vaxchora is approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older.",
      "Vaxchora is administered as a single dose and is estimated to provide protection against cholera for up to 5 years.",
      "In a clinical trial, Vaxchora was found to be 77.3% effective in preventing symptomatic cholera caused by serogroup Ogawa.",
      "The vaccine was also found to be 92.3% effective in preventing severe cholera, defined as cholera requiring hospitalization or resulting in death.",
      "Vaxchora does not provide protection against other serogroups of cholera, such as serogroup El Tor."
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "vicuna-7b_response": "The first cholera vaccine approved in the US was the killed-virus cholera vaccine, also known as the Dukor-Smith vaccine. It was developed by Dr. John Dukor and Dr. Harold Smith in the 1960s and was licensed for use in the US in 1967. The vaccine was made by inactivating the cholera bacteria with formaldehyde, and it was administered orally in a single dose. The Dukor-Smith vaccine was effective against both classical and El Tor strains of cholera. It was replaced by the more effective live-virus cholera vaccine, known as the oral cholera vaccine, in the 1970s.",
    "vicuna-7b_fact_raw": "1. The first cholera vaccine approved in the US was known as the Dukor-Smith vaccine.\n2. The Dukor-Smith cholera vaccine was developed by Dr. John Dukor and Dr. Harold Smith.\n3. The Dukor-Smith vaccine was licensed for use in the US in 1967.\n4. The vaccine was made by inactivating the cholera bacteria with formaldehyde.\n5. The Dukor-Smith vaccine was replaced by the oral cholera vaccine in the 1970s.",
    "vicuna-7b_fact": [
      "The first cholera vaccine approved in the US was known as the Dukor-Smith vaccine.",
      "The Dukor-Smith cholera vaccine was developed by Dr. John Dukor and Dr. Harold Smith.",
      "The Dukor-Smith vaccine was licensed for use in the US in 1967.",
      "The vaccine was made by inactivating the cholera bacteria with formaldehyde.",
      "The Dukor-Smith vaccine was replaced by the oral cholera vaccine in the 1970s."
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "vicuna-7b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is the Fc receptor 3B (FcR3B) gene.\nCVID is a primary immunodeficiency disorder characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections. CVID can be caused by both genetic and environmental factors. Monogenic causes of CVID are rare, but they account for about 10-15% of all cases.\nThe FcR3B gene provides instructions for making a protein called Fc receptor 3B, which is involved in the clearance of immune complexes from the blood. Mutations in the FcR3B gene can lead to reduced function of this protein, resulting in reduced clearance of immune complexes and an increased risk of infections.\nStudies have shown that mutations in the FcR3B gene are the most common monogenic cause of CVID in Europeans, accounting for about 50% of all cases. Other genes that have been identified as causes of CVID include the SH2D1A gene, the CD40L gene, and the ICOS gene.\nIt is important to note that CVID can also be caused by environmental factors such as exposure to certain viruses or toxins, and in some cases, the cause may be unknown. Early diagnosis and management of CVID can help to prevent serious infections and improve the quality of life for individuals with the disorder.",
    "vicuna-7b_fact_raw": "1. The Fc receptor 3B (FcR3B) gene is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.\n2. CVID is characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections.\n3. Monogenic causes account for about 10-15% of all CVID cases.\n4. Mutations in the FcR3B gene can lead to reduced function of the Fc receptor 3B protein.\n5. Mutations in the FcR3B gene account for about 50% of all monogenic cases of CVID in Europeans.",
    "vicuna-7b_fact": [
      "The Fc receptor 3B (FcR3B) gene is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
      "CVID is characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections.",
      "Monogenic causes account for about 10-15% of all CVID cases.",
      "Mutations in the FcR3B gene can lead to reduced function of the Fc receptor 3B protein.",
      "Mutations in the FcR3B gene account for about 50% of all monogenic cases of CVID in Europeans."
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "vicuna-7b_response": "The IFIT1 gene, also known as interferon, alpha-2, is a gene that encodes for a protein called interferon-alpha-2. Interferon-alpha-2 is a type of interferon, which is a group of signaling proteins that are produced by cells in response to viral infections or other harmful stimuli.\nIn the context of Systemic Lupus Erythematosus (SLE), the role of IFIT1 gene is not well understood. However, some studies have suggested that IFIT1 gene may play a role in the development of SLE.\nOne study published in the journal Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls. Additionally, another study published in the journal Rheumatology in 2019 found that IFIT1 gene may be associated with the development of lupus nephritis, a complication of SLE that affects the kidneys.\nHowever, more research is needed to fully understand the role of IFIT1 gene in the development and progression of SLE.",
    "vicuna-7b_fact_raw": "1. The IFIT1 gene encodes for a protein called interferon-alpha-2.\n2. Interferon-alpha-2 is a type of interferon produced by cells in response to viral infections or other harmful stimuli.\n3. Some studies suggest that the IFIT1 gene may play a role in the development of Systemic Lupus Erythematosus (SLE).\n4. A study published in Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls.\n5. Research published in the journal Rheumatology in 2019 suggested that the IFIT1 gene may be associated with the development of lupus nephritis, a kidney complication of SLE.",
    "vicuna-7b_fact": [
      "The IFIT1 gene encodes for a protein called interferon-alpha-2.",
      "Interferon-alpha-2 is a type of interferon produced by cells in response to viral infections or other harmful stimuli.",
      "Some studies suggest that the IFIT1 gene may play a role in the development of Systemic Lupus Erythematosus (SLE).",
      "A study published in Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls.",
      "Research published in the journal Rheumatology in 2019 suggested that the IFIT1 gene may be associated with the development of lupus nephritis, a kidney complication of SLE."
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "vicuna-7b_response": "The Liverpool Elbow Score (LES) is a clinical scoring system used to assess the severity of elbow pain in patients with elbow osteoarthritis. It is a simple, reliable, and valid tool that can be used in clinical practice to assess the functional status of patients with elbow osteoarthritis.\nThe LES is based on the patient's ability to perform five tasks with their affected elbow:\n1. Flexion: The patient is asked to bend their elbow to 90 degrees.\n2. Extension: The patient is asked to straighten their elbow.\n3. Internal rotation: The patient is asked to rotate their forearm so that their little finger faces forward.\n4. External rotation: The patient is asked to rotate their forearm so that their little finger faces backward.\n5. Pronation: The patient is asked to bend and straighten their wrist.\nEach task is scored on a scale of 0 to 3, with 0 indicating complete loss of function and 3 indicating normal function. The scores for each task are then added together to give a total LES score, which ranges from 0 to 15.\nThe LES has been shown to be a reliable and valid tool for assessing the functional status of patients with elbow osteoarthritis. It can be used to monitor the progress of patients over time and to guide treatment decisions, such as the need for surgical intervention.\nIn summary, the Liverpool Elbow Score is a clinical scoring system used to assess the severity of elbow pain in patients with elbow osteoarthritis. It is based on the patient's ability to perform five tasks with their affected elbow and provides a simple, reliable, and valid tool for assessing the functional status of patients with elbow osteoarthritis.",
    "vicuna-7b_fact_raw": "1. The Liverpool Elbow Score (LES) is used to assess the severity of elbow pain in patients with elbow osteoarthritis.\n2. The LES is a clinical scoring system that assesses the functional status of patients with elbow osteoarthritis.\n3. The LES involves the patient performing five tasks with their affected elbow, which are scored on a scale of 0 to 3.\n4. The total LES score ranges from 0 to 15, with 0 indicating complete loss of function and 3 indicating normal function.\n5. The LES is used to monitor the progress of patients over time and to guide treatment decisions.",
    "vicuna-7b_fact": [
      "The Liverpool Elbow Score (LES) is used to assess the severity of elbow pain in patients with elbow osteoarthritis.",
      "The LES is a clinical scoring system that assesses the functional status of patients with elbow osteoarthritis.",
      "The LES involves the patient performing five tasks with their affected elbow, which are scored on a scale of 0 to 3.",
      "The total LES score ranges from 0 to 15, with 0 indicating complete loss of function and 3 indicating normal function.",
      "The LES is used to monitor the progress of patients over time and to guide treatment decisions."
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "vicuna-7b_response": "The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases. The project was launched in 2012 and is expected to run until 2021.\nIn terms of sarcoma, the 100,000 Genomes Project has made significant efforts to sequence sarcoma patients' genomes. The project has sequenced the genomes of over 1,000 sarcoma patients, and the data has been used to identify new genetic mutations that can help in the diagnosis and treatment of sarcoma.\nOne of the key findings from the 100,000 Genomes Project's sarcoma research is the identification of new genetic subtypes of sarcoma. These subtypes can help in the development of more targeted treatments for sarcoma patients. For example, the project has identified a subtype of sarcoma called \"undifferentiated pleomorphic sarcoma\" (UPS), which is a rare and aggressive form of sarcoma. The project's research has shown that UPS is caused by a specific genetic mutation, which can help in the development of new treatments for this subtype of sarcoma.\nIn addition to identifying new genetic subtypes of sarcoma, the 100,000 Genomes Project has also helped in the development of new diagnostic tools for sarcoma. The project has used whole-genome sequencing to identify genetic mutations that can help in the diagnosis of sarcoma. This has led to the development of new diagnostic tests that can help in the early detection of sarcoma, which can improve patient outcomes.\nOverall, the 100,000 Genomes Project's efforts on sarcoma have been significant. The project's research has identified new genetic mutations that can help in the diagnosis and treatment of sarcoma, and has helped in the development of new diagnostic tools for this type of cancer. The project's research has also helped in the identification of new genetic subtypes of sarcoma, which can help in the development of more targeted treatments for sarcoma",
    "vicuna-7b_fact_raw": "1. The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases.\n2. The project was launched in 2012 and is expected to run until 2021.\n3. Over 1,000 sarcoma patients' genomes have been sequenced by the 100,000 Genomes Project.\n4. The project has identified a subtype of sarcoma called \"undifferentiated pleomorphic sarcoma\" (UPS).\n5. The 100,000 Genomes Project has contributed to the development of new diagnostic tests for sarcoma.",
    "vicuna-7b_fact": [
      "The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases.",
      "The project was launched in 2012 and is expected to run until 2021.",
      "Over 1,000 sarcoma patients' genomes have been sequenced by the 100,000 Genomes Project.",
      "The project has identified a subtype of sarcoma called \"undifferentiated pleomorphic sarcoma\" (UPS).",
      "The 100,000 Genomes Project has contributed to the development of new diagnostic tests for sarcoma."
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "vicuna-7b_response": "Protein ALEX1 is a protein that is involved in various cellular processes, including DNA repair, transcriptional regulation, and cell cycle progression. However, I do not have information on whether protein ALEX1 contains armadillo repeats.\nArmadillo repeats are a type of protein domain that is composed of a series of repeating units of approximately 60 amino acids. They are named after the armadillo, which has a similar structure. Armadillo repeats are found in a variety of proteins, including some that are involved in cellular processes such as DNA repair and transcriptional regulation. However, I do not have information on whether protein ALEX1 contains armadillo repeats.\nIf you have any additional information about protein ALEX1, such as its amino acid sequence or the experimental techniques used to study it, I may be able to provide more information.",
    "vicuna-7b_fact_raw": "1. Protein ALEX1 is involved in various cellular processes including DNA repair, transcriptional regulation, and cell cycle progression.\n2. Armadillo repeats are composed of a series of repeating units of approximately 60 amino acids.\n3. Armadillo repeats are named after the armadillo due to a similar structure.\n4. Proteins with armadillo repeats are involved in cellular processes such as DNA repair and transcriptional regulation.",
    "vicuna-7b_fact": [
      "Protein ALEX1 is involved in various cellular processes including DNA repair, transcriptional regulation, and cell cycle progression.",
      "Armadillo repeats are composed of a series of repeating units of approximately 60 amino acids.",
      "Armadillo repeats are named after the armadillo due to a similar structure.",
      "Proteins with armadillo repeats are involved in cellular processes such as DNA repair and transcriptional regulation."
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "vicuna-7b_response": "There are several enzymes that remove histone modifications from chromatin. Here are some examples:\n1. Histone deacetylases (HDACs): HDACs remove acetyl groups from histone tails, leading to a more compact chromatin structure. Some examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.\n2. Histone demethylases: Histone demethylases remove methyl groups from histone tails, leading to a more open chromatin structure. Some examples of histone demethylases include JMJD3, JMJD6, and KDM6A.\n3. Histone methyltransferases: Histone methyltransferases add methyl groups to histone tails, leading to a more compact chromatin structure. Some examples of histone methyltransferases include SETDB1, SET7, and KMT2A (also known as MLL).\n4. Chromatin remodeling complexes: Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, can remove histone modifications and reposition chromatin to different regions of the genome.\nOverall, the removal of histone modifications by these enzymes plays a crucial role in regulating gene expression and chromatin structure.",
    "vicuna-7b_fact_raw": "1. Histone deacetylases (HDACs) remove acetyl groups from histone tails.\n2. Examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.\n3. Histone demethylases remove methyl groups from histone tails.\n4. Examples of histone demethylases include JMJD3, JMJD6, and KDM6A.\n5. Chromatin remodeling complexes can remove histone modifications and reposition chromatin.",
    "vicuna-7b_fact": [
      "Histone deacetylases (HDACs) remove acetyl groups from histone tails.",
      "Examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.",
      "Histone demethylases remove methyl groups from histone tails.",
      "Examples of histone demethylases include JMJD3, JMJD6, and KDM6A.",
      "Chromatin remodeling complexes can remove histone modifications and reposition chromatin."
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "vicuna-7b_response": "Head CT scans are a type of medical imaging test that uses X-rays to create detailed images of the brain and surrounding structures. While head CT scans are generally considered safe, they do have some risks associated with them.\nOne potential risk of head CT scans is the possibility of developing a brain tumor as a result of exposure to radiation. However, the risk of developing a brain tumor from a head CT scan is relatively low, and the benefits of the test typically outweigh the risks in most cases.\nThe risk of developing a brain tumor from a head CT scan is generally considered to be low, especially when compared to the potential benefits of the test. Head CT scans are often used to diagnose and treat a wide range of conditions, including traumatic brain injuries, stroke, and certain types of infections.\nIn general, the risk of developing a brain tumor from a head CT scan is highest in people who have had multiple CT scans over the course of their lifetime. However, the risk is still relatively low, and most people do not need to worry about developing a brain tumor as a result of a single head CT scan.\nIf you are concerned about the risks associated with head CT scans, it is important to discuss your concerns with your healthcare provider. They can help you understand the potential risks and benefits of the test and make an informed decision about whether or not to have a head CT scan.",
    "vicuna-7b_fact_raw": "1. Head CT scans use X-rays to create detailed images of the brain and surrounding structures.\n2. There is a potential risk of developing a brain tumor from exposure to radiation during a head CT scan.\n3. The risk of developing a brain tumor from a head CT scan is generally considered to be low.\n4. Head CT scans are used to diagnose and treat conditions such as traumatic brain injuries, stroke, and certain types of infections.\n5. The risk of developing a brain tumor from a head CT scan is highest in people who have had multiple CT scans over their lifetime.",
    "vicuna-7b_fact": [
      "Head CT scans use X-rays to create detailed images of the brain and surrounding structures.",
      "There is a potential risk of developing a brain tumor from exposure to radiation during a head CT scan.",
      "The risk of developing a brain tumor from a head CT scan is generally considered to be low.",
      "Head CT scans are used to diagnose and treat conditions such as traumatic brain injuries, stroke, and certain types of infections.",
      "The risk of developing a brain tumor from a head CT scan is highest in people who have had multiple CT scans over their lifetime."
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "vicuna-7b_response": "Otx2 is associated with the pluripotent state of embryonic stem cells. Otx2 is a transcription factor that plays a crucial role in the regulation of embryonic stem cell self-renewal and differentiation. It has been shown to be essential for the maintenance of pluripotency in embryonic stem cells and for the generation of differentiated cell types. Otx2 is also involved in the regulation of gene expression in the developing nervous system, and it has been shown to be expressed in a variety of cell types, including neural stem cells, germ cells, and cancer cells.",
    "vicuna-7b_fact_raw": "1. Otx2 is associated with the pluripotent state of embryonic stem cells.\n2. Otx2 is a transcription factor that regulates embryonic stem cell self-renewal and differentiation.\n3. Otx2 is essential for the maintenance of pluripotency in embryonic stem cells.\n4. Otx2 is involved in the regulation of gene expression in the developing nervous system.\n5. Otx2 is expressed in various cell types, including neural stem cells, germ cells, and cancer cells.",
    "vicuna-7b_fact": [
      "Otx2 is associated with the pluripotent state of embryonic stem cells.",
      "Otx2 is a transcription factor that regulates embryonic stem cell self-renewal and differentiation.",
      "Otx2 is essential for the maintenance of pluripotency in embryonic stem cells.",
      "Otx2 is involved in the regulation of gene expression in the developing nervous system.",
      "Otx2 is expressed in various cell types, including neural stem cells, germ cells, and cancer cells."
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "vicuna-7b_response": "The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS). The exact number of DHS in the murine beta globin locus region can vary depending on the study and the method used to identify DHS.\nOne study using chromatin immunoprecipitation (ChIP) and DNaseI sequencing to identify DHS in the murine beta globin locus region reported the presence of over 100 DHS in this region [1]. Another study using a similar approach reported the presence of over 50 DHS in the murine beta globin locus region [2].\nIt is worth noting that the number of DHS in the murine beta globin locus region may be different in other studies, as different methods and conditions can lead to different results.\nReferences:\n1. Liu JS, et al. Genome-wide analysis of DNase I hypersensitivity in the mouse beta-globin locus. Genome Res. 2005;15(1):10-18.\n2. Zhang Y, et al. Genome-wide analysis of DNase I hypersensitivity in the mouse beta-globin locus. Genome Res. 2005;15(1):10-18.",
    "vicuna-7b_fact_raw": "1. The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS).\n2. The exact number of DHS in the murine beta globin locus region can vary depending on the study and method used.\n3. One study reported the presence of over 100 DHS in the murine beta globin locus region.\n4. Another study reported the presence of over 50 DHS in the murine beta globin locus region.\n5. The studies mentioned used chromatin immunoprecipitation (ChIP) and DNaseI sequencing to identify DHS.",
    "vicuna-7b_fact": [
      "The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS).",
      "The exact number of DHS in the murine beta globin locus region can vary depending on the study and method used.",
      "One study reported the presence of over 100 DHS in the murine beta globin locus region.",
      "Another study reported the presence of over 50 DHS in the murine beta globin locus region.",
      "The studies mentioned used chromatin immunoprecipitation (ChIP) and DNaseI sequencing to identify DHS."
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "vicuna-7b_response": "Sure, here are some European influenza vaccines:\n1. Fluarix: This is a trivalent influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Yamagata or B/Victoria strain). Fluarix is manufactured by GlaxoSmithKline.\n2. Fluzone: This is a trivalent influenza vaccine that protects against the same three strains of influenza virus as Fluarix. Fluzone is also manufactured by GlaxoSmithKline.\n3. Fluvirin: This is a trivalent influenza vaccine that protects against the same three strains of influenza virus as Fluarix and Fluzone. Fluvirin is manufactured by Seqirus.\n4. Fluad: This is a quadrivalent influenza vaccine that protects against four strains of influenza virus: two A strains (an A/H3N2 strain and an A/H1N1 strain) and two B strains (a B/Victoria strain and a B/Yamagata strain). Fluad is manufactured by Novartis.\n5. FluLaval: This is a trivalent influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Yamagata or B/Victoria strain). FluLaval is manufactured by Sanofi Pasteur.\n6. FluMist: This is a live attenuated influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Victoria strain). FluMist is manufactured by MedImm",
    "vicuna-7b_fact_raw": "1. Fluarix is a trivalent influenza vaccine manufactured by GlaxoSmithKline.\n2. Fluzone is a trivalent influenza vaccine also manufactured by GlaxoSmithKline.\n3. Fluvirin is a trivalent influenza vaccine manufactured by Seqirus.\n4. Fluad is a quadrivalent influenza vaccine manufactured by Novartis.\n5. FluLaval is a trivalent influenza vaccine manufactured by Sanofi Pasteur.",
    "vicuna-7b_fact": [
      "Fluarix is a trivalent influenza vaccine manufactured by GlaxoSmithKline.",
      "Fluzone is a trivalent influenza vaccine also manufactured by GlaxoSmithKline.",
      "Fluvirin is a trivalent influenza vaccine manufactured by Seqirus.",
      "Fluad is a quadrivalent influenza vaccine manufactured by Novartis.",
      "FluLaval is a trivalent influenza vaccine manufactured by Sanofi Pasteur."
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "vicuna-7b_response": "Yes, the Paramyxovirus geneome is segmented and negative-sense RNA.\nParamyxoviruses are a type of virus that infects mammals and birds. They have a single-stranded, negative-sense RNA genome, which means that the nucleotide sequence of the RNA is complementary to that of the virus's mRNA. The negative-sense RNA is synthesized in the nucleus of the infected cell and is then transported to the cytoplasm, where it is translated into proteins by the ribosomes.\nParamyxoviruses are further classified into two genera: Pneumovirinae and Rubulavirinae. Pneumovirinae includes the respiratory syncytial virus (RSV), which is a major cause of respiratory illness in children, and the metapneumovirus, which causes respiratory disease in pigs. Rubulavirinae includes the measles virus, which is a highly contagious disease that causes fever, cough, and rash.\nThe Paramyxovirus genome is segmented, meaning that it is composed of several smaller RNA segments that are produced by the viral RNA-dependent RNA polymerase. These segments are then assembled into a single genome during the replication process. The segmented nature of the Paramyxovirus genome allows the virus to evolve and adapt to new hosts and environments more quickly than a single, continuous genome would.",
    "vicuna-7b_fact_raw": "1. Paramyxoviruses have a single-stranded, negative-sense RNA genome.\n2. The nucleotide sequence of the Paramyxovirus RNA is complementary to that of the virus's mRNA.\n3. Paramyxoviruses infect mammals and birds.\n4. The respiratory syncytial virus (RSV), which causes respiratory illness in children, is classified under the Pneumovirinae genus of Paramyxoviruses.\n5. The measles virus, which causes fever, cough, and rash, is classified under the Rubulavirinae genus of Paramyxoviruses.",
    "vicuna-7b_fact": [
      "Paramyxoviruses have a single-stranded, negative-sense RNA genome.",
      "The nucleotide sequence of the Paramyxovirus RNA is complementary to that of the virus's mRNA.",
      "Paramyxoviruses infect mammals and birds.",
      "The respiratory syncytial virus (RSV), which causes respiratory illness in children, is classified under the Pneumovirinae genus of Paramyxoviruses.",
      "The measles virus, which causes fever, cough, and rash, is classified under the Rubulavirinae genus of Paramyxoviruses."
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "vicuna-7b_response": "Roflumilast cream is a topical medication that is used to treat atopic dermatitis, a chronic inflammatory skin condition that affects the skin and can cause severe itching and rashes. Roflumilast cream works by reducing inflammation and improving the skin barrier function, which helps to prevent further irritation and itching.\nRoflumilast cream is applied to the affected areas of skin twice daily, usually in the morning and evening. It is important to use the medication as directed by your healthcare provider to achieve the best results.\nIt is important to note that Roflumilast cream is not suitable for everyone and may cause side effects such as redness, itching, or dryness at the application site. If you experience any side effects, it is important to inform your healthcare provider.\nIt is also important to consult with your healthcare provider before using Roflumilast cream if you have any underlying medical conditions or are taking any other medications.",
    "vicuna-7b_fact_raw": "1. Roflumilast cream is used to treat atopic dermatitis.\n2. Roflumilast cream works by reducing inflammation and improving skin barrier function.\n3. The cream is typically applied to the affected areas of skin twice daily.\n4. Side effects of Roflumilast cream may include redness, itching, or dryness at the application site.\n5. Consultation with a healthcare provider is recommended before using Roflumilast cream, especially for those with underlying medical conditions or those taking other medications.",
    "vicuna-7b_fact": [
      "Roflumilast cream is used to treat atopic dermatitis.",
      "Roflumilast cream works by reducing inflammation and improving skin barrier function.",
      "The cream is typically applied to the affected areas of skin twice daily.",
      "Side effects of Roflumilast cream may include redness, itching, or dryness at the application site.",
      "Consultation with a healthcare provider is recommended before using Roflumilast cream, especially for those with underlying medical conditions or those taking other medications."
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "vicuna-7b_response": "There are several tools that have been developed for identifying and visualizing ncRNA promoters. Here are some of the most popular ones:\n1. RNAPIII-DB: RNAPIII-DB is a database that provides information about the promoters of RNA polymerase III-transcribed genes, including non-coding RNAs. It provides a comprehensive list of RNA polymerase III promoters, along with their genomic locations and transcription start sites.\n2. ENCODE: ENCODE (Encyclopedia of DNA Elements) is a large-scale project that aims to identify all the functional elements in the human genome. It provides a comprehensive list of non-coding RNA promoters, along with their genomic locations and transcription start sites.\n3. ChIP-seq peaks: ChIP-seq (Chromatin Immunoprecipation Sequencing) is a technique that is used to identify the binding sites of transcription factors and other proteins in the genome. Many tools have been developed to analyze ChIP-seq data, and some of these tools can be used to identify non-coding RNA promoters.\n4. DNase-seq peaks: DNase-seq (DNA Sequencing of Digested Genomic DNA) is a technique that is used to identify the regions of the genome that are accessible to the cell's enzymes. Many tools have been developed to analyze DNase-seq data, and some of these tools can be used to identify non-coding RNA promoters.\n5. Motif-finding tools: Motif-finding tools are software programs that can be used to identify the DNA sequences that are associated with specific transcription factor binding sites. Some of these tools can be used to identify non-coding RNA promoters by identifying the DNA sequences that are associated with RNA polymerase III or other transcription factors that are known to be involved in non-coding RNA transcription.\nOverall, there are many tools available for identifying and visualizing ncRNA promoters. The choice of tool will depend on the specific research question and the type of data that is available.",
    "vicuna-7b_fact_raw": "1. RNAPIII-DB is a database that provides information about the promoters of RNA polymerase III-transcribed genes, including non-coding RNAs.\n2. ENCODE (Encyclopedia of DNA Elements) is a project that aims to identify all functional elements in the human genome and provides information on non-coding RNA promoters.\n3. ChIP-seq is a technique used to identify the binding sites of transcription factors in the genome, and tools developed for ChIP-seq data analysis can identify non-coding RNA promoters.\n4. DNase-seq is a technique used to identify regions of the genome that are accessible to enzymes, and tools developed for DNase-seq data analysis can identify non-coding RNA promoters.\n5. Motif-finding tools are software programs that can identify DNA sequences associated with specific transcription factor binding sites and can be used to identify non-coding RNA promoters.",
    "vicuna-7b_fact": [
      "RNAPIII-DB is a database that provides information about the promoters of RNA polymerase III-transcribed genes, including non-coding RNAs.",
      "ENCODE (Encyclopedia of DNA Elements) is a project that aims to identify all functional elements in the human genome and provides information on non-coding RNA promoters.",
      "ChIP-seq is a technique used to identify the binding sites of transcription factors in the genome, and tools developed for ChIP-seq data analysis can identify non-coding RNA promoters.",
      "DNase-seq is a technique used to identify regions of the genome that are accessible to enzymes, and tools developed for DNase-seq data analysis can identify non-coding RNA promoters.",
      "Motif-finding tools are software programs that can identify DNA sequences associated with specific transcription factor binding sites and can be used to identify non-coding RNA promoters."
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "vicuna-7b_response": "The SWIM tool is a computational tool that uses a combination of gene expression data and protein-protein interaction data to identify genes that are associated with specific biological processes and pathways. The tool has been used to identify genes that are down-regulated in glioblastoma, which is a type of brain cancer.\nSome examples of genes that the SWIM tool has identified as being down-regulated in glioblastoma include:\n* PTEN: PTEN is a tumor suppressor gene that is often inactivated in glioblastoma. It encodes a protein that plays a role in regulating cell growth and survival.\n* TP53: TP53 is a gene that encodes a protein that acts as a tumor suppressor. It is one of the most frequently mutated genes in glioblastoma and is involved in regulating cell growth and division.\n* CDKN2A: CDKN2A is a gene that encodes a protein that is involved in regulating cell growth and division. It is often inactivated in glioblastoma and is a target for therapy.\n* PTEN inducible phosphatase: PTEN inducible phosphatase is a gene that encodes a protein that is involved in regulating cell growth and survival. It is down-regulated in glioblastoma and may play a role in the development of the disease.\nIt's important to note that these are just a few examples of genes that the SWIM tool has identified as being down-regulated in glioblastoma, and that the tool may identify other genes as well. Additionally, it's important to note that the SWIM tool is a computational tool and the results should be validated by other methods.",
    "vicuna-7b_fact_raw": "1. The SWIM tool identified PTEN as a tumor suppressor gene that is often inactivated in glioblastoma.\n2. TP53, a gene that acts as a tumor suppressor, is one of the most frequently mutated genes in glioblastoma.\n3. CDKN2A, a gene involved in regulating cell growth and division, is often inactivated in glioblastoma.\n4. PTEN inducible phosphatase is a gene down-regulated in glioblastoma and may play a role in the development of the disease.\n5. The SWIM tool uses gene expression data and protein-protein interaction data to identify genes associated with specific biological processes and pathways.",
    "vicuna-7b_fact": [
      "The SWIM tool identified PTEN as a tumor suppressor gene that is often inactivated in glioblastoma.",
      "TP53, a gene that acts as a tumor suppressor, is one of the most frequently mutated genes in glioblastoma.",
      "CDKN2A, a gene involved in regulating cell growth and division, is often inactivated in glioblastoma.",
      "PTEN inducible phosphatase is a gene down-regulated in glioblastoma and may play a role in the development of the disease.",
      "The SWIM tool uses gene expression data and protein-protein interaction data to identify genes associated with specific biological processes and pathways."
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "vicuna-7b_response": "There are several R packages that have been developed for studying TADs (transcriptional activity domains). Some of these packages include:\n1. TADs: This package provides a set of functions for analyzing TADs in genomic data. It includes functions for identifying TADs, calculating TAD size, and visualizing TAD patterns.\n2. TADmap: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n3. TADtools: This package provides a set of functions for analyzing TADs in genomic data. It includes functions for identifying TADs, calculating TAD size, and visualizing TAD patterns.\n4. TADview: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n5. TADplot: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n6. TADplotR: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n7. TADplotter: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n8. TADplotterR: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n9. TADviewR: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n10. TADview: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\nThese packages are widely used in the field of genomics and are known for their accuracy and ease of use",
    "vicuna-7b_fact_raw": "1. The R package \"TADs\" includes functions for identifying TADs, calculating TAD size, and visualizing TAD patterns.\n2. \"TADmap\" is an R package that provides functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n3. \"TADtools\" is an R package designed for analyzing TADs, including functions for identifying and visualizing them.\n4. \"TADview\" is an R package that offers functions for visualizing TADs through heatmaps, track plots, and other methods.\n5. \"TADplot\" is an R package that provides visualization functions for TADs in genomic data.",
    "vicuna-7b_fact": [
      "The R package \"TADs\" includes functions for identifying TADs, calculating TAD size, and visualizing TAD patterns.",
      "\"TADmap\" is an R package that provides functions for creating heatmaps, track plots, and other visualizations of TAD patterns.",
      "\"TADtools\" is an R package designed for analyzing TADs, including functions for identifying and visualizing them.",
      "\"TADview\" is an R package that offers functions for visualizing TADs through heatmaps, track plots, and other methods.",
      "\"TADplot\" is an R package that provides visualization functions for TADs in genomic data."
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "vicuna-7b_response": "One bioconductor tool that has been developed for accessing bacterial regulatory networks is the \"BioNetGen\" package. This package allows users to build and analyze regulatory networks for bacteria using a variety of data types, including gene expression data, DNA sequence data, and protein-protein interaction data. The package provides a range of tools for building and analyzing regulatory networks, including tools for identifying regulatory relationships between genes, predicting the effects of mutations on gene expression, and simulating the behavior of regulatory networks under different conditions. Overall, BioNetGen is a powerful tool for studying bacterial regulatory networks and understanding how they contribute to the behavior and function of bacteria.",
    "vicuna-7b_fact_raw": "1. The \"BioNetGen\" package is a bioconductor tool developed for accessing bacterial regulatory networks.\n2. BioNetGen allows users to build and analyze regulatory networks using gene expression data, DNA sequence data, and protein-protein interaction data.\n3. The package includes tools for identifying regulatory relationships between genes.\n4. BioNetGen can predict the effects of mutations on gene expression.\n5. The package can simulate the behavior of regulatory networks under different conditions.",
    "vicuna-7b_fact": [
      "The \"BioNetGen\" package is a bioconductor tool developed for accessing bacterial regulatory networks.",
      "BioNetGen allows users to build and analyze regulatory networks using gene expression data, DNA sequence data, and protein-protein interaction data.",
      "The package includes tools for identifying regulatory relationships between genes.",
      "BioNetGen can predict the effects of mutations on gene expression.",
      "The package can simulate the behavior of regulatory networks under different conditions."
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "vicuna-7b_response": "The shikimate pathway is a metabolic pathway that produces aromatic amino acids, which are the building blocks of proteins. The end products of the shikimate pathway are the aromatic amino acids: phenylalanine, tyrosine, and tryptophan. These amino acids are essential for the growth and survival of all living organisms, including bacteria, archaea, and eukaryotes.\nPhenylalanine is used to produce tyrosine, which is then used to produce the catecholamine neurotransmitters, such as dopamine, norepinephrine, and epinephrine. These neurotransmitters play important roles in the regulation of mood, appetite, and the body's response to stress. Tyrosine is also used to produce L-DOPA, which is used to treat Parkinson's disease.\nTryptophan is used to produce the neurotransmitter serotonin, which is involved in regulating mood, appetite, and sleep. Tryptophan is also used to produce melatonin, which regulates the body's sleep-wake cycle.\nIn summary, the end products of the shikimate pathway are the aromatic amino acids phenylalanine, tyrosine, and tryptophan, which are essential for the growth and survival of all living organisms. These amino acids are used to produce the catecholamine neurotransmitters and the neurotransmitter serotonin, which play important roles in regulating mood, appetite, and sleep.",
    "vicuna-7b_fact_raw": "1. The shikimate pathway produces aromatic amino acids: phenylalanine, tyrosine, and tryptophan.\n2. Phenylalanine is used to produce tyrosine.\n3. Tyrosine is used to produce catecholamine neurotransmitters such as dopamine, norepinephrine, and epinephrine.\n4. Tyrosine is also used to produce L-DOPA, which is used to treat Parkinson's disease.\n5. Tryptophan is used to produce the neurotransmitter serotonin and the hormone melatonin.",
    "vicuna-7b_fact": [
      "The shikimate pathway produces aromatic amino acids: phenylalanine, tyrosine, and tryptophan.",
      "Phenylalanine is used to produce tyrosine.",
      "Tyrosine is used to produce catecholamine neurotransmitters such as dopamine, norepinephrine, and epinephrine.",
      "Tyrosine is also used to produce L-DOPA, which is used to treat Parkinson's disease.",
      "Tryptophan is used to produce the neurotransmitter serotonin and the hormone melatonin."
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "vicuna-7b_response": "Yes, cabergoline is used for the treatment of Nelson's syndrome.\nNelson's syndrome is a rare condition that occurs in patients with a history of prostate cancer and the excessive production of prolactin, a hormone that is responsible for the growth and development of the prostate gland. Cabergoline is a dopamine agonist that is used to reduce the production of prolactin in the body.\nCabergoline is typically used in patients with prostate cancer who have developed Nelson's syndrome as a result of the spread of the cancer to the pituitary gland, which regulates the production of hormones in the body. Cabergoline works by blocking the receptors in the pituitary gland that stimulate the production of prolactin, thereby reducing the levels of prolactin in the blood.\nIn addition to reducing the levels of prolactin, cabergoline can also help to relieve the symptoms of Nelson's syndrome, such as high blood pressure, headaches, and impotence. Cabergoline is usually taken as a daily oral medication, and the dosage may need to be adjusted based on the individual patient's response to the treatment.\nIt is important to note that while cabergoline is effective in treating Nelson's syndrome, it may not be suitable for all patients. Patients with a history of heart disease or stroke, or those who are pregnant or breastfeeding, should not take cabergoline. It is always recommended to consult a healthcare professional before starting any new medication.",
    "vicuna-7b_fact_raw": "1. Cabergoline is used for the treatment of Nelson's syndrome.\n2. Nelson's syndrome is a rare condition that occurs in patients with a history of prostate cancer and excessive production of prolactin.\n3. Cabergoline is a dopamine agonist that reduces the production of prolactin in the body.\n4. Cabergoline works by blocking the receptors in the pituitary gland that stimulate the production of prolactin.\n5. Cabergoline is usually taken as a daily oral medication.",
    "vicuna-7b_fact": [
      "Cabergoline is used for the treatment of Nelson's syndrome.",
      "Nelson's syndrome is a rare condition that occurs in patients with a history of prostate cancer and excessive production of prolactin.",
      "Cabergoline is a dopamine agonist that reduces the production of prolactin in the body.",
      "Cabergoline works by blocking the receptors in the pituitary gland that stimulate the production of prolactin.",
      "Cabergoline is usually taken as a daily oral medication."
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "vicuna-7b_response": "Liebenberg syndrome is a rare genetic disorder characterized by a combination of physical and developmental abnormalities. The main manifestation of Liebenberg syndrome is a set of distinct physical features that are present in most individuals with the condition. These features include:\n1. Short stature: People with Liebenberg syndrome are typically shorter than average, with a height that is below the 3rd percentile for their age.\n2. Craniofacial abnormalities: Liebenberg syndrome is characterized by a distinctive facial appearance, including a broad and flat face, a prominent forehead, and a small jaw.\n3. Brachycephaly: Liebenberg syndrome is also associated with a shortened head circumference, which results in a broad and flat face.\n4. Delayed motor development: Children with Liebenberg syndrome often have delayed motor development, including delayed crawling and walking.\n5. Intellectual disability: Liebenberg syndrome is associated with mild to moderate intellectual disability, which can range from learning difficulties to more significant impairments.\n6. Heart defects: Some individuals with Liebenberg syndrome may have congenital heart defects, such as a hole in the heart (patent foramen ovale) or a narrowing of the valve between the heart and the lungs (pulmonary stenosis).\nIt's important to note that the severity of these symptoms can vary widely among individuals with Liebenberg syndrome, and some people may have only a few of these features. Additionally, some people with Liebenberg syndrome may have other health problems that are not related to the condition.",
    "vicuna-7b_fact_raw": "1. Liebenberg syndrome is a rare genetic disorder.\n2. Individuals with Liebenberg syndrome typically have a height below the 3rd percentile for their age.\n3. Liebenberg syndrome is characterized by craniofacial abnormalities, including a broad and flat face, a prominent forehead, and a small jaw.\n4. Children with Liebenberg syndrome often experience delayed motor development.\n5. Liebenberg syndrome is associated with mild to moderate intellectual disability.",
    "vicuna-7b_fact": [
      "Liebenberg syndrome is a rare genetic disorder.",
      "Individuals with Liebenberg syndrome typically have a height below the 3rd percentile for their age.",
      "Liebenberg syndrome is characterized by craniofacial abnormalities, including a broad and flat face, a prominent forehead, and a small jaw.",
      "Children with Liebenberg syndrome often experience delayed motor development.",
      "Liebenberg syndrome is associated with mild to moderate intellectual disability."
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "vicuna-7b_response": "Sure, here are some oral bioavailable MPS1 kinase inhibitors:\n1. BAY 53-5538 (Nexavar)\n2. TAS-102 (Xeloda)\n3. MK-8628 (Merck)\n4. GSK2879582 (GlaxoSmithKline)\n5. BAY 1439022 (Bayer)\n6. GSK1070885 (GlaxoSmithKline)\n7. MK-8629 (Merck)\n8. BAY 1841285 (Bayer)\n9. GSK2879571 (GlaxoSmithKline)\n10. MK-8627 (Merck)\nNote: This list is not exhaustive and there may be other oral bioavailable MPS1 kinase inhibitors available. It's important to consult with a medical professional for the most up-to-date information on available treatments.",
    "vicuna-7b_fact_raw": "1. BAY 53-5538 is an orally bioavailable MPS1 kinase inhibitor.\n2. TAS-102 is an orally bioavailable MPS1 kinase inhibitor.\n3. MK-8628 is an orally bioavailable MPS1 kinase inhibitor.\n4. GSK2879582 is an orally bioavailable MPS1 kinase inhibitor.\n5. BAY 1439022 is an orally bioavailable MPS1 kinase inhibitor.",
    "vicuna-7b_fact": [
      "BAY 53-5538 is an orally bioavailable MPS1 kinase inhibitor.",
      "TAS-102 is an orally bioavailable MPS1 kinase inhibitor.",
      "MK-8628 is an orally bioavailable MPS1 kinase inhibitor.",
      "GSK2879582 is an orally bioavailable MPS1 kinase inhibitor.",
      "BAY 1439022 is an orally bioavailable MPS1 kinase inhibitor."
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "vicuna-7b_response": "Yes, golimumab, also known as Simponi, has been tested for its potential to cause or worsen diabetes.\nGolimumab is a biologic drug that is used to treat several autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking the action of a protein called tumor necrosis factor (TNF), which is involved in the immune system's response to inflammation.\nThere have been several studies that have investigated the potential for golimumab to cause or worsen diabetes. One study, published in the journal Diabetes Care in 2012, found that golimumab was associated with an increased risk of developing diabetes compared to placebo. The study followed over 1,000 patients with rheumatoid arthritis for one year and found that 1.5% of patients who received golimumab developed diabetes, compared to 0.7% of patients who received placebo.\nAnother study, published in the journal Arthritis Care & Research in 2015, found that golimumab was associated with an increased risk of developing diabetes in patients with psoriatic arthritis. The study followed over 300 patients with psoriatic arthritis for one year and found that 4.3% of patients who received golimumab developed diabetes, compared to 1.5% of patients who received placebo.\nIt is important to note that the risk of developing diabetes with golimumab is generally low, and the drug is still considered a useful treatment option for many patients with autoimmune diseases. However, patients who are at higher risk for diabetes or who have a history of diabetes should be closely monitored while taking golimumab.\nIn summary, golimumab has been tested for its potential to cause or worsen diabetes, and there is some evidence to suggest that it may be associated with an increased risk of developing diabetes. However, the risk is generally low, and golimumab is still considered a useful treatment option for many patients with autoimmune diseases.",
    "vicuna-7b_fact_raw": "1. Golimumab, also known as Simponi, has been tested for its potential to cause or worsen diabetes.\n2. Golimumab is used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.\n3. A study published in the journal Diabetes Care in 2012 found that golimumab was associated with an increased risk of developing diabetes compared to placebo in patients with rheumatoid arthritis.\n4. The same study reported that 1.5% of patients who received golimumab developed diabetes, compared to 0.7% of patients who received placebo.\n5. Another study published in the journal Arthritis Care & Research in 2015 found that 4.3% of patients with psoriatic arthritis who received golimumab developed diabetes, compared to 1.5% of patients who received placebo.",
    "vicuna-7b_fact": [
      "Golimumab, also known as Simponi, has been tested for its potential to cause or worsen diabetes.",
      "Golimumab is used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.",
      "A study published in the journal Diabetes Care in 2012 found that golimumab was associated with an increased risk of developing diabetes compared to placebo in patients with rheumatoid arthritis.",
      "The same study reported that 1.5% of patients who received golimumab developed diabetes, compared to 0.7% of patients who received placebo.",
      "Another study published in the journal Arthritis Care & Research in 2015 found that 4.3% of patients with psoriatic arthritis who received golimumab developed diabetes, compared to 1.5% of patients who received placebo."
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "vicuna-7b_response": "Progeria is a rare genetic disorder that affects children and causes them to age rapidly. It is caused by a mutation in the LMNA gene, which is located on chromosome 18. This mutation results in the production of a defective protein called lamin A, which is responsible for maintaining the structure of the cell's nucleus.\nThe LMNA gene is inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated gene, one from each parent, to develop progeria. If a child only inherits one copy of the mutated gene from one parent, they will not develop progeria but will be a carrier of the condition.\nProgeria is a very rare disorder, affecting only about 1 in every 4-8 million children born worldwide. Despite its rarity, progeria has gained significant attention due to the efforts of the Progeria Research Foundation, which was founded in 1999 to support research into the condition and find a cure.",
    "vicuna-7b_fact_raw": "1. Progeria is caused by a mutation in the LMNA gene.\n2. The LMNA gene is located on chromosome 18.\n3. The mutation in the LMNA gene results in the production of a defective protein called lamin A.\n4. The LMNA gene is inherited in an autosomal recessive pattern.\n5. Progeria affects about 1 in every 4-8 million children born worldwide.",
    "vicuna-7b_fact": [
      "Progeria is caused by a mutation in the LMNA gene.",
      "The LMNA gene is located on chromosome 18.",
      "The mutation in the LMNA gene results in the production of a defective protein called lamin A.",
      "The LMNA gene is inherited in an autosomal recessive pattern.",
      "Progeria affects about 1 in every 4-8 million children born worldwide."
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "vicuna-7b_response": "Common variants at 12q14 and 12q24 have been associated with various traits and diseases.\nAt 12q14, a region known as 12q14.11 has been associated with several traits and diseases. One of the most well-known associations is with schizophrenia, where variants in this region have been found to be associated with an increased risk of developing the disorder. Other associations include with bipolar disorder, autism, and attention deficit hyperactivity disorder (ADHD).\nAt 12q24, a region known as 12q24.31 has been associated with several traits and diseases. One of the most well-known associations is with Alzheimer's disease, where variants in this region have been found to be associated with an increased risk of developing the disorder. Other associations include with type 2 diabetes, obesity, and cardiovascular disease.\nIt's important to note that these associations are complex and may be influenced by multiple genetic and environmental factors. Further research is needed to fully understand the role of these variants in disease development and to identify potential therapeutic targets.",
    "vicuna-7b_fact_raw": "1. Variants at 12q14 have been associated with an increased risk of developing schizophrenia.\n2. The 12q14 region has also been linked to bipolar disorder, autism, and ADHD.\n3. Variants at 12q24 have been associated with an increased risk of developing Alzheimer's disease.\n4. The 12q24 region has also been linked to type 2 diabetes, obesity, and cardiovascular disease.\n5. The associations between these genetic variants and diseases are influenced by multiple genetic and environmental factors.",
    "vicuna-7b_fact": [
      "Variants at 12q14 have been associated with an increased risk of developing schizophrenia.",
      "The 12q14 region has also been linked to bipolar disorder, autism, and ADHD.",
      "Variants at 12q24 have been associated with an increased risk of developing Alzheimer's disease.",
      "The 12q24 region has also been linked to type 2 diabetes, obesity, and cardiovascular disease.",
      "The associations between these genetic variants and diseases are influenced by multiple genetic and environmental factors."
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "vicuna-7b_response": "The Roundabout (Robo) receptors are G protein-coupled receptors that play a role in the guidance of axon growth and pathfinding during development. They are expressed in various tissues, including the nervous system, and are involved in the regulation of cell adhesion, migration, and differentiation.\nThe ligands of the Roundabout receptors are various proteins and peptides, including:\n1. Slit: Slit is a transmembrane protein that is expressed in the ventral nerve cord of Drosophila and is a potent ligand for Roundabout receptors. It is involved in the guidance of nerve cell axons during development.\n2. Netrin: Netrin is a family of proteins that are expressed in various tissues and are involved in the guidance of various types of neurons. Netrin-1 and Netrin-3 are potent ligands for Roundabout receptors and are involved in the guidance of motor neurons in the spinal cord.\n3. Neurturin: Neurturin is a protein that is expressed in the developing nervous system and is a potent ligand for Roundabout receptors. It is involved in the guidance of motor neurons in the spinal cord.\n4. L1CAM: L1CAM is a cell adhesion molecule that is expressed in various tissues and is a potent ligand for Roundabout receptors. It is involved in the guidance of axons in the developing nervous system.\n5. Semaphorin: Semaphorin is a family of proteins that are involved in the guidance of various types of neurons. Semaphorin 3A is a potent ligand for Roundabout receptors and is involved in the guidance of sensory neurons in the peripheral nervous system.\nOverall, the ligands of the Roundabout receptors are involved in the regulation of cell adhesion, migration, and differentiation, and play a crucial role in the guidance of axon growth and pathfinding during development.",
    "vicuna-7b_fact_raw": "1. Slit is a ligand for Roundabout receptors and is involved in axon guidance during development.\n2. Netrin-1 and Netrin-3 are ligands for Roundabout receptors and are involved in the guidance of motor neurons in the spinal cord.\n3. Neurturin is a ligand for Roundabout receptors and is involved in the guidance of motor neurons in the spinal cord.\n4. L1CAM is a ligand for Roundabout receptors and is involved in axon guidance in the developing nervous system.\n5. Semaphorin 3A is a ligand for Roundabout receptors and is involved in the guidance of sensory neurons in the peripheral nervous system.",
    "vicuna-7b_fact": [
      "Slit is a ligand for Roundabout receptors and is involved in axon guidance during development.",
      "Netrin-1 and Netrin-3 are ligands for Roundabout receptors and are involved in the guidance of motor neurons in the spinal cord.",
      "Neurturin is a ligand for Roundabout receptors and is involved in the guidance of motor neurons in the spinal cord.",
      "L1CAM is a ligand for Roundabout receptors and is involved in axon guidance in the developing nervous system.",
      "Semaphorin 3A is a ligand for Roundabout receptors and is involved in the guidance of sensory neurons in the peripheral nervous system."
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "vicuna-7b_response": "Yes, TFII-I plays a role in megakaryopoiesis. TFII-I is a transcription factor that is involved in the regulation of gene expression. In the process of megakaryopoiesis, TFII-I is recruited to the promoter region of the genes that are involved in the differentiation of megakaryocytes. TFII-I helps to activate the transcription of these genes, which is necessary for the proper development of megakaryocytes.\nMegakaryocytes are a type of blood cell that are responsible for producing platelets. Platelets are important for blood clotting and for preventing bleeding. In order for megakaryocytes to differentiate and become fully functional platelets, they must undergo a process called maturation. This process is regulated by a number of different genes, and TFII-I plays a role in the regulation of these genes.\nOverall, TFII-I is an important factor in the development and maturation of megakaryocytes, and is therefore involved in the process of megakaryopoiesis.",
    "vicuna-7b_fact_raw": "1. TFII-I is a transcription factor involved in the regulation of gene expression.\n2. TFII-I is recruited to the promoter region of genes involved in the differentiation of megakaryocytes during megakaryopoiesis.\n3. TFII-I activates the transcription of genes necessary for the proper development of megakaryocytes.\n4. Megakaryocytes are a type of blood cell responsible for producing platelets.\n5. Platelets are important for blood clotting and preventing bleeding.",
    "vicuna-7b_fact": [
      "TFII-I is a transcription factor involved in the regulation of gene expression.",
      "TFII-I is recruited to the promoter region of genes involved in the differentiation of megakaryocytes during megakaryopoiesis.",
      "TFII-I activates the transcription of genes necessary for the proper development of megakaryocytes.",
      "Megakaryocytes are a type of blood cell responsible for producing platelets.",
      "Platelets are important for blood clotting and preventing bleeding."
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "vicuna-7b_response": "Yes, atenolol is metabolized by CYP2D6. Atenolol is a beta-blocker medication that is used to treat hypertension, angina, and heart failure. It is a substrate of CYP2D6, which is an enzyme that is responsible for the metabolism of a number of drugs, including beta-blockers.\nCYP2D6 is a polymorphic enzyme, which means that it can vary in its activity among individuals. Some people have two copies of the active form of the enzyme (extensive metabolizers), while others have one copy of the active form and one copy of a less active form (intermediate metabolizers), and still others have two copies of the less active form (poor metabolizers). This can affect the rate at which atenolol is metabolized and can lead to variations in the efficacy and side effects of the medication.\nIn summary, atenolol is metabolized by CYP2D6, which is an enzyme that is responsible for the metabolism of a number of drugs, including beta-blockers. The metabolism of atenolol can be affected by the activity of CYP2D6, which can vary among individuals.",
    "vicuna-7b_fact_raw": "1. Atenolol is metabolized by the enzyme CYP2D6.\n2. Atenolol is used to treat hypertension, angina, and heart failure.\n3. CYP2D6 is responsible for the metabolism of various drugs, including beta-blockers.\n4. CYP2D6 is a polymorphic enzyme, meaning its activity can vary among individuals.\n5. Variations in CYP2D6 activity can affect the rate at which atenolol is metabolized.",
    "vicuna-7b_fact": [
      "Atenolol is metabolized by the enzyme CYP2D6.",
      "Atenolol is used to treat hypertension, angina, and heart failure.",
      "CYP2D6 is responsible for the metabolism of various drugs, including beta-blockers.",
      "CYP2D6 is a polymorphic enzyme, meaning its activity can vary among individuals.",
      "Variations in CYP2D6 activity can affect the rate at which atenolol is metabolized."
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "vicuna-7b_response": "ExpansionHunter is a tool that allows users to monitor and analyze the performance of their Expansion Tanks. It provides real-time data on the temperature, pressure, and volume of the water in the tank, as well as alerts for any potential issues.\nThere are several versions of ExpansionHunter available, including:\n1. ExpansionHunter Pro: This version is designed for commercial and industrial applications, and provides advanced features such as remote monitoring and alerts, customizable alert thresholds, and data export options.\n2. ExpansionHunter Lite: This version is a simplified version of ExpansionHunter Pro, and is designed for residential use. It provides basic features such as temperature and pressure monitoring, and alerts for potential issues.\n3. ExpansionHunter Cloud: This version allows users to access their ExpansionHunter data and alerts from anywhere, using a web browser or mobile device. It also provides advanced features such as remote monitoring and alerts, and data export options.\n4. ExpansionHunter API: This version allows users to integrate ExpansionHunter data and alerts into their existing systems, using an API. It provides advanced features such as customizable alert thresholds, and data export options.\nOverall, ExpansionHunter is a powerful tool that provides real-time data and alerts for Expansion Tanks, allowing users to monitor and optimize the performance of their systems.",
    "vicuna-7b_fact_raw": "1. ExpansionHunter Pro is designed for commercial and industrial applications.\n2. ExpansionHunter Lite is designed for residential use.\n3. ExpansionHunter Cloud allows users to access data and alerts from anywhere using a web browser or mobile device.\n4. ExpansionHunter API allows integration of data and alerts into existing systems using an API.",
    "vicuna-7b_fact": [
      "ExpansionHunter Pro is designed for commercial and industrial applications.",
      "ExpansionHunter Lite is designed for residential use.",
      "ExpansionHunter Cloud allows users to access data and alerts from anywhere using a web browser or mobile device.",
      "ExpansionHunter API allows integration of data and alerts into existing systems using an API."
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "vicuna-7b_response": "Adamts18, also known as adamalysin-like protein 18, is a protein that has been shown to play a role in hormone receptor signaling. Specifically, Adamts18 has been shown to regulate the activity of estrogen receptors, which are a type of hormone receptor that plays a key role in the development and progression of breast cancer.\nResearch has shown that Adamts18 can interact with estrogen receptors and affect their activity. For example, one study found that Adamts18 can inhibit the transcriptional activity of estrogen receptors by promoting their degradation. This can potentially help to regulate the levels of estrogen receptors in the body and prevent the development of breast cancer.\nAdditionally, Adamts18 has been shown to play a role in the regulation of other hormone receptors, such as androgen receptors and progesterone receptors. However, the exact mechanisms by which Adamts18 regulates these receptors are not fully understood.\nOverall, while more research is needed to fully understand the role of Adamts18 in hormone receptor signaling, it is clear that this protein plays an important role in regulating the activity of hormone receptors and potentially affecting the development and progression of certain types of cancer.",
    "vicuna-7b_fact_raw": "1. Adamts18 is known to play a role in hormone receptor signaling.\n2. Adamts18 has been shown to regulate the activity of estrogen receptors.\n3. Estrogen receptors are involved in the development and progression of breast cancer.\n4. Adamts18 can inhibit the transcriptional activity of estrogen receptors by promoting their degradation.\n5. Adamts18 is also involved in the regulation of other hormone receptors, such as androgen receptors and progesterone receptors.",
    "vicuna-7b_fact": [
      "Adamts18 is known to play a role in hormone receptor signaling.",
      "Adamts18 has been shown to regulate the activity of estrogen receptors.",
      "Estrogen receptors are involved in the development and progression of breast cancer.",
      "Adamts18 can inhibit the transcriptional activity of estrogen receptors by promoting their degradation.",
      "Adamts18 is also involved in the regulation of other hormone receptors, such as androgen receptors and progesterone receptors."
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "vicuna-7b_response": "Thiazovivin is a chemical compound that is used as an insecticide. It works by disrupting the central nervous system of insects, leading to paralysis and death. Thiazovivin is a systemic insecticide, which means that it moves through the plant and is taken up by the roots, leaves, and other parts of the plant. This allows the insecticide to protect the entire plant, including any insects that may be feeding on it. Thiazovivin is commonly used to control a wide range of pests, including aphids, thrips, whiteflies, and spider mites. It is also used as a seed treatment to protect young plants from pests and diseases.",
    "vicuna-7b_fact_raw": "1. Thiazovivin is used as an insecticide.\n2. Thiazovivin disrupts the central nervous system of insects, leading to paralysis and death.\n3. Thiazovivin is a systemic insecticide, meaning it is absorbed by plants and moves through roots, leaves, and other parts.\n4. Thiazovivin is used to control pests such as aphids, thrips, whiteflies, and spider mites.\n5. Thiazovivin can be used as a seed treatment to protect young plants from pests and diseases.",
    "vicuna-7b_fact": [
      "Thiazovivin is used as an insecticide.",
      "Thiazovivin disrupts the central nervous system of insects, leading to paralysis and death.",
      "Thiazovivin is a systemic insecticide, meaning it is absorbed by plants and moves through roots, leaves, and other parts.",
      "Thiazovivin is used to control pests such as aphids, thrips, whiteflies, and spider mites.",
      "Thiazovivin can be used as a seed treatment to protect young plants from pests and diseases."
    ]
  }
]